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The thesis investigates approaches to estimating productivity costs in economic evaluation, 
focusing on application of the friction cost approach (FCA) using low back pain as a case 
study. Individual studies of validating a Single-Item Presenteeism Question (SIPQ), 
estimation of the friction period by occupation in the United Kingdom (UK), and comparison 
of sickness certification records with self-reported data are reported. Further, the thesis 
explores the impact of the approaches on cost-effectiveness estimates using the FCA.  
 
Results suggest SIPQ is a valid and responsive measure, and that self-reported data provides 
more complete data than sickness certification records. Stratified friction periods estimates 
were used in the FCA approach to generate absenteeism costs. This is the first time the FCA 
is used in a cost effectiveness study to report productivity costs, presenteeism, 
compensation mechanisms and multiplier effects in UK. In this case study, consideration of 
full productivity costs and applying detailed friction periods did not alter interpretation of 
the cost-effectiveness estimates.  
 
Further testing of these approaches in the UK is required, considering growing evidence and 
merit for accurate estimates of productivity costs. Overall, the research contributes to 
methods for assessing productivity in economic evaluation, and further illustrates the 































This thesis has benefited significantly from the support and guidance of my supervisors, 
Pelham Barton, Joanna Coast, Sue Jowett, and Martyn Lewis. I deeply appreciate their 
commitment, leadership, insightful guidance and technical expertise throughout this 
doctoral research process. I am particularly grateful for the time they dedicated to reading, 
advising, challenging and discussing this work throughout the period of my research.  
 
The work presented in the thesis was supported by the Arthritis Research UK Primary Care 
Centre Doctoral Research Award as part of an NIHR programme of work funded through 
Keele University. I would like to acknowledge the funders and colleagues associated with the 
Keele University primary care and health sciences who provided important support during 
the PhD: Particular thanks go to Martyn Lewis and David Whitehurst. 
 
I would also like to thank my colleagues in the Health Economics Unit, for their support. To 
my colleagues and friends, Lazaros, Raymond, Kennedy, Anita, Lillian and others with whom I 
discussed aspects of my PhD and who commented on chapters, thank you.  
 
Many thanks to the brethren and special friends at the Deeper Life Bible Church, and in the 
Deeper Life Campus Fellowship, thank you all for your constant encouragement, support and 
prayers through this challenging PhD experience. A special thank you to Mum, Dad, and all 
my siblings, I love you all and I know you all can’t wait for this to end so you can have more 
of me! 
 
Finally, all I am, and all I have, I give the glory to the most High God. Thank You for Your 







I declare that the work presented in this thesis was carried out in accordance with the 
requirements of the University of Birmingham. The work is original, except where indicated 
in the write-up.  No part of this thesis has been submitted for any other academic award.  
 
 





















CHAPTER ONE INTRODUCTION .......................................................................................... 1 
1.1 Background ........................................................................................................................... 1 
1.2 The case of low back pain ..................................................................................................... 5 
1.3 Productivity costs issues addressed in this thesis ................................................................ 6 
1.4 Structure of the PhD thesis................................................................................................... 7 
CHAPTER TWO ECONOMICS AND LOST PRODUCTIVITY .................................................... 11 
2.1 Introduction ........................................................................................................................ 11 
2.2 Theoretical foundations of economic evaluation .............................................................. 11 
2.2.1 Welfare economics and extra-welfarism ......................................................... 12 
2.3 Economic Evaluation Theory and Practice .................................................................... 15 
2.3.1 Cost-minimisation analysis (CMA) ....................................................................... 16 
2.3.2 Cost-effectiveness analysis (CEA) ........................................................................ 16 
2.3.3 Cost-utility analysis (CUA) ................................................................................... 17 
2.3.4 Cost-benefit analysis (CBA) .................................................................................. 18 
2.3.5 Cost-consequence analysis (CCA) ........................................................................ 19 
2.4 Decision making in economic evaluation: the threshold approach ................................... 20 
2.5 Defining productivity costs ................................................................................................. 23 
2.6 Considerations for including productivity costs in economic evaluations ......................... 25 
2.6.1 Normative foundations ....................................................................................... 25 
2.6.2 The choice of perspective .................................................................................... 26 
2.6.3 Ethical implications .............................................................................................. 28 
2.7 Key factors influencing productivity costs .......................................................................... 30 
2.7.1 Absence from work (absenteeism) ..................................................................... 30 
2.7.2 Reduced productivity at work (presenteeism) .................................................... 30 
2.7.3 Compensation mechanisms and multiplier effects ............................................. 31 
2.8 Measurement of paid lost productivity: theory and practice ............................................ 31 
2.8.1 Measurement: Absenteeism ............................................................................... 31 
2.8.2 Measurement: Presenteeism .............................................................................. 33 
2.8.3 Measurement: Compensation mechanisms and multiplier effects .................... 34 
2.8.4 Summary of measurement approaches .............................................................. 35 
2.9 Valuation approaches for paid lost productivity ................................................................ 36 
2.9.1 Valuation of Absenteeism ................................................................................... 36 
2.9.2 Valuation of presenteeism .................................................................................. 44 
2.10 Summary and conclusions: unresolved issues in estimation of productivity costs ......... 45 
2.10.1 Progress to date ................................................................................................. 45 
2.10.2 Discussion of unresolved measurement and valuation issues .......................... 46 
2.10.3 Overall conclusion ............................................................................................. 48 
CHAPTER THREE ASSESSMENT OF THE FRICTION COST APPROACH IN PRACTICE: A 
SYSTEMATIC REVIEW ....................................................................................................... 49 
3.1 Introduction ........................................................................................................................ 49 
 
 
3.2 Methods .............................................................................................................................. 50 
3.2.1 Search strategy .................................................................................................... 50 
3.2.2 Inclusion and exclusion criteria ........................................................................... 51 
3.2.3 Data selection and extraction .............................................................................. 51 
3.3 Results................................................................................................................................. 54 
3.3.1 Study selection .................................................................................................... 54 
3.3.2 Overview of the Studies ...................................................................................... 54 
3.3.3 Methodological aspects of valuing productivity costs ........................................ 58 
3.4 Discussion ........................................................................................................................... 68 
3.5 Conclusion .......................................................................................................................... 72 
CHAPTER FOUR LITERATURE REVIEW OF REDUCED PRODUCTIVITY AT WORK 
(PRESENTEEISM) MEASURES AND THEIR INCLUSION IN ECONOMIC EVALUATION STUDIES
 ....................................................................................................................................... 74 
4.1 Introduction ........................................................................................................................ 74 
4.2 Background to review ......................................................................................................... 74 
4.3 Methods .............................................................................................................................. 75 
4.3.1 Search strategy .................................................................................................... 75 
4.3.2 Inclusion and exclusion criteria ........................................................................... 77 
4.3.3 Data extraction strategy ...................................................................................... 77 
4.4 Results................................................................................................................................. 80 
4.4.1 Characteristics of the scoping review .................................................................. 84 
4.4.2 The assessment of presenteeism costs in practice ............................................. 85 
4.4.3 Monetary estimates of presenteeism in current practice .................................. 95 
4.5 Discussion ........................................................................................................................... 97 
4.6 Conclusion ........................................................................................................................ 102 
CHAPTER FIVE AN OVERVIEW OF THE CLINICAL AREA ..................................................... 103 
5.1 Introduction ...................................................................................................................... 103 
5.2 What is Low back pain? .................................................................................................... 103 
5.3 Epidemiology of low back pain ......................................................................................... 104 
5.3.1 Types of non-specific low back pain (NSLBP) .................................................... 104 
5.3.2 Prevalence of low back pain .............................................................................. 104 
5.3.3 Incidence of low back pain ................................................................................ 106 
5.3.4 Identification of low back pain .......................................................................... 106 
5.3.5 Aetiology of low back pain ................................................................................ 107 
5.4 Management of low back pain ......................................................................................... 110 
5.4.1 Introduction ....................................................................................................... 110 
5.4.2 An overview of current national treatment guidelines ..................................... 111 
5.4.3 Currently available interventions for managing non-specific low back pain .... 112 
5.4.4 Subgrouping of low back pain patients ............................................................. 119 
5.5 Assessing the economic burden of back pain .................................................................. 121 
5.6 Cost of low back pain ........................................................................................................ 122 
5.7 The study data sets ........................................................................................................... 126 
5.7.1. Intervention Study 1: The STarT Back trial ....................................................... 127 
 
 
5.7.2. Intervention Study 2: The IMPaCT Back study ................................................. 130 
5.8 Conclusion ........................................................................................................................ 132 
CHAPTER SIX ESTIMATING A FRICTION PERIOD FOR THE UK ........................................... 134 
6.1 Introduction ...................................................................................................................... 134 
6.2 Rationale ........................................................................................................................... 134 
6.3 Data and Background ....................................................................................................... 136 
6.4 Methodology .................................................................................................................... 138 
6.4.1 Standardising vacancy duration definition ........................................................ 139 
6.4.2 Occupational categories .................................................................................... 139 
6.4.3 Measuring the average duration to fill a vacancy – Data sources .................... 141 
6.4.4 Weighting friction period estimates for national level data ............................. 147 
6.4.5 Work-related questionnaire used in the studies............................................... 148 
6.4.6 Identifying a friction period in the data sets ..................................................... 149 
6.5 Results: Estimating a friction period for the UK ............................................................... 150 
6.5.1 Vacancy duration ............................................................................................... 150 
6.6 Feasibility of using sickness certification records to identify work absence in economic 
evaluation ............................................................................................................................... 156 
6.6.1 Population of the sample .................................................................................. 157 
6.6.2 Measurement and analysis ............................................................................... 158 
6.7 Results............................................................................................................................... 159 
6.7.1 Characteristics of the data sources ................................................................... 159 
6.7.2 Summary of self-reported absence and sickness certificates measures .......... 159 
6.7.3 Overall agreement between the electronic medical records and self-report .. 160 
6.7.4 Association between self-report and sickness certification absence episodes 
using the inter rater kappa ......................................................................................... 161 
6.8 Discussion ......................................................................................................................... 162 
6.8.1 Estimation of a friction period for the UK ......................................................... 162 
6.8.2 Feasibility of using sickness certification records in identifying friction periods
 167 
6.9 Conclusions ....................................................................................................................... 171 
CHAPTER SEVEN CONSTRUCT VALIDITY AND RESPONSIVENESS OF THE SINGLE-ITEM 
PRESENTEEISM QUESTION IN PATIENTS WITH LOWER BACK PAIN .................................. 174 
7.1 Introduction ...................................................................................................................... 174 
7.2 Rationale ........................................................................................................................... 174 
7.3 Psychometric testing of outcome measures .................................................................... 177 
7.4 Methods ............................................................................................................................ 178 
7.4.1 Study population and design ............................................................................. 178 
7.4.2 Patient reported outcome measures ................................................................ 178 
7.4.3 Analysis .............................................................................................................. 183 
7.4.4 Validity ............................................................................................................... 183 
7.4.5 Responsiveness and sensitivity to change ........................................................ 187 
7.5 Results............................................................................................................................... 190 
7.5.1 Participant Characteristics ................................................................................. 190 
 
 
7.5.2 Reduced Productivity – Presenteeism ............................................................... 192 
7.5.3 Construct Validity .............................................................................................. 192 
7.5.4 Responsiveness .................................................................................................. 197 
7.6 Discussion ......................................................................................................................... 199 
7.7 Conclusion ........................................................................................................................ 204 
CHAPTER EIGHT : COST-UTILITY ANALYSES OF STRATIFIED MANAGEMENT CARE 
INTERVENTIONS TARGETED AT LBP PATIENTS: THE SBT AND IBS EVALUATIONS ............. 205 
8.1 Introduction ............................................................................................................. 205 
8.2 Approaches to productivity assessment..................................................................... 207 
8.2.1 Work-related outcomes .................................................................................... 207 
8.2.2 Valuation of productivity costs .......................................................................... 208 
8.3 Methods 1: STarT Back Study .................................................................................... 215 
8.3.1 Study design ...................................................................................................... 215 
8.3.2 Outcomes for economic analysis ....................................................................... 215 
8.3.3 Health outcomes ............................................................................................... 216 
8.3.4 Healthcare resource use and costs ................................................................... 216 
8.4 Methods 2: IMPaCT Back Study ................................................................................ 217 
8.4.1 Study design ...................................................................................................... 217 
8.4.2 Outcomes for economic analysis ....................................................................... 217 
8.4.3 Health outcomes ............................................................................................... 217 
8.4.4 Healthcare resource use and costs ................................................................... 218 
8.5 Analytic methods ..................................................................................................... 218 
8.5.1 Missing data ....................................................................................................... 218 
8.5.2 Exploring variations in cost and work outcomes between groups ................... 219 
8.5.3 Cost-Utility analysis ........................................................................................... 219 
8.5.4 Sensitivity Analysis ............................................................................................. 221 
8.6 Results 1:  The STarT Back Trial ................................................................................ 222 
8.6.1 Study population ............................................................................................... 222 
8.6.2 Work-related outcomes .................................................................................... 222 
8.6.3 Productivity Costs: The human capital method ................................................ 223 
8.6.4 Productivity costs: Methodological applications of the friction cost approach 224 
8.6.5 SBT Friction cost approach: Impact of absenteeism, presenteeism and multiplier 
effects. ........................................................................................................................ 226 
8.6.6 SBT Friction cost approach: Impact of absenteeism, presenteeism and multiplier 
effects in subgroup analysis. ...................................................................................... 227 
8.6.7 Cost-utility analysis ............................................................................................ 230 
8.6.8 Cost-effectiveness planes – overall healthcare and societal cost perspective . 232 
8.6.9 Cost-effectiveness planes for the subgroup analysis ........................................ 234 
8.6.10 Healthcare perspective cost-effectiveness acceptability curves (CEACs) ....... 239 
8.6.11 Societal cost perspective CEACs: overall analysis ........................................... 239 
8.6.12 Healthcare and societal cost perspective CEACs for the stratified analysis ... 240 
8.6.13 Sensitivity Analysis ........................................................................................... 245 




8.7 Results 2: The IMPaCT Back study ............................................................................ 248 
8.7.1 Study population ............................................................................................... 248 
8.7.2 Work-related outcomes .................................................................................... 248 
8.7.3 Productivity costs: Human capital method related costs ................................. 249 
8.7.4 Methodological applications of the friction cost approach .............................. 250 
8.7.5 IBS Friction cost approach: Impact of absenteeism, presenteeism and multiplier 
effects ......................................................................................................................... 252 
8.7.6 IBS Friction cost approach: Impact of absenteeism, presenteeism and multiplier 
effects in subgroup analysis ....................................................................................... 253 
8.7.7 Estimation of the cost-utility analysis from a societal perspective ................... 256 
8.7.8 Cost-utility planes – overall healthcare and societal cost perspective ............. 258 
8.7.9 Cost-effectiveness planes for the subgroup analysis ........................................ 260 
8.7.10 Healthcare and societal cost perspective cost-effectiveness acceptability 
curves (CEACs) ............................................................................................................ 265 
8.7.11 Cost-effectiveness acceptability curves (CEACs) for the subgroup analysis ... 266 
8.7.12 Sensitivity Analysis ........................................................................................... 271 
8.7.13 Sensitivity analysis on cost-utility estimates ................................................... 272 
8.8 Discussion ......................................................................................................................... 274 
8.9 Conclusion .......................................... 283Chapter Nine GENERAL DISCUSSION AND CONCLUSIONS
 ..................................................................................................................................................................... 285 
9.1 Introduction ...................................................................................................................... 285 
9.2 Issues addressed in this thesis .......................................................................................... 286 
9.3 Comparison with other contributions .............................................................................. 293 
9.4 Strengths of the research ................................................................................................. 295 
9.5 Limitations of the research ............................................................................................... 296 
9.6 Implications for future research ....................................................................................... 299 
9.7 Implications for policy ...................................................................................................... 302 
9.8 Conclusion ........................................................................................................................ 303 
Appendix A.1 Chapter Three systematic review search strategies .................................... 306 
Appendix A.2 Chapter Three references for individual studies identified .......................... 307 
Appendix B.1 Chapter Four systematic review search strategies ...................................... 311 
Appendix B.2 Chapter Four references for individual studies identified ............................ 312 
Appendix C.1 ................................................................................................................. 314 
C.1.1 Healthcare resource use for the  STarT Back Trial ............................................ 314 
C.1.2 Unit costs for the STarT Back Trial..................................................................... 315 
Appendix C.2 ................................................................................................................. 316 
C.2.1 Healthcare resource use for the IMPaCT Back study ........................................ 316 
C.2.2 Unit costs for the IMPaCT Back Trial ................................................................. 317 







LIST OF TABLES 
Table 3:1 Summary of disease conditions identified ............................................................................................. 55 
Table 3:2 Summary of the studies included in this review .................................................................................... 56 
Table 3:3 Detailed extractions of friction cost approach methodological details ................................................. 60 
Table 4:1 Summary of productivity loss instruments from literature review ....................................................... 81 
Table 4:2 Summary of economic costing studies from review .............................................................................. 86 
Table 4:3 Summary of productivity loss instruments identified from the systematic review assessing ............... 91 
Table 5:1 Selected cost-of-illness national total cost estimates for low back pain ............................................. 123 
Table 5:2 Summary of the data sets and study design ........................................................................................ 127 
Table 6:1 Friction period estimates for UK in months (number), by occupational level, for 2009-2011 – DLA 
Piper dataset .............................................................................................................................................. 151 
Table 6:2 Friction period estimates for UK in months (number), by occupational level, for 2007-2009 CIPD ... 152 
Table 6:3 Friction period estimates for UK in months, by occupational level, for 2007-2011 (Based on vacancies 
filled by job centre plus and alternative recruitment channels) ONS ........................................................ 153 
Table 6:4 Estimated friction period in months, by occupational level, for 2009-2011 (Based on vacancies filled 
by the University of Birmingham) UoB ...................................................................................................... 154 
Table 6:5 Self-reported absence from work for employment patients ............................................................... 159 
Table 6:6 Sickness certificates issued during study period ................................................................................. 160 
Table 6:7 Agreement of self-reported work absence with sickness certificates for the study datasets ............. 161 
Table 7:1 Summary of patient outcomes and instruments used in the SBT and IBS Studies .............................. 179 
Table 7:2 Characteristics of patients employed at baseline assessment. ........................................................... 190 
Table 7:3 Reduced productivity for patients with back pain at baseline and Follow-up .................................... 192 
Table 7:4 Construct validity: correlations between the SIPQ and other constructs at baseline and follow-up .. 194 
Table 7:5 Known-group validity of the SIPQ among risk groups at baseline and follow-up ............................... 196 
Table 7:6 Longitudinal construct validity correlations between the SIPQ and pain, disability, psychological, 
general and quality of life measures .......................................................................................................... 197 
Table 7:7 Responsiveness of the SIPQ change scores by proxy measures (given by global change in condition of 
back pain variable and RMDQ>30% criterion) ........................................................................................... 198 
 
 
Table 7:8 Mean change in presenteeism for the single-item question among back pain patients based on the 
change in back pain condition 6 point severity question. ......................................................................... 199 
Table 8:1 Average multiplier estimates per job category for Absenteeism and presenteeism .......................... 209 
Table 8:2 Comparison of overall work-related outcomes for participants in paid employment between the two 
study arms ................................................................................................................................................. 223 
Table 8:3 Comparison of risk-group work-related outcomes for participants in paid employment between the 
two study groups ....................................................................................................................................... 225 
Table 8:4 Back pain mean (SD) societal costs per patient and year for patients reporting resource utilisation 
data ............................................................................................................................................................ 227 
Table 8:5 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Low-risk ............................................................................................................................ 228 
Table 8:6 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Medium-risk ..................................................................................................................... 229 
Table 8:7 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: High-risk category ............................................................................................................ 230 
Table 8:8 Incremental societal costs and incremental QALYs: Point estimates for the SBT base-case analysis . 232 
Table 8:9 Mean cost differences, mean QALY differences, incremental cost-effectiveness ratios from varying 
friction periods and corresponding three sensitivity analyses (SA1, SA2 and SA3) ................................... 247 
Table 8:10 Comparison of overall work-related outcomes for participants in paid employment (work status, 
absenteeism and presenteeism loss) between the two study arms ......................................................... 249 
Table 8:11 Comparison of work-related outcomes for participants in paid employment (work status, 
absenteeism and presenteeism loss) between the two groups ................................................................ 251 
Table 8:12 Back pain mean (SD) societal costs per patient and year for patients reporting resource utilisation 
data: Overall analysis ................................................................................................................................. 253 
Table 8:13 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Low-risk ............................................................................................................................ 254 
Table 8:14 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Medium-risk ..................................................................................................................... 255 
 
 
Table 8:15 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: High-risk ........................................................................................................................... 256 
Table 8:16 Incremental societal costs and incremental QALYs: Point estimates incorporating absenteeism and 
presenteeism for the IBS base-case analysis ............................................................................................. 258 
Table 8:17 Mean cost differences, mean QALY differences, incremental cost-effectiveness ratios from varying 






















LIST OF FIGURES 
Figure 3:1 Flow diagram showing study selection for review of FCA application ................................................. 53 
Figure 4:1 Flow diagram showing study selection of assessing presenteeism in economic studies. .................... 79 
Figure 6:1 Collapsing the Standard Occupational Classification 2000 (SOC 2000) into the DLA Piper Dataset 
friction period ............................................................................................................................................ 143 
Figure 6:2 Collapsing the Standard Occupational Classification 2000 (SOC 2000) into the CIPD Dataset .......... 145 
Figure 6:3 All organisations – Summary of friction period estimates for UK in months (number), by occupational 
level ............................................................................................................................................................ 150 
Figure 6:4 DLA Piper – Summary of friction period estimates for UK in months (number), by two occupational 
level categories (2009-2011)...................................................................................................................... 152 
Figure 6:5 Summary of friction period estimates for UK in months (number), by two occupational level 
categories (2007-2009) .............................................................................................................................. 153 
Figure 6:6 Summary of friction period estimates for UK in months (number), by two occupational level 
categories (2007-2011) .............................................................................................................................. 154 
Figure 6:7 UoB – Summary of friction period estimates for UK in months, by five level occupational categories 
(2007-2009)................................................................................................................................................ 155 
Figure 6:8 Criteria used in marching the self-report and GP sickness certification data sources ....................... 158 
Figure 7:1 The Single-Item Presenteeism Question wording .............................................................................. 180 
Figure 7:2 Overall distributions of SIPQ scores across the 11 points of the SIPQ ............................................... 191 
Figure 8:1 Cost-utility plane for the overall comparison of stratified management care compared to usual care 
for societal costs ........................................................................................................................................ 233 
Figure 8:2 Cost-utility planes for the stratified analysis of stratified management care compared to usual care 
for a societal perspective – low-risk group ................................................................................................ 235 
Figure 8:3 Cost-utility plane for the stratified analysis of stratified management care compared to usual care for 
a societal perspective: medium-risk category ........................................................................................... 237 
Figure 8:4 Cost-utility plane for the stratified analysis of stratified management care compared to usual care for 
a societal perspective: High-risk category ................................................................................................. 238 
Figure 8:5 CEAC for the healthcare perspective .................................................................................................. 239 
 
 
Figure 8:6 CEAC for the overall healthcare and societal perspective .................................................................. 240 
Figure 8:7 CEACs curves for the three risk group comparisons of stratified primary care management compared 
to current best practice from a healthcare perspective. ........................................................................... 241 
Figure 8:8 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier 
effects based on a single friction period. ................................................................................................... 242 
Figure 8:9 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier 
effects based on a two-level category friction period DLA. ....................................................................... 243 
Figure 8:10 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier 
effects based on a five-level friction period CIPD ...................................................................................... 243 
Figure 8:11 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier 
effects based on a five-level friction period ONS ....................................................................................... 244 
Figure 8:12 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier 
effects based on a five-level friction period UoB ....................................................................................... 244 
Figure 8:13 CEAC for the societal perspective excluding multiplier effects ........................................................ 245 
Figure 8:14 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice from a societal perspective based on a single friction period using the FCA for 
absenteeism and HCA for presenteeism .................................................................................................... 246 
Figure 8:15 Cost-utility plane for the overall comparison of stratified care (phase 3) compared to usual care 
(phase 1) for the societal perspective ........................................................................................................ 259 
Figure 8:16 Cost-utility plane for the low-risk group analysis of stratified care (phase 3) compared to usual care 
(phase 1) from societal perspective ........................................................................................................... 261 
Figure 8:17 Cost-utility plane for the Medium-risk group analysis of stratified care (phase 3) compared to usual 
care (phase 1) from societal perspective ................................................................................................... 263 
 
 
Figure 8:18 Cost-utility plane for the High-risk group analysis of stratified care (phase 3) compared to usual care 
(phase 1) from societal perspective ........................................................................................................... 264 
Figure 8:19 CEAC for the overall healthcare and societal perspective ................................................................ 266 
Figure 8:20 Cost-utility acceptability curves for the three risk groups analysis of stratified care (phase 3) 
compared to usual care (phase 1) (healthcare perspective). .................................................................... 267 
Figure 8:21 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (single occupation level friction period). ............................................. 268 
Figure 8:22 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (two level occupation level friction period DLA) ................................. 269 
Figure 8:23 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (five occupation level friction period CIPD). ........................................ 269 
Figure 8:24 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (five occupation level friction period ONS) ......................................... 270 
Figure 8:25 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (five occupation level friction period UoB) ......................................... 270 
Figure 8:26 CEAC for the overall societal perspective sensitivity analysis .......................................................... 271 
Figure 8:27 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 













AFP Adjusted friction periods 
ALWQ Angina-related limitations at work questionnaire 
ASHE Annual Survey of Hours and Earnings 
CBA Cost-benefit analysis 
CBT  Cognitive behavioural therapy 
CEA  Cost-effectiveness analysis 
CEAC  Cost-effectiveness acceptability curve 
CIPD  Chartered Institute of personnel and development 
COI  Cost of illness 
COPD  Chronic obstructive pulmonary disorder 
CPI Consumer price index 
CUA Cost-utility analysis 
DLA  DLA piper LLP 
EHCA  Employer Health and Coalition of Tampa assessment instrument  
EQ-5D EuroQol  
ES Effect size 
EWPS Endicott Work Productivity scale 
FCA Friction cost approach 
GRI Guyatt responsiveness index 
HAD Hospital Anxiety and Depression scale 
HAQ Health and Assessment Questionnaire  
HCM Human capital method 
HLQ Health and Labour Questionnaire  
HPQ Health and Work Performance Questionnaire  
HRPQ-D Health Related Productivity Questionnaire Diary 
IBS  Impact Back Study 
ICER Incremental cost-effectiveness ratio 
IMPaCT Back Implementation study to improve Patient Care through 
Targeted treatment for back pain 
IQWiG Institute for Quality and Efficiency in Healthcare 
LBP Low back pain 
MIDAS Migraine Disability Assessment Questionnaire  
MWPLQ Migraine work and productivity loss questionnaire  
NHS National Health Service 
NHS EED National Health Service economic evaluation database 
NICE National Institute for Health and Care Excellence (NICE) 
NSAIDS Non-steroidal anti-inflammatory drug 
 
 
NSLBP Non-specific low back pain 
NS-SEC National statistics socio-economic classification 
ONS Office of national statistics  
OST Osterhaus technique  
PCS Pain and Catastrophising scale 
QALYs Quality-Adjusted Life years 
QQ Quantity and Quality questionnaire  
RMDQ Roland Morris Disability questionnaire  
SBT STarT Back Trial 
SD Standard  Deviation 
SF-12 MCS SF-12 mental health component summary measure 
SF-12 PCS SF-12 physical component summary measure  
SIC Standard industrial classification 
SIPQ Single-item Presenteeism Question 
SOC Standard occupational classification 
SPS Stanford Presenteeism Scale 
SRM Standardised response mean 
STarT Back Subgrouping for Targeted Treatment 
TSK Tampa scale for Kinesiophobia 
UFP Unadjusted friction periods 
UoB University of Birmingham 
WALS Work activity limitations scale  
WHI Work and health interview questionnaire  
WIS Work Instability Scale 
WLQ Work limitations questionnaire  
WL-WRF Work Role and Functioning scale 
WPA US Washington panel approach 
WPAI Work Productivity and Activity Impairment Questionnaire 
WPAI-GH Work Productivity and Activity Impairment Questionnaire 
General Health 





CHAPTER ONE  
   
The increasing demands on limited healthcare resources have raised questions about how to 
make resource allocation decisions. Economic evaluations are often used as a means of 
guiding decision makers in the efficient allocation of scarce healthcare resources. In 
economic evaluation research, the costs and benefits of an intervention are compared. They 
are used to determine the relative efficiency of new interventions and to determine whether 
to fund a new intervention or not (Drummond  et al., 2005). Application of these analyses, it 
is argued, could potentially result in cost containment, healthcare demand management and 
maximisation of benefits from healthcare spending (Morris  et al., 2007).  
  
The role of economic evaluation has become increasingly important in recent years. While 
the impact of these evaluations on final decision making may be uncertain (Buxton, 2006; 
Williams et al., 2008), a recent review of national pharmaco-economic guidelines shows that 
most countries now use economic evaluation in funding decisions of pharmaceutical 
interventions (Knies et al., 2010). For instance, in the UK, since 1999 the National Institute 
for Clinical excellence, now known as the National Institute for Health and Care Excellence 
(NICE), has produced national level guidance on effectiveness and cost-effectiveness of 
devices and interventions for the National Health Service (NICE, 2008; NICE, 2013). One of 
the main issues of controversy in most economic guidelines is the normative question of 
which perspective should be considered in such analyses (Drummond and Rutten, 2008). The 
study perspective is the viewpoint from which an economic evaluation is conducted 
(Drummond et al., 2005). The choice of perspective is important as it determines the costs 
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and benefits to be considered in an evaluation. Most national guidelines recommend 
performing economic evaluation from either (i) a narrow perspective, often that of a health 
service (payer), incorporating only costs falling within the healthcare budget, or (ii) the 
societal perspective, which includes all relevant costs and benefits (Knies et al., 2010; 
Pritchard and Sculpher, 2000).  
                                        
In the UK context, economic evaluation research is often conducted using an extra-welfarist 
approach with an associated NHS (payer) perspective for assessing resource use (Brouwer et 
al., 2008; NICE, 2013). Elsewhere, however, others have advocated for a societal perspective 
(Gold et al., 1996; Brouwer et al., 1997a). Arguments in favour of this perspective are related 
to the basic principles of economic evaluation founded in welfare economics (Byford and 
Raftery, 1998; Johannesson, 2009). In addition, some argue that adopting a narrow 
perspective would be to deny the reality of costs falling outside the healthcare budget which 
could lead to biased health policies for society (Drummond et al., 2005). Adopting a societal 
perspective implies that all relevant costs and effects should be included, irrespective of who 
bears the costs and receives the benefits (Gold et al., 1996).   
  
If the principle of a societal perspective is adopted, one of the main areas of controversy is 
the estimation of productivity costs of illness. Productivity costs are defined as ‘Costs 
associated with production loss and replacement costs due to illness, disability and death of 
productive persons, both paid and unpaid’ (Brouwer et al., 1997a) (p 254). Broadly, in the 
context of paid labour, productivity costs can emerge as a result of absenteeism and 
presenteeism. Absenteeism is when an individual is away from work due to illness, disability 
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(morbidity) or premature death (mortality). Productivity losses can also emerge as a result of 
reduced productivity at work (presenteeism) due to disease which often precedes or follows 
absenteeism (Brouwer et al., 2002). 
 
There have been various methodological debates on the estimation of productivity costs, 
including whether, and how, to incorporate such costs in economic evaluation studies 
(Brouwer et al., 1997a; Koopmanschap et al., 1997; Koopmanschap et al., 1995; Liljas, 1998; 
Brouwer and Koopmanschap, 2005; Johannesson and Karlsson, 1997). In addition, there are 
several on-going debates around additional work related situations such as compensation 
mechanisms and multiplier affects that can either reduce or increase productivity losses 
related to disease. Not all absenteeism or presenteeism results in reduced production as 
internal compensation within an organisation can potentially reduce productivity (Jacob-
Tacken et al., 2005; Severens et al., 1998; Krol et al., 2012). Additionally, there can be 
productivity losses resulting from negative effects of employee sickness on team 
productivity, output and substitutability (Nicholson et al., 2006; Zhang et al., 2012; Krol et al., 
2012; Pauly et al., 2008). Such costs are often termed as ‘multiplier effects’. The multiplier is 
defined as, “the cost of an absence as a proportion (often greater than one) of the absent 
worker’s daily wage”, (Nicholson et al., 2006) (p 112). Little is known about how to 
incorporate these costs in economic evaluations and the overall impact of including 
compensation costs and multiplier effects in economic evaluation studies.  
 
The significant costs associated with productivity loss increase the need to ensure rigorous 
methodological developments in estimation of these costs. Furthermore, the lack of 
4 
 
consensus regarding the most appropriate method for valuing both absenteeism and 
presenteeism costs necessitates further developmental work in this area (Pritchard and 
Sculpher, 2000; Knies et al., 2010). In the literature, three distinct approaches to valuation of 
productivity costs have been considered. These are the human capital approach, the friction 
cost approach, and the US panel Washington approach. The human capital approach is the 
traditionally used method, with productivity benefits based on the present value of lost time 
due to illness, disability or death (Weisbrod, 1961; Sculpher, 2001). This method has been 
criticised for generating unrealistic estimates of productivity loss (Koopmanschap and van 
Ineveld, 1992). The friction cost approach, was developed by health economists from the 
Netherlands as a result of perceived limitations and unrealistic theoretical assumptions of 
the human capital approach. The approach limits productivity loss to the friction period – 
time required to restore production to original levels (Koopmanschap et al., 1995; 
Koopmanschap and van Ineveld, 1992). A proxy to this period is the time it takes to replace 
and train a worker either from the labour market or from the unemployed ranks 
(Koopmanschap et al., 1997). Friction costs then broadly encompass lost production during 
the friction period and the costs of hiring and training new individuals (Koopmanschap and 
Rutten, 1996). In an alternative consideration of productivity loss, the US panel approach 
recommended valuation of productivity costs through a generic preference measure such as 
the Quality Adjusted Life Years (QALY) (Gold et al., 1996).  
 
Much of the empirical research in relation to these three approaches has focussed on the US 
panel approach. The theory in relation to the friction cost approach does not appear to have 
been translated into routine practice in economic evaluation studies. Little is currently 
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known about whether and how this method is applied in different country contexts. In 
addition, prospective research is needed to better understand components of productivity 
loss when using the friction cost approach in chronic episodic diseases such as low back pain. 
The application of the FCA in retrospective studies of chronic illnesses may provide a 
foundation for alternative ways of assessing the frequency, length of friction periods and 
friction costs in other disease areas and in future investigations. There is therefore merit for 
further exploration and developments on the practical application of the FCA.  
 
This thesis considers methodological issues relating to alternative approaches to valuation 
and inclusion of productivity costs in economic evaluation in the United Kingdom (UK), with 
a particular focus on the friction cost approach and applications in the clinical area of low 
back pain. Low back pain is used as a case study in this methodological research as 
productivity costs are particularly relevant for this area. Economic evaluation of stratified 
management for care of patients with low back pain is used to explore issues relevant to 
productivity costs and economic evaluation research.   
 
  
As a vehicle for exploring the feasibility and implications of the alternative methodological 
approaches developed in this thesis, the stratified management care intervention for low 
back pain sufferers is used as a case-study. This section briefly summarises the burden and 
importance of the clinical area of low back pain with a comprehensive overview provided in 
Chapter Five of this thesis.  
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Low back pain is a health condition associated with significant burden on primary and 
secondary healthcare services in the UK. It is a very common disorder and nearly five million 
people develop back pain each year in the UK (Hay et al., 2008). Additionally, low back pain 
will affect 80-85% of people over their life-time (Hoy et al., 2010a). The condition mainly 
affects individuals of working age leading to work absence and disability which are 
associated with significant economic costs to society (Ostelo et al., 2008). Low back pain has 
been found to be very costly in the UK, with estimated direct healthcare costs of £1.6 billion 
and indirect costs totalling £10.7 billion in 1998 (Maniadakis and Gray, 2000). It has been 
estimated that treating the different types of back pain costs the NHS over £1 billion per 
year (NICE, 2009b). Although indirect costs comprise the majority of the economic burden of 
low back pain, there is still uncertainty about the methodological approaches used to 
estimate these costs.  
 
  
The main questions addressed in this thesis include controversies and unresolved issues 
regarding the measurement and inclusion of productivity costs of absenteeism and 
presenteeism within a UK setting. The overall aim of the thesis is to contribute to the 
theoretical and methodological literature involved in the practical valuation of productivity 
costs using the friction cost approach and related to the inclusion of absence from work 
(absenteeism), reduced productivity (presenteeism) and wage-related multiplier effects in 





These questions are:            
1. How common is the application of the friction cost approach in valuing productivity 
costs in UK economic evaluation studies?  
2. How has presenteeism been measured and applied in economic evaluation research?  
3. What is the appropriate length of a friction period for the UK? 
4. Can sickness certification records be used as a proxy for self-reported work absence 
data?  
5. Is the Single-Item Presenteeism Question (SIPQ) a valid and responsive measure 
among low back pain patients?  
6. How does the inclusion of productivity costs using the alternative valuation methods 
explored in this thesis impact on the results of the cost-effectiveness analyses?  
 
Economic analysis of stratified primary care management in patients with low back pain is 
used to explore the methodological and empirical issues in this thesis. Using data from the 
Subgrouping for Targeted Treatment (STarT Back) Trial and IMplementation study to 
improve Patient Care through Targeted treatment for back pain (IMPaCT) Back study, this 
thesis demonstrates the application of alternative approaches for estimating productivity 
costs within an economic evaluation framework. It furthers explores the impact of these 
approaches on overall productivity and cost-effectiveness analysis results  
 
  
The literature reviews conducted in this thesis informed the empirical studies on the validity 
for the Single-Item Presenteeism Question, feasibility of comparing the sickness certification 
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records with self-report absence records and application of the friction approach in the UK, 
in order to provide further evidence of alternative methods for valuing productivity loss 
within economic evaluation. These methodological approaches were then used in the 
available data sets to generate cost-effectiveness estimates of subgrouping in back pain 
patients from a societal perspective. Overall, the thesis is reported in nine chapters, the 
content of which is outlined below:  
 
Chapter Two provides a review of the literature on the theoretical and methodological 
concepts of economic evaluation and applications of productivity costs. It also discusses the 
theoretical foundations of economic evaluation and the role of productivity costs within the 
economic evaluation framework. It then highlights important literature regarding past and 
on-going debates on the estimation of productivity costs and their inclusion in economic 
evaluation. 
 
Chapter Three systematically reviews literature on economic studies that have involved 
applications of the friction cost approach. The review focuses on identifying cost-of-illness 
and economic evaluation studies that have applied the friction cost approach to productivity 
cost valuation. This chapter therefore reviews important under-explored questions for 
future research on productivity costs in economic evaluation.   
 
Chapter Four systematically reviews literature on instruments that have been used in 
measuring presenteeism and in generating presenteeism monetary estimates. The 
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systematic review focuses on identifying economic evaluation studies that have reported on 
the measurement and valuation approaches for presenteeism. 
 
Chapter Five provides an overview of the clinical area of low back pain covered in this 
research. It details the incidence and prevalence of low back pain, and the current treatment 
strategies available for treatment of the condition. Clinical and economic evidence is 
provided for the various treatment strategies. Next, evidence of the economic burden 
associated with low back pain is provided with a particular focus on the UK. Finally a detailed 
description of the data sets used in this thesis is provided.      
 
Chapter Six describes methodological developments in the application of the friction cost 
approach. An investigation is carried out to obtain a UK specific length of friction period 
estimate. The investigation goes beyond the traditional friction cost approach to explore the 
estimation of more detailed friction periods disaggregated by occupation. Moreover, the 
comparability of sickness certification records with self-reported work absence records is 
explored. An investigation is carried out to determine whether sickness certification records 
can be used as an alternative to self-reported sickness absence records in their absence 
within economic evaluation.  
 
Chapter Seven examines the construct validity and responsiveness of a Single-Item 
Presenteeism Question (SIPQ) tool among low back pain sufferers. The validity of the tool is 
tested by means of correlation analysis, known-group validity and divergent validity. 
Responsiveness is tested by means of correlational analysis and distribution-based analysis.  
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Chapter Eight reports findings from the societal cost-utility analysis of stratified care in low 
back patients from the STarT Back Trial and IMPaCT Back studies. The chapter includes 
empirical applications of methodological work developed in Chapters Six and Seven and 
provides an insight into the influence of productivity costs in economic evaluations. The 
inclusion of full productivity costs of absenteeism and presenteeism using the friction cost 
approach, and the impact on overall cost-effectiveness outcomes is investigated and 
reported. Further, the effect of using friction period values disaggregated by occupation is 
examined. The impact of incorporating effects of back-related sickness on team work and 
substitutability on productivity cost estimates, and cost-effectiveness outcomes, is 
presented.      
  
Chapter Nine brings together the aims and objectives of the thesis as set out at the 
beginning of the thesis. It provides a discussion of the findings, strengths and limitations of 
the research. The implications for policy and research are discussed and the overall 











CHAPTER TWO  
  
This chapter consists of two parts. Sections 2.1 to 2.4 provide an overview of the theoretical 
and economic foundations of economic evaluation, and the general approaches to carrying 
out economic evaluation. Sections 2.5 to 2.9 focus on the role of productivity costs in 
economic evaluation, what they are and how they are estimated and applied. The chapter 
also includes a discussion of the main debates and developments in the estimation of 
productivity costs in relation to both absenteeism and presenteeism and their inclusion in 
economic evaluation. Finally, an overview of unresolved issues is provided in Section 2.10 to 
identify areas for further research. 
 
 
Economics is a discipline that is concerned with the allocation of scarce resources. The 
discipline of economics that is used in guiding the efficient allocation of scarce resources 
within the healthcare sector is known as health economics (Witter, 2000). To contribute to 
the resource allocation process, health economists rely on both normative and positive 
economic theories originating from the discipline of economics (Morris  et al., 2007; Coast et 
al., 2008a). Positive economics is objective and uses theories to predict social phenomena, 
while normative economics is based on value judgements and aims to inform how resources 
should be allocated (Boadway and Bruce, 1984). For the most part, health economics has 
focused on normative analysis of health and healthcare, particularly through economic 




Economic evaluation is a tool used in health economics with the aim of guiding decision 
makers when choosing between different interventions by comparing their costs and 
benefits (Drummond et al., 2005). It stems from the realisation that healthcare resources are 
scarce, and yet market mechanisms are unable to optimally allocate these resources, hence 
decision makers have to choose between interventions (Williams, 1983; Folland and 
Goodman A, 2001; Gafni et al., 2012). As a result, there has been a rise in methodological 
and analytical approaches to economic evaluation of healthcare interventions. The majority 
of these developments have focused on the more recent analytical frameworks of cost-
effectiveness analysis (CEA) and cost-utility analysis (CUA) with a lesser focus on the more 
traditional cost-benefit analysis (CBA) (Drummond et al., 2005; McIntosh et al., 2010).  
  
2.2.1 Welfare economics and extra-welfarism   
Economic evaluation has become increasingly popular in recent years because of its ability 
to guide decision makers in choosing between programmes (Brouwer and Koopmanschap, 
2000). However, this increased popularity has also been followed by controversy, evidenced 
by the substantial literature on the theoretical foundations of economic evaluation 
methodology with a particular focus on cost-effectiveness analysis and cost-utility analysis 
(Garber and Phelps, 1997; Weinstein et al., 1997; Brouwer and Koopmanschap, 2000). Much 
of the theoretical debate in relation to the foundations of economic evaluation is associated 
with differences in views on key methodologies in the normative analysis of health and 
healthcare. These divergent views are based on distinctions between the approaches of 




2.2.1.1 Welfare economics  
While the underlying theory of economic evaluation can be traced back to traditional 
welfare economics, there has been debate around embedding the theory and practice of 
economic evaluation in the alternative extra-welfarist framework (Brouwer and 
Koopmanschap, 2000; Birch and Donaldson, 2003). Welfare economics is a theoretical 
framework concerned with systematic analysis of resource allocation, exclusively in terms of 
individual utilities and is the principal normative tradition in economics (Drummond et al., 
2005; Morris  et al., 2007). Welfarism assumes that social welfare (utilities) is an aggregation 
of individual welfare (utilities) and that individuals are the best judges of their own welfare 
(Gold et al., 1996; Coast, 2004). In principle, welfarism limits the evaluative space to 
individuals (Brouwer et al., 2008).   
 
Economic evaluation is based on Paretian welfare economics. The Pareto principle suggests 
that optimality in resource allocation occurs if one person can be made ‘better off’ without 
another being made ‘worse off’ (Tsuchiya and Williams, 2001). This principle is, however, 
impractical as inevitably some people will benefit and some will lose out when policy 
decisions are made. It is because of this limitation in evaluations that Kaldor (1939) and 
Hicks (1939), proposed the less restrictive compensation principle (Kaldor, 1939; Hicks, 1939; 
Layard and Glaister, 1994). According to these proponents, a welfare gain to society could be 
achieved if the potential gainers (in theory) compensate potential losers and remain better 
off (Kaldor, 1939; Pearce, 1971). There were questions raised on the equity implications of 
applying this approach, particularly in the process of evaluating gainers and losers, and how 
to determine the reallocation of resources. The proponents of this principle, however, 
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argued that the compensation is only hypothetical and that the overall aim should be to 
assess global welfare gains and not the distribution of this welfare (Brazier et al., 2007).  
 
The cost-benefit analysis (CBA) approach, often based on willingness-to-pay assessments is 
one type of economic evaluation rooted in the theory of welfare economics that attempts to 
provide guidance on societal preferences (McIntosh et al., 2010). However, equity concerns 
have been raised about the appropriateness of using CBA in decision-making because its 
valuation of outcomes is performed in monetary terms (Drummond et al., 2005). In addition, 
it has been reported that individuals find it difficult to value health in monetary terms (Ryan 
et al., 2003). For this reason, the ‘extra-welfarist’ theoretical framework has been suggested, 
which goes beyond the traditional welfarist approach (Brouwer et al., 2008). 
 
2.2.1.2 Extra-welfarism  
The normative framework of analysis that is not restricted to a function of individual utilities 
is what is commonly known as extra-welfarism (Brouwer et al., 2008). The focus of welfare 
economics in the past has been considered too narrow, with suggestions to broaden its 
perspective to include aspects such as individuals’ capabilities (Brouwer et al., 2008). This 
alternative framework, first proposed by Culyer (1989), draws on a number of different 
theories including, but not limited to, the capability approach developed by Amartya Sen 
(Culyer, 1989; Cookson, 2005; Coast et al., 2008b).  
  
In healthcare, extra-welfarism typically extends the evaluative space to one of health, with 
the main objective being to maximise health from a given budget (Culyer, 1989; 
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Johannesson, 1995; Brouwer et al., 2008). Health gains are often measured in terms of 
quality-adjusted life years (QALYs) (Drummond  et al., 2005). Priority for resource allocation 
is placed on those interventions and individuals where the highest health gains in relation to 
additional costs are realised (Hauck et al., 2004). Nevertheless, it is this specific focus on 
health in current practice that has caused some to question whether extra-welfarism does 
indeed offer anything extra above traditional welfarism (Birch and Donaldson, 2003). A 
practical application of the extra-welfarist approach using QALYs in the UK healthcare sector 
is seen in the economic guidelines for economic analysis provided by the National Institute 
for Health and Care Excellence (NICE, 2013). In the recent guidelines, there is an explicit 
requirement to use the QALY when assessing benefits for evaluations to be submitted to the 
cost-effectiveness panel (NICE, 2013).   
  
Overall, there are two major theoretical frameworks that decision makers can draw on in 
making decisions about resource allocation within the health sector. These are the 
traditional welfarist economics framework and the extra-welfarist framework linked to the 
capability approach. Each of these frameworks has their associated limitations and the 
choice between approaches remains a matter of debate.   
 
   
Economic evaluation involves identifying, measuring and comparing the costs and benefits 
of alternative interventions (Drummond et al., 2005). Evaluation of costs and benefits can be 
conducted in different ways, which primarily differ in whether and how associated health 
benefits are considered. The techniques, which include the cost-minimisation analysis, cost-
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effectiveness analysis, cost-utility analysis, cost-benefit analysis, and cost-consequence 
analysis, are described below. 
 
2.3.1 Cost-minimisation analysis (CMA)  
A cost-minimisation analysis is a form of economic evaluation in which an assumption is 
made that the health outcomes of two or more interventions are equal, and hence the 
objective is on minimising cost by choosing the least costly intervention (Gray et al., 2010). 
The attraction with this method lies in its ease of analysis and interpretation (Dakin and 
Wordsworth, 2013). However, it has been criticised for failure to focus on estimating the 
joint density of costs and benefits and in quantifying uncertainty surrounding the 
incremental cost-effectiveness ratio (ICER) (Briggs and O'Brien, 2001). As a result, the cost-
minimisation analysis technique has been limited because of its applicability only in rare 
situations.  
 
2.3.2 Cost-effectiveness analysis (CEA)  
In a cost-effectiveness analysis, costs are calculated and the value of health benefits 
assessed in terms of natural units such as life years gained (Drummond et al., 2005). The 
difference between the costs, divided by the difference between the benefits, expressed in 
natural outcomes determines what is known as the incremental cost-effectiveness ratio 
(ICER) (Drummond et al., 2005). Interventions are then compared against each other based 
on cost per unit of effectiveness. CEA aims to guide resource allocation through 




Nevertheless, the CEA methodology is associated with some limitations. CEA is not suited for 
resource allocation when interventions have different outcomes because it uses natural 
units related to the particular intervention, and is therefore appropriate for answering 
questions on technical efficiency and not allocative efficiency (Drummond et al., 2005).  
  
2.3.3 Cost-utility analysis (CUA) 
Increased research efforts into generic measures better suited for allocative efficiency have 
led to the development of a CEA variant known as cost-utility analysis. The CUA is a form of 
economic evaluation in which health outcomes are presented as a single generic measure. 
CUA is based on the extra-welfarist theoretical framework, with health benefits expressed in 
quality adjusted life years (QALY) (Drummond et al., 2005). The QALY is a generic measure of 
health outcomes, which combines both aspects of quality-of-life (morbidity) and quantity of 
life (mortality) into a single measure (Weinstein and Stason, 1977; Williams, 1985). In CUA, 
the quality-adjusted sets of weights (utilities) are applied to the time spent in potential 
health states resulting from an intervention. This provides the number of quality adjusted 
life years hence incorporating the effects of an intervention on both the quality and quantity 
of life. QALY weights are anchored on a 0 (equivalent to death) to 1 (signifying full health) 
scale (Drummond et al., 2005). Cost-utility is commonly measured by a ratio (ICER) 
expressed as an additional cost per QALY gained. Cost-utility analysis has been widely used 
in decision making within the UK (Buxton, 2006; NICE, 2013) and increasingly in other 





2.3.4 Cost-benefit analysis (CBA) 
CBA is the traditional economic evaluation approach rooted in welfare economics, in which 
costs and benefits to society are valued and expressed in monetary terms and weighed 
against each other (McIntosh et al., 2010). The aim of CBA studies is to guide decision 
makers in prioritising programmes that yield the greatest gain in net benefits to society 
(Boardman et al., 2006). 
  
The valuation of outcomes in monetary terms provides a platform for the comparison of 
costs and benefits of an intervention to determine its net social benefit. The net social 
benefit is the difference between the incremental programme benefits and the incremental 
programme costs (Dolan and Edlin, 2002). A positive net social benefit signifies that the 
programme is worthwhile and vice versa. The attraction with this approach is that it enables 
comparisons to be made both within and across different sectors of the economy (Gafni, 
2006).  
   
The two broad methods used in monetary valuation of health outcomes are the human 
capital approach and the Willingness-to-pay (WTP) or contingent valuation approach (CV). In 
the human capital approach, the value of monetary benefits is estimated through 
production gains to the economy (Johannesson, 1996; Drummond et al., 2005). These gains 
accrue from increased production of individuals at their workplace as a result of treatment, 
and are valued based on wage-rates. However, this approach has been criticised for ignoring 
aspects such as estimates of quality of life gains and individuals outside of the labour market 
(Johannesson and Jonsson, 1991).  
19 
 
Instead, the contingent valuation or willingness-to-pay approach, which provides a 
framework for assessing the sacrifice individuals are willing to make in order to enjoy 
benefits of an intervention, has been proposed as a more appropriate method for estimating 
benefits (Frew, 2010). A growing number of direct stated preference exercises, performed 
through survey methods based on hypothetical market scenarios, have been reported within 
the health economics literature (Ryan et al., 2001; McIntosh et al., 2010). Nevertheless, 
apart from recent methodological advancements in assessing health outcomes through WTP 
studies (McIntosh et al., 1999), practical application of CBA methods within the economic 
analysis of healthcare remains relatively limited (Cookson, 2005). This is partly because of 
the ethical concerns about attaching monetary values on the length and quality of life 
especially in countries traditionally not based on payment systems (Gafni, 2006). These 
methodological challenges have meant CBA has rarely been used within healthcare; instead 
economic evaluation remains dominated by cost-effectiveness analysis and cost-utility 
analysis.  
 
2.3.5 Cost-consequence analysis (CCA)   
In a cost-consequence analysis, costs and benefits are calculated but not combined into cost-
effectiveness ratios or QALYs (Russell et al., 1996). Rather, CCA results are reported in a 
tabular form with all relevant costs and consequences disaggregated and presented 
separately (Brazier et al., 2007; Gray et al., 2010). Decision makers are then allowed to 
interpret, prioritise, and assign their own value weights to the tabulated costs and 
consequences (Coast, 2004). Cost-consequence analysis is often used as the first step to 
other forms of economic evaluations.  
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Roberts et al., (2012) recently used a cost-consequence analysis to investigate the costs and 
benefits of partner notification models for sex partners of individuals with chlamydia, 
gonorrhoea and non-gonococcal urethritis (Roberts et al., 2012). Healthcare costs were 
categorised into clinical and pharmaceutical costs and resource data, with the outcome 
comprising the number of partners treated by strategy listed. As the study was based on an 
exploratory trial, the authors argued that in this context of cost-consequence,  ‘Resource use 
data collected, costs estimated and the results of this study will be useful for informing 
development of future RCTs’ (Roberts et al., 2012) (p20). 
 
Proponents of this approach have argued that it provides useful information that can enable 
decision makers to determine returns on investment without requiring detailed costs and 
effectiveness analysis (Wilkinson, 1999). Furthermore, CCA provides decision makers with 
the flexibility to tailor cost analyses to their own setting and perspective (Mauskopf et al., 
1998). The limitation with this approach however is that decision makers are left with the 
challenge of interpreting the costs and consequences from the results and in attaching 
appropriate weights for the different outcomes in question (Gray et al., 2010). 
 
 
Decision makers in many health-care systems are faced with challenges concerning optimal 
approaches of maximising health benefits subject to healthcare budget constraints (Eichler 
et al., 2004). The most commonly used analytical framework is the cost-utility variant of the 
cost-effectiveness approach as evidenced by the various economic evaluation guidelines 
introduced by many countries (Knies et al., 2010). In order to be transparent and explicit in 
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priority setting, decision makers need a set of decision rules to determine what is and what 
is not cost-effective, hence the need for some kind of acceptable threshold value (Eichler et 
al., 2004).   
 
The threshold approach is the preferred method used by the United Kingdom’s National 
Institute for Health and Care Excellence, an organisation that provides guidance to the 
National Health Service (NHS) (Culyer et al., 2007). The method of decision-making adopted 
for this thesis and discussed in this section is based on cost-effectiveness within the UK 
healthcare context.   
  
In this context, the threshold approach involves estimating an incremental cost-effectiveness 
ratio (ICER). This is the ratio of additional costs and additional effects generated by an 
intervention, expressed as the incremental cost per Quality Adjusted Life Year (QALY) gained 








      
 
The ICER value generated is then compared against a threshold ICER value of a QALY, above 




Internationally, countries have mostly been implicit about an acceptable threshold ICER 
value, although possible threshold values have been associated with some countries 
(Appleby et al., 2007; Bridges et al., 2010). In the UK, NICE has been associated with a 
threshold cost per QALY gained value purported to range between £20,000-30,000 (Rawlins 
and Culyer, 2004; McCabe et al., 2008). The empirical basis for the cost per QALY threshold 
range used by NICE or how decisions are taken in relation to the threshold, however, 
remains somewhat unclear (Appleby et al., 2009). The main debate on the NICE threshold 
has been on the empirical basis for this threshold and whether the current threshold value 
should be changed over time (Towse, 2009; Raftery, 2009). Previous work on assessing the 
social value of a QALY in the UK assessed how QALYs from different healthcare recipients 
should be weighted and how this potentially affects the existing NICE threshold (Donaldson 
et al., 2011). The majority of methods used for aggregating the data available resulted in 
values of a QALY of around £18000 to £40,000 (Donaldson et al., 2011). Additional survey 
work on this research found no convincing evidence for changing the NICE threshold. Some 
have argued that in a budget-constrained healthcare system such as the United Kingdom’s 
NHS, the threshold should be based on opportunity cost (Claxton et al., 2013). This is 
because as new interventions are funded, existing services are likely to be displaced within 
the system. The work on generating a threshold value based on opportunity cost reported 
that the ‘best’ estimate of the threshold value using routine data for 2008 to 2010 was 
estimated to be around £18,000 per QALY.  
 
Similarly, a threshold value of $50,000 per QALY gained is commonly applied in the United 
States (Bridges et al., 2010). However, questions have been raised about the theoretical or 
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scientific justification for choosing this value (Bridges et al., 2010). The idea of these 
thresholds remains an important issue among health economists with recommendations for 
further research on this value (Weinstein et al., 1997; Hirth et al., 2000; Appleby et al., 2007; 
Appleby et al., 2009).  
  
One area of controversy surrounding the application of CEA results to the threshold 
approach, relates to the inclusion of costs that go beyond direct healthcare costs (Olsen and 
Richardson, 1999). In the context of economic evaluations, exclusion or inclusion of 
productivity costs could affect overall CEA results. A recent study from the Netherlands (Krol 
et al., 2011) reported that inclusion or exclusion of productivity costs significantly affected 
incremental costs in a number of studies. This illustrates the importance of clearly reporting 
all relevant costs and consequences considered in an analysis. Moreover, further scientific 
research on whether and how to explicitly determine acceptable decision making ICER 




Economic analysis of healthcare treatments involves a range of costs that are linked with the 
health sector (direct healthcare costs), patients and their families (indirect healthcare costs), 
resource use in other sectors, and productivity costs (mainly absence from work, disability, 
death and reduced productivity costs). Given the focus of the thesis, this section focuses on 
the indirect costs associated with work-related productivity loss (Drummond et al., 2005). 
While healthcare costs were the focus of most early research, recent literature has involved 
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various debates and discussions of estimation and valuation of indirect costs of illness, 
commonly known as productivity costs.  
 
Productivity costs are defined as ‘Costs associated with production loss and replacement 
costs due to illness, disability and death of productive persons, both paid and unpaid’ 
(Brouwer et al., 1997a) (p254). The United States Washington panel defined productivity 
costs as ‘costs associated with lost or impaired ability to work or engage in leisure activities 
due to morbidity and lost economic productivity due to death’ (Gold et al., 1996) (p181). The 
US Washington panel definition differs by specifically incorporating the value of lost leisure 
time. Productivity costs are often classified into paid working time, unpaid working time and 
leisure time (Sculpher, 2001).    
 
In the context of paid labour, productivity costs often considered in economic evaluation can 
occur through patients having paid work and being absent from work as a result of sickness, 
disability or death - together known as absenteeism, and working with limitations due to 
sickness - known as presenteeism (van den Heuvel et al., 2010; Sculpher, 2001). Although 
much research on estimating productivity costs has focused on effects of paid working time, 
there is also debate around the effects of unpaid labour and leisure time in economic 
evaluation (Pritchard and Sculpher, 2000). While it is important to consider the effects of 
sickness and care on unpaid labour and leisure time, this thesis focuses solely on aspects of 






The question of whether and how productivity costs should be incorporated in economic 
evaluation forms an important area of debate (Olsen and Richardson, 1999; Pritchard and 
Sculpher, 2000; Brouwer et al., 2006). In considering the case for whether productivity costs 
should be included in economic evaluation, three issues are discussed: the normative 
foundations for performing economic evaluations, the choice of perspective, and the ethical 
implications of including productivity costs.  
 
2.6.1 Normative foundations  
The normative foundation for economic evaluation is either the traditional welfare economic 
or recent extra-welfarist economic framework (Brouwer and Koopmanschap, 2000). If a 
welfarist perspective is utilised in an economic evaluation, then all costs and benefits should 
be included, hence, justifying the inclusion of productivity costs (Brouwer et al., 1997a; 
Hauck et al., 2004). As economic evaluation has its theoretical foundations in welfare 
economics, exclusion of relevant productivity costs in an economic analysis would be 
inconsistent with the theory in this area (Johannesson, 1995).  
  
The extra-welfarist theoretical framework on the other hand focuses on maximising health 
for a given budget. As a result, productivity costs are normally excluded on grounds that they 
are not within the decision maker’s budget. This, for example, can be seen in the case of 
UK’s NICE which does not recommend inclusion of productivity costs in economic analysis 
panel submissions in either the reference-or non-reference case analyses (NICE, 2013). As 
current practice stands, the extra-welfarist approach, which does not explicitly provide for 
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the inclusion of productivity costs, continues to form the normative foundations for 
economic evaluations in the healthcare arena within the UK. There is growing interest 
however in applying the capability approach in health economics with the realisation that 
interventions are associated with various benefits that accrue beyond health (Coast et al., 
2008a), and this broader perspective might necessitate a societal assessment of costs.  
  
2.6.2 The choice of perspective   
The perspective of the economic analysis generally determines the scope of relevant costs 
and benefits to be considered. As such, the relevant perspective plays a critical role in 
whether productivity costs are to be included in the analysis. The two most utilised 
perspectives are the healthcare perspective (payer) and societal perspective (Gold et al., 
1996; Sculpher, 2001; Drummond et al., 2008). Evaluations performed from a healthcare 
perspective typically include direct healthcare costs and patient related health benefits, and 
exclude costs such as productivity costs that do not fall within the payer’s healthcare budget. 
However, the limitation with this perspective is that exclusion of these costs when 
conducting economic analysis might not accurately reflect the true societal costs of an 
intervention (Krol et al., 2011). Furthermore, adopting such a perspective would be to deny 
the reality of costs falling outside the healthcare budget which could lead to biased health 
policies based on inefficient changes in healthcare and loss in total societal welfare (Byford 
and Raftery, 1998; Sculpher, 2001; Drummond et al., 2005).    
 
In contrast, economic evaluations carried out from a societal perspective should typically 
include productivity costs (when appropriate) as a requirement for including all relevant 
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costs and benefits. The common practice however is that economic evaluation studies are 
often restricted to a narrow healthcare perspective (Johannesson, 2009), although there is a 
strong theoretical preference for considering a societal perspective (Gold et al., 1996; Byford 
and Raftery, 1998; Drummond et al., 2008), even when conducted from an extra-welfarist 
perspective.   
  
Indeed, among health economists in the US, Canada, and the Netherlands, the general 
consensus is that economic evaluation should be carried out from a societal perspective 
even when conducted from an extra-welfarist perspective (Gold et al., 1996; Torrance et al., 
1996; Byford and Raftery, 1998; Johannesson, 2009). Nevertheless, this perspective is not 
always the most selected option. For example in the UK, recent NICE guidelines, recommend 
the use of an NHS and Personal Social Services (PSS) (provider) perspective (NICE, 2013).  
 
In Germany, the Institute for Quality and Efficiency in Healthcare (IQWiG) recommends 
inclusion of costs from the statutory health insurance perspective (Drummond and Rutten, 
2008). Some have argued for the use of a two-perspective approach as the standard 
(Brouwer et al., 2006). In this approach, cost-effectiveness results should be presented with 
and without broader costs to society. For example, the most recent NICE guidelines from the 
UK acknowledge the potential relevance of costs outside the NHS and PSS perspective and 
provide for their inclusion separately from the reference case, but these do not include 
productivity costs (NICE, 2013). Similar recommendations have been made in US submission 
guidelines with a societal perspective accepted in a secondary analysis (AMCP, 2012). Only a 
28 
 
few guidelines, for example Australian guidelines, explicitly allow submissions for economic 
evaluations using either a healthcare or societal perspective (PBAC, 2008).   
  
It is therefore argued in this thesis that a societal perspective, which is more in line with 
economic theory, would be more appropriate for economic evaluation. This is because it 
allows for a broader assessment of costs irrespective of who incurs them, hence providing 
the case for the inclusion of productivity costs in economic evaluation.   
  
2.6.3 Ethical implications   
One area of contention in economic evaluation is the inclusion of productivity costs and the 
possible equity implications that are likely to result from this (Pritchard and Sculpher, 2000). 
Some have argued that incorporating productivity costs in the analysis may lead to the 
prioritisation of individuals in society who are in employment, at the expense of those who 
are not in employment (Koopmanschap and Rutten, 1993; Johannesson, 2009). As such, 
inclusion of these costs could result in resource allocation decisions that discriminate against 
some population groups, for example, older people who are not in employment. Others 
have raised concerns that consideration of productivity loss might also lead to ethical issues 
around valuing productivity loss for women differently compared to men, as a result of 
probable differences in wage rates (Luce, 1996).  
  
While these ethical concerns are important, there are different options that can be 
considered in order to minimise their impact. Some have argued, for example, that 
economic evaluation can be reported with productivity costs included and equity 
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considerations explicitly reported to decision makers (Brouwer et al., 2006). Moreover, cost-
effectiveness analysis results can be presented with, and without, productivity costs to 
enable policy makers to incorporate their own value judgements to weigh up alternative 
implications of including these costs (Pritchard and Sculpher, 2000; Koopmanschap et al., 
2005) .  
  
In dealing with potential differences in wage-rates, health economists have recommended 
using alternate wages, including a single average, national or sector-specific wage-rate as 
equity checks (Russell et al., 1996). In relation to older people, some have argued that 
productivity gains from those who are working can potentially be translated into healthcare 
benefits for older people (Johannesson, 2009).      
  
To conclude, in spite of important theoretical and ethical implications, there remain strong 
grounds both theoretically and practically that productivity costs should be considered in 
economic evaluation. However, the case for incorporating these costs is stronger when 
considering a welfarist approach than in the current expression of extra-welfarism. In this 
thesis, the argument used is that it is important to understand the impact of decisions on 









2.7.1 Absence from work (absenteeism) 
Absenteeism can be defined as reduced productivity resulting from individuals not being 
able to report to work due to health problems (Sculpher, 2001). Absenteeism includes 
various time components including sick days off work, time away from work related to short 
and/or long-term work disability, or death (Schultz et al., 2009). Traditionally, health 
economists have concentrated on estimating indirect costs in relation to absenteeism 
(Beaton et al., 2005).  
 
2.7.2 Reduced productivity at work (presenteeism) 
Presenteeism in healthcare is a concept of lost productivity that refers to reduced 
productivity or performance while at work due to ill health (Schultz and Edington, 2007; 
Cooper and Dewe, 2008). Sickness will tend to affect workers in various ways with both the 
quality and quantity of the employee’s work being affected (Hemp, 2004). Recent interest in 
this concept has been driven by reports that it is associated with much more significant costs 
than absenteeism. For example, a UK Sainsbury Centre for Mental Health study estimates 
that presenteeism accounts for 1.5 times more lost working time than absenteeism, with 
presenteeism costs of mental health problems alone estimated at £15 billion per year (SCMH, 
2007). Assessing presenteeism may be particularly important in generating theoretical 
advances in determining how absenteeism starts and how sickness affects and influences 





2.7.3 Compensation mechanisms and multiplier effects 
Recent research has shown that actual productivity costs can be limited during working 
hours as a result of compensation mechanisms (Koopmanschap et al., 1995; Koopmanschap 
and Rutten, 1996; Zhang et al., 2012; Krol et al., 2012). This is because a sick employee could 
potentially make up for reduced productivity or absence during normal hours or by putting 
in extra hours. Additionally, colleagues at the work place may take on some roles in the 
short-term at no cost in order to compensate for potential productivity losses.  
          
Indeed, researchers who have explored compensation mechanisms found existence of 
compensations suggesting overall lower productivity costs than is traditionally reported 
(Severens et al., 1998; Brouwer et al., 2002; Jacob-Tacken et al., 2005; Krol et al., 2012). 
However, others have argued that productivity losses from a sick employee can also lead to 
extra costs as a result of the negative impact on productivity of co-workers particularly 
where team work is involved (Pauly et al., 2002; Pauly et al., 2008). Such costs have been 
termed as multiplier effects. Multiplier effects have been shown to impact significantly on 
overall productivity changes in studies investigating smoking cessation among Dutch citizens 
(Krol et al., 2012), and in treating rheumatoid arthritis among UK citizens (Zhang et al., 2012). 
 
 
2.8.1 Measurement: Absenteeism 
Measurement of lost productivity is generally a complex issue with potential practical and 
administrative challenges (Evanoff et al., 2002; Pole et al., 2006). Absenteeism is measured 
by identifying the time individuals have missed from work due to sickness. The two most 
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common approaches for measuring lost productivity from work due to sickness involve the 
use of (i) objective or (ii) subjective measures. Objective measures include administrative 
records on sickness absence such as employment databases or registries for work absences 
due to sickness. Subjective measures include self-reported questionnaires or patient diaries. 
  
Administrative records have the advantage of continuous follow up, easy data collection 
with relatively low-cost means, and the potential to provide large samples of employee 
sickness absence records without the possibility of recall errors or perception biases (Pole et 
al., 2006). Nevertheless, administrative datasets have various limitations, particularly when 
applied in economic evaluation. The obvious challenge is that there are difficulties in 
accessing these records due to ethical concerns, cost and effort of having to contact 
different employers of individuals as part of a study (Knies et al., 2010). Further, databases 
may have incomplete productivity loss data, loss of employee follow-up due to job losses or 
changes in work roles, and failure in some cases to capture long-term absence from work 
data (Young et al., 2002).  
  
Consequently, subjective values based on self-reported estimates of sickness absence from 
questionnaires have often been applied and have become an acceptable approach in 
economic evaluation research (Ferrie et al., 2005). Productivity loss is usually generated 
from self-reported questionnaires, interviews or diary recording methods. The diary and 
interview methods are generally used less frequently, as they are perceived to be time 
consuming and costly to administer when compared to retrospective self-reported 
questionnaires (van Poppel et al., 2002). Nevertheless, these approaches tend to provide 
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more valid estimates as they reduce recall bias in comparison to the use of self-reported 
questionnaires (van den Brink et al., 2005).   
 
A recall period of three months for absenteeism has recently been recommended (Zhang et 
al., 2011). However, there is no consensus among economists on the appropriate recall 
period, although it has been argued that this choice should be guided by a trade-off between 
increased data collection costs and on responder burden (Zhang et al., 2011). The validity of 
different recall periods however deserves further scientific research. 
 
2.8.2 Measurement: Presenteeism 
There has been an increase in the number of self-report instruments developed to measure 
the impact of presenteeism at the work place. This was partly in response to the inability of 
administrative datasets to incorporate and capture presenteeism possibly resulting in an 
underestimation of productivity costs (Evanoff et al., 2002). Researchers have also 
attempted to derive methods for attaching a monetary value to presenteeism - mostly over 
short periods of time - based on the output of the presenteeism scores from these 
instruments, although many questions in relation to transparency and extrapolation of these 
costs remain (Brooks et al., 2010). Some of these self-report instruments can be used to 
generate outputs that provide monetary values (Schultz et al., 2009). However, evidence 
about the most appropriate methods for estimating the economic burden of presenteeism is 




The most popular and widely used presenteeism instruments include the work limitations 
questionnaire (WLQ) (Lerner et al., 2001) and the Stanford presenteeism scale (SPS) (Turpin 
et al., 2004). For instruments measuring both absenteeism and presenteeism, the Work 
Productivity and Activity Impairment (WPAI) (Reilly et al., 1993) and Health and Labour 
Questionnaire (HLQ) have commonly been used (Brooks et al., 2010). However, few studies 
(Ozminkowski et al., 2004; Tang et al., 2009; Zhang et al., 2010b), have attempted to 
compare presenteeism results from two or more presenteeism measures, and the results 
from these have varied depending on the questionnaire chosen. A recall period of one week 
for presenteeism has been recommended (Zhang et al., 2011), although further empirical 
studies assessing the validity of different recall periods for presenteeism are needed. A more 
detailed review of presenteeism measures is provided in the systematic review in Chapter 
Four of this thesis.   
 
2.8.3 Measurement: Compensation mechanisms and multiplier effects 
To comprehensively estimate productivity costs, data are required pertaining to 
employment status, absenteeism, presenteeism and the job characteristics of sick 
employees. Such data are not always easy to collect. In previous attempts, respondents have 
been asked to report whether their absence was compensated for during their absence or 
whether extra hours had been undertaken to make up for lost work using questionnaires 
(Jacob-Tacken et al., 2005; Zhang et al., 2012).  
 
Similarly, few studies to date have attempted to generate wage-related multiplier estimates 
for adjusting for effects of productivity loss on team productivity (Pauly et al., 2002; Pauly et 
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al., 2008; Zhang et al., 2012). In order to estimate wage-related multiplier effects, data 
would be required on specific work characteristics such as team work dynamics, and 
availability of substitutes. Such data are difficult to obtain in an economic evaluation setting 
because of costs and challenges in obtaining ethical approvals. Data for compensation 
mechanisms and multiplier estimates can be obtained either from employers or employees. 
However, the evidence shows that the multiplier values generated from employers are 
always different compared with those of employees (Jacob-Tacken et al., 2005; Zhang et al., 
2012). 
  
Therefore, in spite of recent developments in adjusting for compensation mechanisms and 
multiplier effects of team work and employee substitutability, more comprehensive studies 
are necessary before consensus about including these costs in economic evaluation can be 
achieved. Of particular research interest, the most appropriate source for wage-related 
multiplier values should be investigated and the implications of including these costs on 
overall productivity costs more explicitly addressed.  
 
2.8.4 Summary of measurement approaches 
To conclude, in light of the methodological challenges associated with self-reported 
measures of absenteeism, for practical purposes economic evaluation research is better 
suited to use of self-reported questionnaires, as accessibility to administrative records and 
objective measurement of lost productivity can be very problematic where patients 
undergoing any single intervention will work in different work places. In the case of 
presenteeism, the lack of consensus on the most reliable presenteeism instrument among 
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researchers has probably contributed to limitations in application of presenteeism measures 
within economic evaluation research. Measures adjusting for compensation mechanisms 
and multiplier effects remain challenging, but there is scope for further research in assessing 




2.9.1 Valuation of Absenteeism  
The methodology for valuing productivity loss has attracted the most attention and debates 
among health economists in the area of productivity costing. This section therefore 
highlights the main areas of discussion and research in the theoretical and practical 
literature on valuing productivity costs in relation to absenteeism from paid employment. 
Potential areas for further research are also identified. The discussion focuses on the three 
main approaches to valuing productivity loss in the field of economic evaluation: i) human 
capital method (HCM) ii) friction cost approach (FCA) iii) US Washington panel approach 
(WPA). In current practice, productivity costs are often valued in monetary terms and 
incorporated in the numerator of the cost-effectiveness (C/E) ratio using either the HCM or 
FCA, compared to the alternative of their inclusion in the denominator using the WPA 
(Weinstein et al., 1997).  
 
2.9.1.1 Human Capital method (HCM)   
Productivity losses in this approach are estimated by multiplying the appropriate wage rate 
value with the time loss resulting from absence, disability, premature death or productivity 
37 
 
gains from the intervention in question  (Liljas, 1998; Sculpher, 2001). The traditional 
method for generating monetary estimates of productivity loss is the human capital method 
(Weisbrod, 1961). This approach, based on neo-classical human capital theory (Weinstein et 
al., 1997), uses the gross wage as the unit of value for assessing the present value of lost 
time due to illness, disability or death (Johannesson, 1996). Thus, productivity costs are 
quantified in terms of foregone earnings during absence, with time lost being valued until an 
individual’s retirement age (Johannesson and Karlsson, 1997). This approach can lead to the 
generation of very high productivity cost estimates. 
 
Therefore, although grounded in economic theory, the method has been criticised for 
estimating potential productivity loss as opposed to actual productivity loss, hence reporting 
overestimated costs (Koopmanschap et al., 1995; Koopmanschap and Rutten, 1996). The 
HCM has also been criticised for distributional allocations that favour specific groups of the 
population. For example, working men tend to earn higher wage rates than women, the 
elderly and minority groups, leading to different cost estimates that are potentially more 
favourable for those in employment and in working men (Tranmer et al., 2005). Some have 
however argued that while most researchers have used a single industry wage rate, a 
variation of wage-rates such as adopting the minimum wage or group specific wage-rates 
can be applied to reduce consequent equity issues (Jacobs and Fassbender, 1998; Berger et 
al., 2001). The search for the most appropriate wage-rate to use, in assessing foregone 





2.9.1.2 Friction cost approach (FCA)  
The high costs associated with the human capital method have attracted many critiques, 
with the most notable being Koopmanschap and van Ineveld who argued that the human 
capital method estimates potential costs as opposed to actual costs since it fails to consider 
compensation mechanisms and replacements dynamics existing within organisations 
(Koopmanschap and van Ineveld, 1992) . They argued that the existence of involuntary 
unemployment and compensation mechanisms within organisations would inevitably limit 
productivity losses related to absence, disability, and death. Koopmanschap and van Ineveld 
(1992) therefore developed the friction cost approach based on the argument that 
productivity loss is limited to the period required to restore production levels within an 
organisation during a period of time known as the friction period (Koopmanschap and van 
Ineveld, 1992; Koopmanschap et al., 1995). This period depends on the time it takes to 
replace and train a replacement worker either from the unemployed or employed ranks of 
the labour market (Koopmanschap et al., 1997). The method assumes compensation occurs 
as absent employees make up for lost production on return to work or existing internal 
labour reserves can prevent short term production loss (Liljas, 1998; Pritchard and Sculpher, 
2000; Brouwer et al., 2002). In the long-term, replacements could be made to prevent 
further productivity loss.    
  
The main focus is then on what is known as friction costs which broadly encompass lost 
production during the short-term period and costs of hiring and training new individuals 
(Liljas, 1998). In order to generate these costs, information is required on the frequency, the 
length of friction period, the average duration of a job vacancy as a proxy for the length of a 
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friction period, and the valuation of lost production during the absence period 
(Koopmanschap et al., 1995). Vacancy durations depend on the efficiency of the labour 
market to match demand and supply as well as on prevailing unemployment levels. As a 
result, it is important to have country-specific vacancy durations for the appropriate 
application of this method. 
 
The friction cost approach also assumes that work absence results in a less than proportional 
reduction in labour productivity, yielding what is termed as a labour elasticity value 
(Koopmanschap and Rutten, 1996). This is an adjustment factor normally used to correct for 
compensation of work absence during normal working hours. A value of 0.8, originally 
proposed by Koopmanschap et al., (1995), has often been used in practical applications of 
the friction cost approach, suggesting that productivity losses are limited to 80% of 
employee output for absences less than the friction period. The value is based on empirical 
estimates reported by the Dutch Economic Costing Institute (de Koning and Tuyl, 1984). It is 
unclear whether this is representative of UK firms, and to date, no attempt has been made 
to generate a labour elasticity value or investigate the existence of internal labour reserves 
in firms in the UK.  
 
Compared to the human capital method, the friction cost approach often generates lower 
estimates particularly in the long-term and proponents of the approach argue that it 
provides more realistic estimates of lost productivity. Nevertheless, the friction cost 
approach has been criticised both theoretically and practically, primarily from proponents of 
the human capital method. The main theoretical criticisms are that the method has no 
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foundation in economic theory, that it has impracticable assumptions (Luce, 1996; 
Johannesson and Karlsson, 1997; Hutubessy et al., 1999) and that it treats lost leisure time 
as having no value (Liljas, 1998). Moreover, the friction cost approach was criticised for 
being limited to paid work. In response, proponents of the approach, for example, 
Koopmanschap et al. (1997) and Brouwer and Koopmanschap (2005) have argued that the 
method is an attempt to generate more practical and realistic valuations of the productivity 
adjustments that occur in the labour economy. In addition, they argue that leisure is not 
treated as having no value, but that rather at the societal level, it is considered to be equal 
between the ill and replacement individual, hence attracting no associated costs 
(Koopmanschap et al., 1997; Brouwer and Koopmanschap, 2005).   
 
However, the main challenge to date in operationalising the friction cost approach is that 
data are required on the average duration of a job vacancy, elasticity value, the frequency of 
absenteeism episodes, and the duration of each specific period of absence. Such data are 
not always available nor easy to collect, which might have contributed to limited application 
of this approach to date (Tranmer et al., 2005). Further research may help to determine 
alternative approaches that can be used to generate specific absence episodes for 
individuals and friction period values specific to country contexts.   
 
2.9.1.3 The US Panel Cost-effectiveness Approach (WPA) 
The US Panel approach was proposed by the US Panel for Cost-Effectiveness Analysis of 
Health and Medicine guidelines (Weinstein et al., 1996). In this method, which differs 
markedly from the friction cost approach and the human capital method, productivity costs 
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components are said to be valued within the denominator (for example through the QALY 
measure) (Weinstein et al., 1997; Sculpher, 2001; Brouwer et al., 2002). The main argument 
of the proponents is that individuals consider the effects of income loss during health state 
valuations (Liljas, 1998; Pritchard and Sculpher, 2000; Brouwer et al., 2002), therefore 
productivity costs should be included in the denominator of the cost-effectiveness ratio in 
order to avoid double counting. This is the preferred approach for the US Panel’s reference 
case (Gold et al., 1996).  
  
This approach when first published generated much controversy, sparking off a debate 
among economists about inclusion of productivity costs in the denominator or numerator 
(Weinstein et al., 1997; Brouwer et al., 1997b; Brouwer et al., 1997a). Some have argued 
that the presence of social security systems and private compensation schemes that partially 
compensate for income losses due to sickness could lead to misinterpretation of productivity 
costs from a societal point of view when considering the WPA (Brouwer et al., 1997a).   
 
It has also been argued that respondents could find it difficult to determine how health 
states are linked to productivity and income. Indeed, existing studies investigating whether 
and how respondents consider income effects when valuing health states have been largely 
inconclusive (Tilling et al., 2010). Nevertheless, some have found that respondents did not 
incorporate income effects when valuing health states, except in situations where explicit 
instructions were given to the respondents to consider them (Krol et al., 2009). Although the 
WPA potentially offers benefits in preventing double counting of productivity losses, various 
questions remain (Sculpher, 2001). This is evidenced by a review (Pritchard and Sculpher, 
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2000) investigating methods that have been used when incorporating productivity costs in 
economic evaluation studies that found a dearth of studies applying this method within the 
United States. There were no applications of this method found in any UK studies, possibly 
due to the lack of consensus on the appropriateness of the method in the literature 
(Pritchard and Sculpher, 2000).   
   
In recent research contributing to the inclusion of productivity costs in the numerator versus 
denominator debate, Nyman has renewed calls for the US to move away from the WPA to 
one of valuing productivity costs in monetary terms and including them in the numerator of 
the ICER (Nyman, 2012). In order to ensure the exclusion of leisure in the HCM and FCA, 
Nyman proposes the use of health status measures that explicitly incorporate questions 
addressing role functions to capture the impact of sickness on leisure time (Nyman, 2012). 
   
This question of whether to incorporate indirect costs within the QALY component therefore 
remains an important theoretical consideration, although the preferred approach seems to 
be the incorporation of productivity costs in the CEA monetary component. Further 
empirical research on whether individuals consider effects of health states on productivity, 
and consequently income, when valuing health states in the commonly used health state 
valuation measures would be valuable. The evidence to date has been inconclusive, and 
further research could provide greater understanding on how the issue of double counting 




To conclude, there have been many debates in the economic evaluation literature regarding 
the most appropriate approach for estimating productivity costs. In spite of the increased 
literature, however, methodological consensus on the most appropriate method for valuing 
productivity costs has not been reached, although the human capital method seems to have 
been used most often in the UK context (Pritchard and Sculpher, 2000). Some have argued 
that the friction cost approach would be more appropriate in European countries where the 
level of both hidden and registered unemployment is sometimes substantial (Berger et al., 
2001). Applications of the WPA have been limited since not all economic evaluations use 
QALYs and due to the uncertainty about whether income effects of lost productivity are 
really captured by current health state measures (Brouwer et al., 1998; Pritchard and 
Sculpher, 2000).  
 
Further, no consensus exists between the most preferable approach between the HCM and 
FCA as shown in existing national economic guidelines (NMA, 2005; Zorgverzerkeringen, 
2006; CADTH, 2006; Graf von der Schulenberg, 2008). The methodological differences 
between productivity cost valuation methods, coupled with a lack of consensus on the most 
appropriate approach for valuing productivity costs, comprise some of reasons that have 
contributed to the exclusion of productivity costs from economic evaluation studies. There 
remains a gap therefore, of empirical work testing applications of existing approaches such 






2.9.2 Valuation of presenteeism   
Few attempts have been made to comprehensively investigate approaches to valuation of 
presenteeism, with most of the literature limited to development of measurement 
instruments. Consequently, values for presenteeism have not been presented as regularly 
and confidently as in the case of absenteeism (Brooks et al., 2010). The methods used in 
valuing absenteeism, particularly the human capital method, have largely been extended for 
use in the monetary valuation of presenteeism (Lofland et al., 2004; Brooks et al., 2010). The 
human capital method has been adjusted to assess monetary loss by multiplying reduced 
productivity time losses estimated by the appropriate wage rate. 
 
The advantage of using this method is that presenteeism cost estimates can easily be 
calculated (Mattke et al., 2007). Nevertheless, there are limitations in its application, as 
when used in valuing absenteeism, since the HCM does not account for additional wage-
related teamwork and work compensation costs. For example, a colleague could be assigned 
to assist an individual working with limitations in the short-term or an additional worker 
could be hired in the long-run to limit further productivity loss. In such cases, the HCM might 
over or underestimate presenteeism costs. The FCA on the other hand appears not to have 








2.10.1 Progress to date   
Various aspects of productivity cost measurement and valuation in relation to both 
absenteeism and presenteeism have been explored. The debate on the most appropriate 
method for valuing productivity loss has received the most attention, with preference for 
the FCA and HCM. However, to date, little progress among health economists has been 
made towards achieving a consensus on which of these approaches to valuation is most 
appropriate. Nevertheless, the HCM is more prevalent both generally and specifically within 
the UK. In relation to the WPA, empirical studies on income effects in health state valuations 
support the argument of including productivity costs in the numerator (cost side) as opposed 
to the denominator (effects) side of the equation.   
     
Furthermore, although the presenteeism concept has been well received in scientific 
literature, and many productivity loss measurement instruments have been developed and 
validated, the choice of the most appropriate instrument remains a matter of debate. 
Recent developments have also seen the extension of total productivity loss to include 
additional components such as effects of compensation mechanisms and aspects of team 
work on overall productivity costs. In spite of progress in this area, there are still 
opportunities for further research to facilitate standardisation of methods in economic 





2.10.2 Discussion of unresolved measurement and valuation issues  
The significant costs associated with productivity losses warrant further research to ensure 
rigorous and standardised approaches are developed. For example, few attempts have been 
made to compare different self-report methods such as the recall and diary approaches. 
Another area of research that has received little attention in work absence methodological 
research relates to the use of sickness certification records, for example, from the general 
practice sickness certification database in the UK. Only one study (Wynne-Jones, 2008) has 
investigated the comparability of these records with self-reported questionnaire data over a 
short-term period of seven days. However, given the importance of accurately estimating 
sickness absence as a measure of productivity loss, this area provides opportunities for 
further research, particularly where productivity loss is estimated over longer periods. 
Economic evaluation studies linked to certification databases provide an opportunity to 
assess agreement between self-reported sickness absence data and sick leave certification 
data (where available). This is an area explored further in Chapter Six of the thesis.  
 
Although many productivity cost instruments have been developed, there are various issues 
that remain unresolved. Most of these instruments currently rely on self-reported data, 
which are inevitably subject to possible recall errors. However, few studies (Goetzel, 2004) 
have attempted to measure the effect of recall periods on productivity loss estimates. Few 
studies (Ozminkowski et al., 2004; Collins et al., 2005) have attempted to compare 
measurement instruments within the same population, although different instruments have 
different approaches to eliciting presenteeism estimates. Furthermore, presenteeism 
measures have mostly comprised multi-item instruments, while few attempts have been 
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made to review and validate single-item measurements of presenteeism. More information 
is needed on the instruments and methods used when generating presenteeism monetary 
estimates. A systematic review of studies that have reported presenteeism costs is provided 
in Chapter Four of this thesis to contribute to the debate in this area. 
  
The valuation of presenteeism has involved an extension of the HCM as used in the valuation 
of absence. The debate around whether to use the FCA appears to have remained on a 
theoretical level. Applications of the FCA when valuing presenteeism are investigated as part 
of the review of presenteeism studies in Chapter Four. To promote further applications of 
the friction cost approach, the valuation of presenteeism using this friction cost approach is 
explored in Chapter Seven of this thesis.  
 
Similarly, the debate on incorporating of compensation mechanisms and multiplier effects 
assessing the impact of productivity loss on team production has attracted few empirical 
studies (Jacob-Tacken et al., 2005; Zhang et al., 2012; Krol et al., 2012). However, further 
evidence is needed on these aspects of productivity cost valuation, as ignoring them could 
lead to over estimation or underestimation of productivity costs. The application of full 
productivity costs incorporating multiplier effects alongside economic evaluation is explored 
in Chapter Seven of this thesis.  
 
The friction cost approach offers benefits to economic evaluation in generating more 
realistic productivity loss estimates compared with the human capital method. This is 
because the friction cost approach values productivity costs only during the time it takes to 
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replace a given worker. However it remains unclear how often this approach has been 
applied in economic evaluation. Whether and how productivity costs are valued can have a 
significant impact on whether an intervention is cost-effective, particularly in the clinical 
area of back pain. If productivity loss is reduced by using the friction cost approach, then 
current interventions in this area could potentially be misrepresented. Further research is 
therefore needed to extend this approach in current economic evaluation studies within 
relevant settings. The application of the friction cost approach in a UK setting therefore 
forms the major foci of the thesis.  
 
2.10.3 Overall conclusion  
It is critical to have reliable measurement and valuation approaches for absenteeism and 
presenteeism if the application of these costs within economic evaluation is to be realised. 
Given a lack of consensus on a preferred approach for valuation of absenteeism and the 
recent developments in measurement and valuation of presenteeism, this chapter has 
discussed the theoretical and methodological debates and issues in relation to estimation 
and incorporation of lost productivity in economic evaluations towards an increased 
research agenda in this area. Before moving on to empirical work suggested by this chapter, 
it is important to understand more fully how the friction cost approach has been applied in 
the UK and how presenteeism has been measured in economic evaluation studies and these 






CHAPTER THREE  
 
 
Chapter Two provided an overview of the theoretical foundations and practical methods for 
economic evaluation, while it also gives an insight into the role of productivity costs in these 
studies. The aim of this chapter is to systematically review applications of the friction cost 
approach (FCA) in practice. It focuses on assessing whether and how the method has been 
applied in the UK and internationally.  
 
One of the main criticisms of the FCA as discussed in Chapter Two of this thesis is that the 
approach is difficult to apply mainly because of a general lack of specific country context 
parameters for its use. One of the key parameters when using the FCA is the length of a 
friction period, which is the transition period required to replace an absent sick worker in an 
organisation. The other important aspect is the elasticity value which compensates for work 
losses during normal working hours. It has been argued that such data are not always 
available in country-specific settings, which might potentially contribute to limited 
application of this approach (Tranmer et al., 2005). Although the advantages and limitations 
of this method have been clearly highlighted, the number of economic studies that have 
attempted to employ this method, and the country settings of these studies, remains largely 
unknown. 
  
The aim of this review was therefore to identify, synthesise and interpret the findings of 
current economic costing research on applications of the friction cost approach to inform 
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policy decision making in healthcare and current practice. The focus is on original cost-of-
illness and economic evaluation studies in the UK and internationally, on the basis that this 
review will provide insights into parameters used when applying the friction cost approach in 
different settings. These studies are used to assess whether and how the friction cost 
approach has been used to assess productivity costs in practice worldwide. 
 
 
3.2.1 Search strategy 
Based on a protocol designed for this thesis, systematic literature searches were conducted 
to identify relevant studies that have valued productivity costs in the literature using the 
friction cost approach. Articles including friction cost related costs were identified in two 
ways: 1) database searches 2) searching bibliographies of identified papers. Searches were 
conducted in the following health bibliographic databases: MEDLINE, EMBASE, PsycINFO, ISI 
Web of Science and the specific health economics database NHS Economic Evaluation (NHS 
EED).    
 
The database searches were initially conducted during November 2010, covering the period 
from 1996 to November 2010, and were limited to those in English for pragmatic reasons. 
This period was chosen in order to reveal the most recent literature on applications of 
friction cost approach. All searches were subsequently updated until 30th April 2013.  
 
The search strategies used for the database searches were based on the following key pre-
defined search keywords: ‘friction cost’ OR ‘friction cost approach’ OR ‘friction cost method’ 
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OR ‘friction period’. Where relevant, Medical Subject Headings (MeSH) containing the words, 
friction costs, friction cost approach, and friction approaches were exploded. A bibliographic 
review of retrieved papers, and relevant systematic review papers eligible for inclusion was 
performed to identify any additional studies. Full details of the search strategy used in this 
review are presented in Appendix A.1. 
 
3.2.2 Inclusion and exclusion criteria  
Studies were included in this review if they were cost-of-illness, cost-utility, cost-
effectiveness, or cost-benefit studies. Articles were included if they discussed, described or 
reported:   
1. Monetary estimates of productivity loss using the FCA 
2. Monetary estimates of productivity costs using both the FCA and HCM 
and were excluded if they: 
1. Gave estimates of productivity using either only the HCM or WPA. 
2. Were methodological papers not reporting any monetary costs. 
3. Were articles discussing methods of valuing productivity costs 
4. Were not full papers (such as conference abstracts, editorials and letters). 
 
3.2.3 Data selection and extraction  
Relevant studies were initially identified by their titles and abstracts. After excluding reviews 
and articles not deemed relevant, the next stage involved reviewing full articles to 
determine their relevance. Each study was evaluated to determine its importance and 
relevance for the review based on a set of exclusion and inclusion criteria. Relevant data 
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were extracted, recorded and tabulated from each article based on the extraction criteria 
below:  
 
Part 1: Overview of the study 
 First author  
 Country setting of study  
 Year of study 
 Analytic technique (cost-of-illness, cost-effectiveness, cost-benefit analysis, cost-of-
illness)  
 Condition 
 Data context/Duration 
 
Part 2: Specific methodological valuation approaches 
 Elasticity value/Source,  
 Friction period values/Source  
 Cost of labour measure used  
 Whether compensation mechanisms or multiplier effects were included and how  
 Whether recruitment and training costs were incorporated  
 Macroeconomic effects adjustments  
 Productivity costs reported 



























OvidSP EMBASE  
Potentially relevant studies (N=79) 
OvidSP MEDLINE  
Potentially relevant studies (N=51) 
 
OvidSP PsycINFO  
Potentially relevant studies (N=9) 
 
NHS EED  
Potentially relevant studies (N=47) 
 
Potentially relevant studies identified by 
database search strategy and screened for 
retrieval (n=186) 
Total unique studies to inspect title and 
abstract (n=123) 






Not relevant (n=36) 
Conference abstracts (n=20) 
 
Full text articles retrieved for more 
detailed evaluation (n=55) 
 
Total included in final review (n=46) 
 





Modelling studies (n=13) 







3.3.1 Study selection 
The literature search identified 186 papers. Details of the selection process are illustrated in 
Figure 3.1. As shown in Figure 3.1, 63 were duplicates resulting in a total of 123 papers. Of 
the remaining articles screened for titles, abstracts and where appropriate full-text, 10 were 
reviews, 2 were editorials or letters, 36 were not relevant to the friction cost approach, and 
20 were conference abstracts. All of these papers were excluded. The full text of the 
remaining 55 potentially relevant articles was obtained. A further 18 articles not meeting the 
study criteria were subsequently excluded. The citations within the remaining articles were 
checked in order to identify any additional costing and economic evaluation studies meeting 
the inclusion criteria. This procedure resulted in the inclusion of 9 additional studies. As a 
result, 46 studies met the inclusion criteria for this review after further exclusion (Figure 3.1). 
A full list of the studies included is provided in Appendix A.2. 
 
3.3.2 Overview of the Studies  
Table 3.2 provides general information about the studies included in the review.   
3.3.2.1 Country setting 
The majority (28) of the studies were conducted in the Netherlands. Seven studies were set 
in the United Kingdom, two in Germany, and one in each of Australia, Ireland, Sweden, 
Canada, Spain, Denmark, Austria, Norway and Greece (Table 3.2). One study conducted an 
economic evaluation based on a multinational clinical trial setting and used country specific 
costing (Rutten-van Molken et al., 2007). Another study conducted economic evaluations in 




Table 3.1 provides a summary of the disease conditions identified in this review. The largest 
group of studies were back pain problems followed by depression and mental health related 
disorders. 
 
Table 3:1 Summary of disease conditions identified 
Disease area No of Studies 
Back pain 8 
Depression/mental health 6 
Chronic obstructive pulmonary 
disease 
4 
Limb disorder 4 
Neck pain 3 
Rheumatoid Arthritis 2 
Arthritis  2 
Cardiovascular heart disease 2 
Cancer 2 




Congenital malfunctions 1 
Lung transplantation 1 
Tubal pregnancy 1 
Obesity 1 
Physical activity 1 
Breast and prostate cancer 1 
Stroke 1 
Haemodialysis 1 
Gestational hypertension 1 
 
3.3.2.3 Economic analysis approach and data context 
Of the 46 studies, 33 used information obtained through randomised clinical trials (RCT), 
nine were national prevalence based studies, one was an observational study, one a national 
survey and two were economic costing studies based in a hospital setting. Thirty-one studies 
were cost-effectiveness analyses, of which five incorporated cost-utility analysis. Thirteen 
were economic cost-of-illness studies, and one used both CEA and CBA (Table 3.2). 
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Table 3:2 Summary of the studies included in this review 
 First author Year Country Perspective Condition Analytical technique Data 
Context/Setting 
Study Duration 
1 Borghouts et al 1999 Netherlands Societal Neck pain COI Prevalence based  1 year 
2 Bosmans et al  2000 Netherlands Societal Major depression CEA/CUA RCT/Treatment 1 year 
3 Brouwers et al 2007 Netherlands Societal Minor mental 
disorders 
CEA RCT 2 years 
4 Brunenberg et al 2005 Netherlands Societal Hip& knee 
replacement 
CEA/CUA RCT/Treatment 12 months 
5 De Brujin et al 2007 Netherlands Societal Shoulder complaints CEA RCT 26 weeks 
6 Dirksen et al 1998 Netherlands Societal Hernia CEA RCT/Treatment 5 years 
7 Van Eijsden et al 2009 Netherlands Societal Upper limb no specific 
disorder 
CEA RCT 1 year 
8 Fautrel et al 2007 Canada Societal Rheumatoid Arthritis COI Convenience 
sample/survey 
1 year 
9 Gallefos and Bakke 2002 Norway Societal COPD CEA, CBA RCT 1 year 
10 Goossens et al 1998 Netherlands Societal Low back pain CEA RCT 3 years 
11 Hakkaart-van Roijen et al 2006 Netherlands Societal/NHS Depressive disorder  CUA RCT/Treatment 1.5 years 
12 Hakkaart-van Roijen et al 2004 Netherlands Societal Bipolar disorder COI Costing/ Treatment 3 years 
13 Hanley et al 2012 Ireland Societal/employer Breast and Prostate 
cancer 
COI COI 1 year 
14 Huscher et al 2006 Germany Societal Rheumatic arthritis 
(RA), ankolysing 
spondylitis, psoriatic 
arthritis (AS), systemic 
lupus (SL). 
COI National treatment 
database 
1 year 
15 Hutubessy et al 1999 Netherlands Societal Back pain  COI Prevalence based 1 year 
16 Jellema et al 2007 Netherlands Societal  Low back pain CEA  C-RCT 1 year 
17 Kaitelidou et al 2005 Greece  Haemodialysis  COI  1 year 
18 Korthals- de Bos  et al  2003 Netherlands Societal Neck pain CEA RCT 1 year 
19 Lewis et al 2007 United Kingdom Societal/NHS Neck pain CEA/CUA RCT/Hospital 0.5 years 
20 Liem et al 1997 Netherlands Societal Hernia CEA RCT/Treatment 1 year 
21 Luengo Fernandez et al 2006 United Kingdom Societal Cardiovascular disease COI Prevalence/National 
study 
1 year 





23 Luijsterburg et al 2007 Netherlands Societal Sciatica CEA RCT 1 year 
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 First author Year Country Perspective Condition Analytical technique Data 
Context/Setting 
Study Duration 




25 Mc Eachan et al 2011 United Kingdom Societal Physical activity CEA RCT 1 year 
26 Mol et al 1999 Netherlands Societal Tubal pregnancy CEA RCT 3 years 
27 Neovius 2012 Sweden Societal Obesity COI costing 38 years 
28 Nikken et al 2005 Netherlands Societal Acute peripheral join 





29 Oliva et al 2005 Spain Societal Cervical and Breast 
cancer 
COI National data 1 year 
30 Poley et al 2001 Netherlands Societal Congenital anorectal 
malfunctions  
CEA RCT 1 year 
31 Ponto et al 2013 Germany Societal Graves orbitopathy COI Observational study 4 years 






33 Rutten-Van Molken 2007 Netherlands Societal/NHS COPD CEA RCT/Multicentre 12months 
34 Saka et al 2009 United Kingdom Societal Stroke  COI Prevalence-based 1 year 
35 Smit et al 2006 Netherlands Societal Depression CEA RCT 12 months 
36 Soegaard et al 2007 Denmark Societal Low back pain CUA RCT 4- 8 years 
37 Stant et al 2003 Netherlands Societal Schizophrenia CEA RCT/Treatment 18 months 
38 Steenstra et al 2006 Netherlands Societal Low back pain CEA/CUA  RCT 2 years 
39 Steuten et al 2007 Netherlands Societal Diabetes CUA Hospital 
setting/Treatment 
2 years 
40 Steuten et al 2006 Netherlands Societal Asthma/COPD CEA Pre-post study  24 months 
41 Van de hout 2009 Netherlands Societal Rheumatoid Arthritis CUA RCT/Treatment 2 years 
42 Van de Roer et al  2008 Netherlands Societal Low back pain CEA RCT 52 weeks 
43 Van Enckevort 1997 Netherlands Societal/life-time Lung transplantation CEA Cohort study 12 months 
44 Van Schayck et al 2009 Netherlands Societal Constructive 
obstructive pulmonary 
disorder 
CEA RCT/Treatment 1 year 
45 Van Tubergen et al 2002 Austria/Netherlan
ds 
Societal Ankylosing Spondylitis CEA/CUA RCT 10 months 




3.3.2.4 Analytical Horizon   
In terms of the length of the study, 27 studies were carried out over a period of one to two 
years, 9 a period of two or more years, and the rest of the studies for a period shorter than 
one year (Table 3.2).   
 
3.3.2.5 Study perspective   
In this review, all studies adopted a societal perspective, of which nine also used a 
healthcare perspective and one also used an employer perspective (Hanly et al., 2012) (Table 
3.2).  
 
3.3.3 Methodological aspects of valuing productivity costs  
3.3.3.1 Length of friction period considered  
The key parameter when valuing productivity loss using the FCA is the friction period. Overall, 
35 (76%) studies explicitly reported the length of the friction period used, of which only 13 
(31%) stated the source of this estimate. The reported length of a friction period from the 
studies identified was between 2 and 6 months (Table 3.3).   
 
The length of the friction period has mostly been assessed as a single value, yet some have 
argued that there are potential differences between individuals that could lead to an 
estimation of inaccurate societal costs for interventions (Koopmanschap and Rutten, 1996). 
The review found only one study that attempted to use disaggregated friction period 
estimates (Hutubessy et al., 1999). This study, from Ireland, used estimates of 2.8 and 3.3 
months for individuals having received basic education and intermediary education 
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respectively, with these estimates being taken from a previous piece of methodological work 
in the Netherlands (Koopmanschap et al., 1995).   
 
Additionally, the friction period depends on the level of unemployment (availability of labour) 
and the ability of the labour market to match demand and supply of labour, factors that 
differ across different countries. It is therefore important to have a length of friction period 
relevant to the particular setting. In this investigation, the majority of studies from the 
Netherlands provided clear sources for the friction period value used. Where reported, the 
source of the length of friction period originated from the Netherlands, with the exception 
of one study (Maniadakis and Gray, 2000) that used friction period estimates from the UK, 
one from Germany (Ponto et al., 2013), and one from Ireland (Hanly et al., 2012).  
   
3.3.3.2 Friction costs to the employer  
Friction costs to employers are the costs of filling a vacancy and training new personnel if an 
employee is to be replaced permanently. There is generally a dearth of information on the 
friction costs to employers. From the review, the majority of studies did not attempt to 
estimate friction costs to the employer. Only one study from Denmark provided estimates of 
the employers’ friction costs, reporting employer replacement costs of $1670 (Soegaard et 






Table 3:3 Detailed extractions of friction cost approach methodological details 






















0.8/ Koning and 
Tuyl, 1984 










3 Brouwers et al.,2006 Netherlands 154 days  
 
Lamers, 2005 0.8/ 
Oostenbrink J et 
al., 
, 2004. 




Mean income by 
age and gender. 
NI 
4 Brunenberg et al., 
2005 








5 De Brujin et al.,2007 Netherlands 154 days  Koopmanschap 
et al., 1995. 
NI NI NI Absence 
days/Cost diaries 
NI NI 





7 Van Eijsden et 
al.,2009 
Netherlands 154 days,  Koopmanschap 
et al, 1995. 
NI NI NI Number of days 
absent/Question
naire 
Average wage NI 






9 Gallefos and Bakke., 
2002 
Norway NI NI 0.7/Source no 
provided 













et al, 1992 







11 Hakkaart-van Roijen 
et a., 2004 







12 Hakkaart-van Roijen Netherlands 154 days NI NI NI NI Absence/questio Standard friction NI 
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18 Korthals- de Bos  et 
al., 2003 
Netherlands 122 days  NI NI NI NI Days of inactivity  
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NI 
19 Lewis et al., 2007 United 
Kingdom 



































































154 days,  Koopmanschap, 
1995. 
NI NI NI Number of days 
absent/Question
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Mean income of  
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90 days  NI NI NI NI Days of certified 
incapacity/Depar
tment of social 
security 
Average wage NI 
25 McEachan et al., 2010 United 
Kingdom 
NI NI 0.8 NI NI Days off 
work/questionnai
re 
Median UK Wage 
rates 
NI 







27 Neovius et al., 2012 Sweden 6 months Van de Hout et 
al 2009 














Age and sex 
friction cost data 
Oostenbrink et al 
2000 
NI 





NI NI NI NI NI Mean income by 
age and sex 
NI 






31 Ponto et al., 2013 Germany 58 days Regional 
employment 
office 


























32 Rivero-Arias et al., 
2010 







33 Rutten-Van Molken 
et al., 2007 
Netherlands 154 NI NI NI NI Days /hours 
/questionnaire 
Weighted 








certified days off 









Age and sex 
friction cost data 
Oostenbrink et al 
2000 
NI 
36 Soegaard et al.,2007 Denmark 3 month 
friction period  
NI NI Replacing an 
employee 
=USD 1670; 





Gross income in 
age and gender  
 
NI 




38 Steenstra et al.,2006 Netherlands 122 days  Oostenbrink et 
al., 2002. 
NI NI NI Days on sick 
leave/ postal 
questionnaires 





39 Steuten et al., 2006 Netherlands NI NI NI NI NI No of sick days 
off/questionnaire 
NI NI 






41 Van de hout et al., 
2009 





42 Van de Roer et al ., 
2008 
Netherlands NI NI NI NI NI Hours of 
absenteeism 
Mean wage by 
age and gender. 
NI 
43 Van Enckevort et al., Netherlands 3 months Average NI NI NI Absence Average wage NI 
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44 Van Schayck et al., 
2009 






costs per hour 
NI 








Gross earnings of 
patients 
NI 






*NI Not included in study
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3.3.3.3 Labour elasticity value  
Another key component of the FCA relates to the elasticity value. The identified studies were 
evaluated to determine if the elasticity of labour time versus labour productivity value 
(elasticity value), often used to adjust for short-term work compensations, was applied 
within the studies. The studies were also assessed for inclusion of multiplier effects that 
have been reported to have a significant impact on overall productivity costs (Krol et al., 
2012). In this review, there were no studies that included costs resulting from negative 
impacts of absenteeism or presenteeism on teamwork, substitutability or overall 
productivity (multiplier effects). Furthermore, none of economic evaluation studies included 
specific compensation mechanisms that have been shown to significantly reduce the impact 
of productivity costs on total societal costs (Jacob-Tacken et al., 2005).  
 
In relation to the elasticity of labour value, the review found that only 9 out of the 46 studies 
reviewed explicitly reported results using the elasticity correction factor (Brouwers et al., 
2007; Borghouts et al., 1999; Hutubessy et al., 1999; van den Hout et al., 2009; Hanley et al., 
2003; Gallefoss and Bakke, 2002; Ponto et al., 2013; Van Schayck et al., 2009; McEachan et 
al., 2011). Of these, seven used an elasticity value of 0.8 originating from the Netherlands 
(Koopmanschap et al., 1995), while one study (Gallefoss and Bakke, 2002) used a value of 0.7 
without providing a clear source. One study from Germany used varying elasticity values (1, 
0.8, and 0.3) for varying sick leave periods, but provided no clear source for these values 
(Ponto et al., 2013). The majority of the studies included in the review, however, did not 




3.3.3.4 Medium-term macro-economic effects 
Another important factor when using the FCA is the occurrence of medium term 
macroeconomic consequences outside the friction period resulting from sickness, disability 
and treatment (Koopmanschap et al., 1995). A macro-econometric model has previously 
been recommended as a way of estimating macro-economic consequences of work absence 
and disability (Koopmanschap et al., 1995). The economic evaluation studies identified 
focussed on generating short-term friction costs, and the majority did not explicitly estimate 
a medium term effect or report using the model by Koopmanschap and colleagues (Table 
3.3). Only three cost-of-illness studies from the UK accounted for medium-term impact by 
adjusting productivity loss for rate of economic activity and current unemployment 
alongside the friction period (Saka et al., 2009; Luengo-Fernandez et al., 2006; Liu et al., 
2002).  
 
3.3.3.5 Valuation of productivity costs 
The valuation of productivity costs using the friction cost approach should consider the 
duration of absence in relation to that of the friction period. Often, productivity losses of 
absence periods shorter than the friction period are adjusted with the labour elasticity value. 
Productivity costs of absences longer than the friction period are assumed to be equal to the 
full cost during the friction period (Koopmanschap et al., 1995). 
 
In this review, the majority of studies did not provide enough details to identify whether this 
adjustment was carried out, and neither was the actual estimation approach used clearly 
documented. Such a lack of detail makes it difficult to compare the calculations used by the 
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different studies. Only one study (Ponto et al., 2013) was identified as having explicitly 
applied elasticity values for varying sick-leave periods (Table 3.3).  
 
3.3.3.6 Cost components and productivity loss data context 
Indirect costs broadly include a variety of costs such as productivity losses (absenteeism and 
presenteeism), and informal costs such as family or relative costs. All 46 studies reviewed 
included the estimation of lost time due to absence from paid working time, with one study 
(Smit et al., 2006) incorporating reduced productivity loss using the FCA. None of the studies 
incorporated leisure related costs. Fifteen studies estimated monetary benefits of unpaid 
labour, while four included patient travel related costs (Table 3.3).  
 
The majority (38 of the 46 studies) used days/hours absent from work as the productivity 
losses component whose cost was assessed (Table 3.3). Four of the studies used certified 
days of incapacity as the productivity loss component (Maniadakis and Gray, 2000; Saka et 
al., 2009; Rivero-Arias et al., 2010; Liu et al., 2002). The rest of the studies did not provide 
details of the productivity metric used to estimate the reported productivity costs. Only two 
studies (Rutten-van Molken et al., 2007; Hakkaart-van Roijen et al., 2004) reported recording 
start and end dates of each absence spell (which is required to successfully apply the friction 
cost approach). The data sources for time loss were: national department dataset (four 
studies), cost-diaries (seven studies), and questionnaires (21 studies), with the remaining 





3.3.3.7 Value of lost labour   
A variety of measures have been used to assess the value of foregone earnings. The 
following measures were used in the majority of studies: a wage for the relevant age-sex 
dependent group (19) and an average wage for all groups (18). The exceptions were a 
weighted average of gross wage (Rutten-van Molken et al., 2007), median wage-rate 
(McEachan et al., 2011), and gross earnings of study participants (Van Tubergen et al., 2002). 
Seven studies reported using the age-group gender based productivity cost per hour from 
the Dutch costing manual (Brunenberg et al., 2005; van Roijen et al., 2006; Liem et al., 1997; 
Smit et al., 2006; Van Schayck et al., 2009; Steuten et al., 2007). The value of foregone 
earnings could not be established in the remaining four studies (Table 3.3).  
 
  
The aim of this systematic review was to assess economic costing studies in which the 
friction cost approach has been used in valuing productivity costs in the UK and 
internationally. It focused on cost-of-illness and original economic evaluation studies. The 
systematic review identified several studies internationally and a very small number in the 
United Kingdom, and provides valuable information to understand methodological 
applications and shortcomings of the friction cost approach. The findings showed wide 
variations in the friction cost approach valuation methodology, highlighting the need to 
increase transparency in the way in which the method is applied and to generate country 
specific economic parameters. The results were presented in two major categories: (i) an 




The systematic review results showed wide variations in friction period estimates from 
different countries, an overall lack of transparency in data sources of these estimates, and 
how aggregated productivity costs were calculated. Moreover, few applications of 
disaggregated friction periods have been generated, with only one study being identified. 
Estimates of the labour elasticity factor and aspects of compensation mechanisms, multiplier 
effects and medium-term macro-economic effects were largely ignored in the studies 
reviewed. Overall, costing studies incorporating the friction costing approach are still rare, 
which could perhaps be attributed to the lack of standardised country context economic 
parameters.  
 
The findings from this review are in agreement with previous literature assessing the 
estimation of productivity costs in practice (Pritchard and Sculpher, 2000). In their 
comprehensive review, Pritchard and Sculpher identified 40 economic evaluation studies of 
which only seven used the friction cost approach. The findings from their review indicated 
that in a number of studies, the methods used to estimate productivity costs were not 
clearly stated, and they advocated improvements to the reporting of productivity costing 
methods. This was particularly the case for studies applying the friction cost approach and 
the US Panel cost-effectiveness approach. Nevertheless, the systematic review in this 
chapter differs from this study in two major ways. Firstly, Pritchard and Sculpher (2000) 
assessed applications of the three productivity cost valuation methods. The systematic 
review in this chapter focusses in greater detail on applications of the friction cost approach 
and hence complements the findings from their review. Secondly, they review only 
economic evaluation studies from the Health Economic Evaluation Database. This review 
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considers cost-of-illness and economic evaluation studies from various databases and 
therefore provides a more comprehensive assessment of the current state of the literature.  
 
Currently, there is very limited evidence on reported friction period estimates within the 
United Kingdom. The reported friction period values for the United Kingdom did not include 
explicit details of relevant data sources (Maniadakis and Gray, 2000; Lewis et al., 2007; Saka 
et al., 2009; Rivero-Arias et al., 2010). In addition, few attempts have been made to 
disaggregate friction periods according to different population groups (Koopmanschap et al., 
1995; Hutubessy et al., 1999). Koopmanschap et al. (1995) previously reported friction 
period estimates disaggregated by education level in the Netherlands. No such estimates 
have been generated in the United Kingdom. 
 
Overall, the systematic review results presented and discussed here highlight a need for 
clearer, structured approaches on how studies apply and report methods of the friction cost 
approach in current practice. Currently, gaps exist in identifying up-to-date valid estimates of 
important factors such as a length of friction periods and elasticity factor relevant for specific 
country settings. Applications of the friction cost approach have routinely relied on 
economic parameters not clearly reported or specific to their country settings. Only one 







Strengths and limitations  
The systematic review has some strengths and limitations. One strength is the diverse range 
of databases from which studies were identified. In addition, the review comprehensively 
assesses cost-of-illness and original economic evaluation studies to provide important 
information on how data relevant for the friction cost approach has been generated. 
Although care has been taken to include all relevant studies, it should be noted that in 
searching the literature, some studies that estimated productivity costs using the friction 
cost approach may have been missed. In the search, specific terms to the method such as 
“friction period” and “friction cost approach” were used to identify studies. Although more 
general terms such as “productivity costs” could have been used, in the context of this study 
(for studies in all disease areas estimating productivity costs), these could have significantly 
increased the number of potential abstracts. Thus, a decision was made to go for a search 
strategy that was more specific to the friction cost approach. This strategy may have missed 
studies that used the friction cost approach, but did not use any of these key words in the 
abstract and were not registered in the chosen databases. Moreover, the review limited the 
chosen studies to original economic evaluations with modelling studies excluded. This is 
because the review aimed to assess how friction cost approach related data is practically 
collected and generated in practice. Additionally, potentially relevant studies could have 
been excluded due to the search strategy employed in the review protocol that excluded 
non English articles and was initially based on reviewing abstracts and titles of papers. 
However, attempts were made to comprehensively review relevant databases and citations 




Implications for policy and research  
Given the limited number of economic evaluation studies that have applied the friction cost 
approach in the UK, these findings provide valuable information for researchers and policy 
makers. Irrespective of the methodological challenges identified, additional economic 
evaluation studies applying the friction cost approach are required in the UK to provide 
further evidence that will enable the comparison of cost estimates with other valuation 
methods and further knowledge on standardised approaches of using the friction cost 
approach.  
 
The general lack of explicit economic parameters necessary for applications of the friction 
cost approach in the UK context necessitates prospective studies estimating the length of a 
friction period, and how this potentially varies in different subgroups. Other potential areas 
of research include assessing labour elasticity values relevant for the United Kingdom. 
Analysis of friction costs to the employer in training and recruiting replacement workers 
should also be considered in such studies. 
 
 
In summary, information on applications of the friction cost approach in economic 
evaluations in the UK and internationally is scarce and the reported methods where applied 
are unclear. Given a lack of consensus among economists on the most preferred approach 
for valuing productivity costs, this review has critically reviewed applications of the friction 
cost approach in cost-of-illness and economic evaluation studies. It has revealed important 
gaps, requiring improvements in reporting methodological aspects of the friction cost 
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approach. One of the most important issues is the lack of any evidence of appropriate 
friction periods for the UK, and the absence of information about how the friction periods 


















Chapter Three comprised a systematic literature review assessing productivity costs in 
practice using the friction cost approach. The aim of this chapter is to report on a further 
systematic review, in this case, of the assessment of presenteeism costs in current practice. 
The chapter also reports on a scoping review identifying currently existing instruments 
developed for the purpose of measuring reduced productivity at work.  
 
The chapter begins by providing a background to the systematic review. This is followed by 
the methods used to identify the articles considered for this review and the approaches used 
in extracting the necessary information. The literature obtained on the methodological 
issues around assessing presenteeism in practice is then discussed. Finally, an overall 
discussion and conclusion is provided, highlighting implications of the findings, and gaps in 
the current research.  
 
  
Most national economic guidelines, adopting a societal perspective, currently recommend 
inclusion of absenteeism costs, but not presenteeism (Knies et al., 2010). One of the main 
criticisms with considering presenteeism in costing studies is a lack of consensus about the 
methodological approaches that should be used to generate monetary estimates from 
existing measures (Johns, 2010; Brooks et al., 2010). In spite of the growing debate on the 
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appropriateness of including these costs in economic evaluation, whether and how 
presenteeism costs are estimated in economic studies remains largely unknown. The 
systematic review aims to contribute to the debate by providing an overview of existing 
presenteeism instruments and evaluating whether and how presenteeism has been assessed 
in economic studies. 
 
The research objectives for this review were: 
(i) To identify current instruments used in measuring health-related reduced productivity. 
This was investigated via a review of systematic literature review studies  
(ii) To assess presenteeism costs in practice. This was assessed by systematically reviewing 
and identifying scientific publications that have reported monetary estimates of 
presenteeism. The review will contribute to current research questions in this growth area. 
 
  
4.3.1 Search strategy  
The review presented in this chapter involved a two stage process.  In the first stage, an 
evaluation of existing systematic reviews reporting presenteeism instruments was 
undertaken from a variety of databases as part of a scoping review exercise to identify and 
populate a list of existing presenteeism instruments. The scoping review was also used to 
assess the breadth of literature on the estimation of presenteeism from these databases. 
Subsequently, a structured systematic review was undertaken to identify economic studies 
that have reported presenteeism costs based on a protocol designed for this thesis. This was 
also to assess whether and how the existing presenteeism instruments identified in the first 
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stage have been used in the measurement of presenteeism within economic evaluation 
practice. Papers relevant to this review were identified in two ways: (i) bibliographic 
database searches (ii) searching bibliographies of papers identified. The searches were 
conducted in three key databases spanning the medical sciences (MEDLINE) and behavioural 
sciences (PsycINFO) commonly used in the systematic reviews identified in the scoping 
exercise, and in health economics (NHS EED). The NHS EED database was included to provide 
a more comprehensive assessment of the costing literature. 
  
The database searches were conducted in January 2011, with no starting date limitation, in 
order to provide an in-depth analysis of existing instruments and costing studies limited to 
those in English. However, all searches were updated to 30th April 2013. The search 
strategies used for the database searches were based on the following pre-determined key 
words: used in the main search were ‘presenteeism’ or ‘reduced productivity’, or 
‘productivity costs’ or ‘lost productivity’ or ‘work limitations’ or ‘work productivity’ or ‘work 
performance’ and subsequently in conjunction with the terms ‘cost and cost analysis’ or 
‘cost-effectiveness analysis’ or ‘cost-utility analysis’. Where relevant, MeSH headings were 
exploded.  A similar search strategy was used to search for relevant papers in the PsycINFO 
and NHS EED. A bibliographic review of all retrieved papers, other electronic sources, and 
systematic review studies relevant to this review was performed to identify any additional 






4.3.2 Inclusion and exclusion criteria  
Two broad categories of studies were considered for this review: The first involved including 
all relevant systematic review studies detailing rating scales of presenteeism. In the 
systematic review, articles were included if they discussed, described or reported:   
 
1. Systematic review studies detailing rating scales measuring presenteeism. 
2. Economic evaluations or cost-of-illness studies reporting presenteeism estimates.
 
and were excluded if they were:  
1. Studies reporting absenteeism only costs 
2. Methodological papers not providing any monetary estimates of presenteeism  
3. Letters and reviews not relevant to this investigation.  
4. Not full papers (such as conference abstracts, editorials and letters). 
  
4.3.3 Data extraction strategy 
Relevant information for this systematic review was initially identified by reviewing abstracts 
of all studies and/or by reviewing their titles. After excluding articles that were not found to 
be relevant, full articles for the remaining studies were downloaded and assessed for 
relevance to the review based on the pre-set inclusion and exclusion criteria. Relevant 




Part 1: Overview of the study 
 First author/year  
 Country of setting 
 Analysis technique (cost-of-illness, cost-effectiveness, cost-benefit analysis, cost-of-
illness) 
  Condition 
 
Part 2: Specific methodological valuation approaches 
 Instrument used/recall period  
 Monetary conversion method  
 Productivity related domains included 
 Whether compensation mechanisms were included  






























Articles identified from reviewing literature 
reviews and other sources (n = 17) 
Studies excluded 
Not relevant to estimation of 
presenteeism costs (n=27) (reviews 
n=2, Protocol (n=1), Secondary 
sources of presenteeism (n=4) Model 
(1) 
 
Potentially relevant studies 
OvidSP MEDLINE (n=387); OvidSP PsycINFO (n = 
139) 
NHS EED (n=21);  
Additional records identified through 
hand searching references of studies (n = 
5) 
Potential relevant studies identified and 
screened for Abstracts and titles (n=564) 
Full Articles retrieved (n=56)  
Duplicates removed (n=16) 
Articles meeting inclusion criteria 
(n=21) 
Final costing studies included (n=26)  
 
Potential relevant studies identified 
and screened for Abstracts and 
titles (n=548) 
 
No monetary estimates (n=102) 
Reviews not relevant to 
presenteeism (n=55) 
Abstracts (n=12) 
Absence/Other costs (n=245) 








The literature search identified a total of 564 potential articles from the three databases 
(387 from Medline, 139 from PsycINFO, 21 from NHS EED and 17 through hand searching). 
As shown in Figure 4.1, 16 of these were duplicates resulting in a total of 548 articles. Details 
of the selection process are illustrated in the flow chart (Figure 4.1). The screening of the 
titles and abstracts against the exclusion and inclusion criteria resulted in a total of 56 
potentially full articles.  The full texts of the remaining 56 potentially relevant papers were 
obtained and assessed. Of these, 21 articles met the inclusion criteria for the review. Five 
additional articles were identified through reviewing citations within the identified papers 
resulting in a total of 26 articles meeting the inclusion criteria. A full list of the studies 
included is provided in Appendix B.2. 
 
An initial search that was not systematic also identified 12 systematic literature review 
studies that have evaluated various aspects of presenteeism measurement instruments. 
From these, a comprehensive list of currently existing presenteeism measures was 




Table 4:1 Summary of productivity loss instruments from literature review 
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4.4.1 Characteristics of the scoping review  
4.4.1.1 Frequency 
The evaluation of systematic reviews reporting on presenteeism instruments identified 24 
instruments (Table 4.1). Each of these instruments was then assessed for frequency of 
appearance in at least one systematic review. The findings indicated that the most 
commonly cited presenteeism instrument was the Work limitations Questionnaire (WLQ), 
appearing in all 12 literature review studies. This was closely followed by the Health and 
Work Performance Questionnaire (HPQ), Work productivity and Activity impairment 
questionnaire (WPAI), Health and Labour Questionnaire (HLQ), and Health and Work 
Questionnaire (HWQ) which appeared in 9, 8, 8, and 7 of the review studies respectively 
(Table 4.1). 
  
4.4.1.2 Generic versus Disease specific 
Three of the instruments including the Migraine Disability Assessment Questionnaire 
(MIDAS), Angina-Related Limitations at Work Questionnaire (ALWQ), and Migraine Work and 
Productivity Loss Questionnaire (MWPLQ) were disease specific questionnaires, while the 
other 21 measures were all generic measures used to assess productivity loss for various 
health conditions. The Work Productivity Activity Impairment Questionnaire (WPAI) was 
created as WPAI general health (WPAI-GH) or WPAI specific health (SH) with similar 
templates only varying in response to the health status being considered for various disease 
conditions. For this review, the specific questionnaires are all reported as part of the original 




4.4.1.3 Presenteeism versus Absenteeism measurement 
The findings showed that only two of the identified instruments, the Work Limitations 
Questionnaire (WLQ) (e.g. (Lerner et al., 2008)) and Stanford Presenteeism Scale (SPS) 
(Collins et al., 2005) exclusively measure presenteeism.  
 
4.4.2 The assessment of presenteeism costs in practice 
The findings presented thus far have provided an overview of existing instruments 
measuring presenteeism in the scientific literature. The following section presents and 
describes the results on how often they have been used in empirical studies.  
 
4.4.2.1 Country setting 
Table 4.2 shows an overview of the studies included in the systematic review. These studies 
originated from eight countries. The majority of the studies identified were from the United 
States (US). The others were from the Netherlands (Boonen et al., 2010; Uegaki et al., 2011), 
from Canada (Zhang et al., 2008; Daley et al., 2009; Li et al., 2006), the United Kingdom 
(Finkelstein et al., 2010), Sweden (Hellgren et al., 2010), and Thailand (Thavorncharoensap et 
al., 2010).  
 
Two multi-country based studies were also identified. One study reported costing estimates 
from Australia, US and the United Kingdom (UK) respectively (Hilton et al., 2008). Another 
study reported cost-estimates from 8 European countries including Germany, Italy, Lithuania, 




Table 4:2 Summary of economic costing studies from review 






Primary measure reported Findings (% -  percentage of total) 






HLQ/ 2 weeks Average wage Presenteeism 
and 
Absenteeism 
Extra work hour’s needed to compensate 
for inefficient hours. 
Annual presenteeism costs: €967; 
Absenteeism €1832 per patient per 
year.  Percentage of total not provided.  
2 Braakman-
Jansen et al 
.,2012 







WPAI: Degree of problems affecting work 
productivity past 7 days on a scale of 0 to 
10. 
 
PRODISQ/QQ: Quantity and quality of 
work on an 11-point NRS from 0 to 10) 
WPAI; Annual presenteeism costs: 
318(73%) and 72(92%) for intervention 
and control.  
Annual absenteeism costs: 116(27%) 
and 6(8%).  
 
PRODISQ/QQ: Annual presenteeism: 
299 (71%) and 154 (95%) for the 
intervention and control. 
Annual absenteeism costs: 120 (29%) 
and 9 (5%). 
  
3 Burton et 
al.,2002 









Work days of reduced productivity  Annual presenteeism: $21.5M (60%) 
Annual Absenteeism: $24.4M (40%).  
 






Not clear Presenteeism 
only 
% of time the respondent was limited in 
performing a specific dimension of job 
tasks 
Annual Presenteeism costs: $1392 to 
$2592 per employee per year.  
Annual Extrapolated to $99M to 
$185M entire population.  
5 Cisternas et al., 
2003 









Reduced work hours due to asthma Annual costs: $4912, Indirect costs: 
$1732 (35%). Presenteeism (28%). 
6 Collins., 2005 US COI/ Chronic 
conditions 
SPS and WOS/ 4 
weeks 
National average 
wage-rates per job 
type/ HCM variant 
Presenteeism 
only 
Percentage of “usual” productivity not 
achieved in the 4-week period. 
Annual costs per employee: $661 
absenteeism, and $6721 Presenteeism. 
10% of total labour costs. 6.8% 
presenteeism. 
7 Daley et al., 
2009 







Extent to which insomnia is responsible 
for reduced productivity on a 0-10 scale.  
Absenteeism $970.6 million 
Presenteeism $5 billion (76%) 










Primary measure reported Findings (% -  percentage of total) 









% reduction in productivity and estimate 
of time lost during past 7 days. 
Presenteeism ($555 to $3792); 
Absenteeism ($85 to $1026) 
9 Fishman and 
Black ,1999 











Degree to which headache affects normal 
activities on a scale of 0 to 10.   
Presenteeism greater than 
absenteeism. Monetised findings not 
included.  







3 months, 12 
months 
National Hourly 
wage rates/ HCM 
Presenteeism 
only 
Number of days when the employee was 
at work but not feeling well, missed hours 
at work. Rate at which performance was 
reduced because of health problems. 
Annual presenteeism:  61% of total 
cost in 10 conditions. 
11 Goetzel et 
al.,2010 





% of time the respondent was limited in 
performing a specific dimension of job 
tasks due to obesity. 
Annual absenteeism and presenteeism 
($2596). Direct costs ($2842). % 
monetised values not incorporated. 
12 Hellgren et 
al.,2010 









Number of days at work with 
rhinitis and self-reported 
productivity while at work during 
the last month/year 
Annual: € 2.7 billion.  




13 Henke et 
al.,2000 
US COI/ PUD and 
GERD 
General 








Reduced productivity  because of PUD or 
GERD 
Presenteeism: Annual PUD costs per 
year $205 (28%), Annual GERD $72 
(27%). 






HPQ/4 weeks Mean Wage-rates 
ONS from UK and 




Performance of an average person 
working in a similar job to patient as well 
as patients own on a self-anchoring scale 
of performance of 0 to 10 (worst to best). 
Annual total costs USD$11.1 billion. 
Presenteeism % not provided. 










Number of unproductive hours spent at 
work during the recall period. 
No monetary details provided of total 
costs. 
16 Lerner et al., 
2008 
US CEA/Fibroids WLQ/2 weeks Average wage/HCM  Presenteeism 
only 
% of time the respondent was limited in 
performing a specific dimension of job 
tasks (%) due to Fibroids. 
Annual Presenteeism: $2341 for 
intervention group; $836 for control 
group. Annual Absenteeism: $2044 for 
intervention group and $540.2 for 
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Primary measure reported Findings (% -  percentage of total) 
control group. % of total not provided.   




% of time the respondent was limited in 
performing a specific dimension of job 
tasks (%) due to Arthritis. 
Total Annual costs: $11,553 
Presenteeism: $4724 (41%)   
 














days at work when the amount done was 
≥ 50% reduced productivity counted as 1 
day of reduced productivity). 
Annual  cost per person:  
£ 1222; Absenteeism: £371 
Presenteeism: £ 765 (63%). 
 
19 Ricci and Chee, 
2005 





 average amount of time between arriving 
at work and starting work on days when a 
worker is not feeling well and the average 
frequency of engaging in five specific 
work behaviours (ie, losing concentration, 
repeating a job, working more). 
Annual cost:  $11.70 billion per year. 
Presenteeism 67% total costs. 








number of work cut-back days as the 
number of days actually worked when ill, 
multiplied by a self-reported inefficiency 
score, which ranged between 0 and 1 (0, 
as efficient as when in good health; 1, 
totally inefficient). 
Annual presenteeism, intervention: 
€2232(33%); Annual total costs: €6766; 
 
Annual presenteeism ,control: 
€3175(39%); Annual total costs: €8614; 
 










Reduced work hours on days at work 
during the recall period quantified based 
on responses to 6 questions. 
Total cost $61.2 billion, absenteeism: 
$14.4 bn, presenteeism: $46.9 bn 
(76.6%). Presenteeism for Arthritis 
(84.4%) and Back pain (69.7%). 










Reduced work hours on days at work 
during the recall period quantified based 
on responses to 6 questions. 
Total productivity costs: $225.8 billion 
per year. Most costly conditions 
included pain (headache, low back 
pain, Arthritis). On average, 
Presenteeism 71% of total costs.  
23 Thavorncharoe
nsap et al., 
2010 
Thailand COI/ Alcohol 
consequences 
Questions from 
WPAI 1 week 





The degree to which the health problem 
affected regular activities evaluated on a 
scale of 11 points, ranging from 0 (no 
effect on work) to 10 (health problem 
prevent person from working). 
Annual Total costs: $ 9,627 million 
Annual Presenteeism: $ 2,804 million 
(29% total). Mortality costs: $6,422 
million. 
 




COI/Maternity HPQ/2 weeks Not included/ HCM Presenteeism 
and 
Decreased work performance due to a 
health problem at 18-, 24- and 52-weeks 
Annual presenteeism, intervention: 
€765(40%); Annual total costs: €1911; 
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Primary measure reported Findings (% -  percentage of total) 
Absenteeism post-partum. Annual presenteeism, control: €655 
(38%); Annual total costs: €1734. 
Overall costs, Indirect costs (37%) 
presenteeism (52%). 















Hours actually worked; degree illness 
affected productivity while working from 
0 (no effect) to 10 (maximum 
impairment); and the degree to which 
illness affected regular activities (from 0-
10).  
Total costs: $41,992 Indirect Costs: 
$16,108.Absenteeism: 
$3402.Presenteeism $5,750.  
Presenteeism (14% total costs).   
26 Zhang et 
al.,2008 












HLQ: single question 
asking how many extra hours individuals 
would have to work to catch up 
on tasks they were unable to complete in 
normal working hours due to 
health problems in the past 2 weeks 
WPAI: impairment while working due to 
health problems in the past 7 days are 
measured on a scale of 0–10. 
WLQ: a 25-item questionnaire 
asking about the frequency of difficulty 
over the past 2 weeks 
over 4 domains of work: time 
management, physical demands, mental- 
interpersonal, and output demands.  
HPQ: overall performance 
on the days they worked during the past 7 
days on a scale of 0–10, 
with 0 indicating total lack of performance 
during time on the job and 10 
indicating no lack of performance during 
time on the job.  
$30.03, $83.05, $284.07, and $285.10 
(HLQ, WLQ, HPQ, WPAI) over 2 a period 
of weeks.  
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4.4.2.2 Disease area 
In general, a range of diseases were covered by the studies and the articles varied from 
national survey based costing studies covering various conditions to cost estimates from 
specific disease conditions. The most common conditions included obesity (Ricci and Chee, 
2005; Goetzel et al., 2010; Finkelstein et al., 2010), rheumatoid arthritis (Zhang et al., 2008; 
Li et al., 2006; Stewart et al., 2003b), migraine (Linde et al., 2012; Fishman and Black, 1999; 
Burton et al., 2002) and insomnia (Daley et al., 2009). Details of the diverse set of conditions 
included are reported in Table 4.2.  
 
4.4.2.3 Economic analysis approach and data context 
The majority of the studies were cross-sectional in design, but two were clinical trials (Smit 
et al., 2006; Uegaki et al., 2011). Three of the studies were cost-effectiveness analyses 
(Snedecor et al., 2009; Smit et al., 2006; Uegaki et al., 2011) while the other twenty-five 
were all cost-of- illness studies (Table 4.2).   
 
4.4.2.4 Type of instrument 
In total, nine presenteeism instruments were identified from the final 28 studies included in 
the second stage of the systematic review (See Table 4.3). Reduced productivity loss was 
measured by a self-constructed questionnaire or visual analogue scale or standardised 
questionnaire. The most commonly used standard questionnaire was the WLQ (Li et al., 
2006; Goetzel et al., 2010; Lerner et al., 2008), followed by the WHI (Ricci and Chee, 2005; 
Stewart et al., 2003a; Stewart et al., 2003b), and the WPAI (Thavorncharoensap et al., 2010; 
Finkelstein et al., 2010; Wilson et al., 2010). Other currently used multi-question instruments 
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included the SPS (Collins et al., 2005) , HLQ (Boonen et al., 2010), PRODISQ (QQ) (Braakman-
Jansen et al., 2012) and HPQ (Hilton et al., 2008). The remaining studies used a self-
constructed global presenteeism question to identify the value of reduced productivity, 
based on a global response 0 – 10 scale (Linde et al., 2012; Fishman and Black, 1999; Daley et 
al., 2009; Burton et al., 2002; Goetzel, 2004; Cisternas et al., 2003; Hellgren et al., 2010; 
Henke et al., 2010) (Tables 4.2,4.3). One study used a modified version of the WLQ (Burton 
et al., 2005) 
Table 4:3 Summary of productivity loss instruments identified from the systematic review assessing  

















No. Instruments used/recall Productivity metrics assessed Study 
1 Health and Labour 
Questionnaire (HLQ) 
Presenteeism and Absenteeism Boonen et al.,2010; Zhang et al.,2008 
2 Quantity and Quality method 
(PRODISQ (Q-Q)) 
Presenteeism and Absenteeism Braakman-Jansen et al .,2012 
3 Work productivity and Activity 
impairment questionnaire 
(WPAI) 
Presenteeism and Absenteeism Braakman-Jansen et al .,2012; Finkelstein 
et al., 2010; Thavorncharoensap et al., 
2010; Wilson et al.,2010; Zhang et 
al.,2008 
4 Stanford Presenteeism Scale 
(SPS)  
Presenteeism only Collins., 2005 
5 Work Limitations 
Questionnaire (WLQ)  
Presenteeism only Goetzel et al.,2010; Lerner et al., 2008; Li 
et al., 2006;  Burton et al.,2005 
6 World Health Organisations 
health and work performance 
questionnaire (HPQ) 
Presenteeism and Absenteeism Hilton et al.,2008; Uegaki et al., 2011; 
Zhang et al.,2008 
7 Work productivity Short 
Inventory (WPSI) 
Absenteeism and Presenteeism Lamb et al., 2006 
8 Work and Health Interview 
(WHI) 
Presenteeism and Absenteeism Ricci and Chee 2005, Stewart et 
al.,2003a; Stewart et al.,2003b 
9 Global presenteeism question  Presenteeism only Burton et al.,2002, Cisternas et al., 2003, 
Daley et al., 2009; Fishman and Black 
,1999; Goetzel et al.,2004; Hellgren et 




4.4.2.5 Productivity loss conversion and monetisation approaches.  
Measurement approaches to presenteeism varied among the identified studies. Productivity 
metrics used by the different studies included estimations of percentage reduced 
productivity, hours needed to compensate for reduced productivity, and overall 
performance assessed using a 0-10 scale. Studies using the WPAI, HLQ and HPQ instruments 
generated productivity loss estimates that were directly translatable into productivity loss, 
while the estimates from the SPS, WLQ, WHI, and QQ could be transformed into reduced 
productivity loss after making some assumptions. In general the approaches used by the 
different studies are summarised in three approaches including direct estimation of 
productivity loss in hours, estimation of perceived percentage loss, and comparative 
approaches of estimates between individuals and employees.  
  
The direct approach generates productivity loss values in a similar way to the approach used 
in obtaining absenteeism productivity loss. A typical question involves asking respondents to 
estimate “the total hours you were unproductive because of an illness”. The duration 
considered as unproductive can sometimes incorporate different work-related aspects. For 
example using the WHI, presenteeism has been estimated from a combination of questions 
such as the average number of hours with low concentration at work, when working more 
slowly than usual, when feeling fatigued at work, and as the time in between arriving at 
work and starting work on the days when an employee is sick (Ricci and Chee, 2005). 
Alternatively respondents are asked to estimate the extra hours that would be needed to 
compensate for inefficient hours as used by the HLQ (Zhang et al., 2008; Boonen et al., 2010). 
The obvious ease of this approach is that it generates a directly usable productivity metric in 
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lost hours. Comparisons with other presenteeism measures suggests this approach 
underestimates values (Zhang et al., 2010b).  
 
The second approach involves asking respondents to provide a perceived overall estimate of 
how much illness has hindered or affected their performance at work. This was the most 
common approach (17 (80%) studies). With these studies the productivity metrics used 
included asking respondents to provide a percentage loss of productivity at work due to 
illness (Braakman-Jansen et al., 2012; Goetzel et al., 2010). For example articles using the 
WLQ, obtained an estimate of the percentage presenteeism loss (or gain) from respondents 
compared to a baseline or benchmark value for each Individual (Lerner et al., 2008; Goetzel 
et al., 2010). An alternative version of this approach involved asking respondents to provide 
an estimate of how illness has affected their performance at work on a 0 –10 scale which 
was then converted into a percentage productivity loss (Finkelstein et al., 2010; Wilson et al., 
2010). Studies using the WLQ (Li et al., 2006; Goetzel et al., 2010; Lerner et al., 2008) and 
SPS (Collins et al., 2005) also assessed perceived limitations in different work function 
domains and for different work aspects. The output from these different domains is often 
then summarised to generate an index which is interpreted as a percentage loss attributed 
to reduced productivity. Conversion of outputs from presenteeism measures assessing 
productivity loss for different work domains remains a complex process. For example, the 
process involved in translating multi-item scores from the WLQ and SPS into an overall score 
involves converting the range of responses from the different domains into percentages 




In the remaining studies an estimate of perceived reduced productivity was estimated using 
non-standard stand-alone single-item questions. Such questions were often used as part of a 
wider questionnaire with a global question asking respondents to either estimate perceived 
impairment on a scale of 0-10 or percentage reduction at work due to illness (Linde et al., 
2012; Fishman and Black, 1999; Daley et al., 2009; Burton et al., 2002; Goetzel, 2004; 
Cisternas et al., 2003; Hellgren et al., 2010; Henke et al., 2010). However, the validity of such 
questions when used as part of a general survey questionnaire of the respective disease 
conditions has not been established.  
 
The third approach from the HPQ questionnaire, found in three studies (Hilton et al., 2008; 
Uegaki et al., 2011; Zhang et al., 2008), involves comparing presenteeism estimates of a 
respondent with those of a colleague in a similar work role or of the respondent in full 
health. Normally, this will be done on a on a scale of 0 (worst performance at work) to 10 
(best performance).  
 
4.4.2.6 Monetisation approaches   
The generation of presenteeism monetary estimates from all the studies identified was 
based on salary conversion approaches. More specifically, with the exception of Smit et al. 
(2006) who used the friction cost approach, the remaining 25 studies explicitly or implicitly 
applied the human capital method using the standard formula: .  
 
A variety of measures were used to assess the value of foregone earnings, and these 
included: an average wage for all groups  (Lerner et al., 2008; Goetzel et al., 2010; Collins et 
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al., 2005; Boonen et al., 2010; Hilton et al., 2008; Cisternas et al., 2003; Braakman-Jansen et 
al., 2012; Li et al., 2006; Thavorncharoensap et al., 2010), age-sex dependent wage-rates 
(Daley et al., 2009; Finkelstein et al., 2010; Fishman and Black, 1999; Linde et al., 2012), and 
a self-reported gross salary (Ricci and Chee, 2005; Henke et al., 2000; Stewart et al., 2003b; 
Wilson et al., 2010) (Table 4.2). The wage-rates used differed in terms of being hourly, 
annual or daily wage-rates. 
 
None of the studies adjusted presenteeism costs for aspects of compensation mechanisms, 
multiplier effects, or included any additional costing elements in the presenteeism 
calculation. 
 
4.4.3 Monetary estimates of presenteeism in current practice 
The level of detail provided on presenteeism cost estimates varied across studies (Table 4.2). 
In total, findings from the review studies show that economic costs of presenteeism were 
reported either in monetary terms or as a percentage of the overall total cost of the illness. 
The results demonstrate that presenteeism is a major economic burden in many health 
conditions. In most studies presenteeism costs accounted for a greater percentage of total 
costs than absenteeism or sick leave, and comprised a significant proportion of the total 
costs of illness reported. 
 
Seventeen studies reported productivity costs as a percentage of the overall total costs of 
the disease condition investigated (Ricci and Chee, 2005; Smit et al., 2006; Henke et al., 2000; 
Fishman and Black, 1999; Collins et al., 2005; Cisternas et al., 2003; Hellgren et al., 2010; 
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Stewart et al., 2003a; Stewart et al., 2003b; Wilson et al., 2010; Goetzel, 2004; Burton et al., 
2002; Daley et al., 2009; Braakman-Jansen et al., 2012; Li et al., 2006; Linde et al., 2012; 
Thavorncharoensap et al., 2010; Uegaki et al., 2011). In the remaining articles, it was not 
possible to extract reduced productivity costs as a percentage of overall costs due to a 
limited level of detail for the cost items. As can be seen in Table 4.2, productivity costs 
reflected on average 52% (ranging 28% to 85%) of the total costs of the disease conditions 
investigated.    
  
In studies that provided a limited level of detail for percentage productivity costs in relation 
to overall total costs, five included costs that enabled a comparison between absenteeism 
and presenteeism (Lerner et al., 2008; Collins et al., 2005; Boonen et al., 2010; Finkelstein et 
al., 2010; Linde et al., 2012). In these studies, productivity loss estimates from presenteeism 
were greater than absenteeism costs.  
 
The three cost-effectiveness studies within this review included productivity losses related 
to presenteeism, but did not provide enough detail to assess the impact of presenteeism on 










The present systematic review was designed to identify studies that have assessed 
presenteeism costs in practice. Presenteeism measures that have been used to generate 
presenteeism costs were identified from both cost-of-illness studies and economic 
evaluations. The systematic review sought to provide insights into existing presenteeism 
instruments, and to assess variations and gaps in the estimation of presenteeism costs. 
 
The results from this systematic review show variations in approaches for estimating 
monetary estimates in existing presenteeism instruments. Another important finding was 
that a number of studies applied global, single-item, standalone presenteeism questions. 
The lack of validity information from the studies using global presenteeism questions shows 
the importance of investigating whether such questions provide valid responses when used 
outside standardised questionnaires. When reported, the economic burden associated with 
presenteeism was clearly highlighted with significant costs associated with various illnesses. 
In most cases presenteeism costs were greater than those for absenteeism and comprised 
the majority of the total costs in most studies.  
 
The systematic review provides further insights into the most commonly applied instruments 
in the economic studies identified. With regards to measurement, the current systematic 
review found that there was variation in the approach used to generate presenteeism loss 
estimates, and in recall periods. Studies used different quantification approaches, and wage-
rate values to generate monetary estimates. It is interesting to note that, given the 
significant costs associated with presenteeism related multiplier effects and possible 
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compensation mechanisms, no studies considered these costs. Moreover, the majority of 
studies used the human capital method when valuing presenteeism. Only one study from 
the Netherlands used the friction cost approach, but did not provide any detail of how this 
application was applied (Smit et al., 2006). 
 
Nine standardised presenteeism instruments used to assess presenteeism costs were 
identified from the review. Each of the instruments identified is associated with its own 
advantages and limitations. For example, direct estimation of time loss enables a direct 
translation of time loss output into productivity costs, but creates challenges in identifying 
appropriate ways of accurately deriving time loss related to aspects of unproductive time 
and extra-hours. In terms of practical application, the approach of deriving perceived time 
loss while working has often been used because of the ease in obtaining estimates from 
respondents. The drawback with this approach is that the presenteeism loss estimates 
generated cannot be compared against any benchmark values as in the case of comparative 
presenteeism measures. Moreover, multi-item and multi-dimensional presenteeism 
instruments in particular are associated with increased responder burden, time and costs 
which could potentially limit consideration of presenteeism costs, suggesting that a single-
item questionnaire may be of value. The validity of non-standardised single-item 
presenteeism questions as identified in this systematic review has not been explicitly 
reported in the studies in which they are normally used. 
 
The findings of this systematic review further support the idea of the general lack of 
consensus about the most appropriate presenteeism measure. The findings of this review 
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are consistent with those of Schultz et al., (2009) who found wide variations in the monetary 
valuation approaches for on-the-job reduced productivity. Few studies (Ozminkowski et al., 
2004; Meerding et al., 2005; Zhang et al., 2010b) have attempted to cross compare 
measurement instruments within the same population, and these have found varying 
presenteeism estimates from these instruments. Little is therefore known about the most 
appropriate method for generating monetary estimates of presenteeism.  
 
The systematic review here generated results from the valuation of presenteeism that 
corroborated the findings of a previous methodological systematic review that found no 
attempt to apply the friction cost approach to US studies (Mattke et al., 2007). Relatively 
similar findings were reported in the systematic review in this chapter, as only one study 
from the Netherlands generated presenteeism costs using the friction cost approach. The 
remaining studies all generated presenteeism costs using the human capital method. The 
strengths and limitations associated with this method were discussed in Chapter Two. 
Notably, however, the method ignores internal work structures aimed at mitigating 
productivity losses, as well as multiplier effects resulting from effects of presenteeism on 
overall team productivity. In such cases, the human capital method might generate either 
over or underestimated productivity costs. Empirical research exploring how to extend the 
friction cost approach to valuing presenteeism is necessary.  
 
To date, little evidence exists on presenteeism cost estimates in the UK. The majority of 
studies included in this review were cost-of-illness studies, indicating gaps in research on 
economic evaluation studies incorporating presenteeism costs and their impact on overall 
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cost-effectiveness results. These findings could possibly be explained by a recent review of 
national economic guidelines clearly showing that the inclusion of presenteeism and work 
compensation costs in economic analysis is not recommended for the majority of national 
economic guidelines (Knies et al., 2010).  
 
Strengths and limitations  
The systematic review presented and discussed in this chapter has some strengths and 
limitations. One strength is that it provides a comprehensive review of studies that have 
assessed presenteeism costs in practice, highlighting how often presenteeism instruments 
have been used in empirical studies. Moreover, the review is based on databases of health 
economics, medical and behavioural science disciplines, hence providing a comprehensive 
overview of existing cost-of-illness and original economic evaluation studies in the literature. 
It provides important information on how presenteeism costs are assessed in practice. A 
limitation of the review is that although major databases were comprehensively searched, it 
is possible that eligible studies may have been omitted. In addition, modelling studies and 
studies not in English were excluded from this review, which may potentially have 
contributed to the small number of economic evaluation studies included in the review. 
These studies were excluded because the focus of the review was to assess how reduced 
productivity data is collected, measured and valued in primary research.  
 
Implications for policy and research 
Given the on-going debates in the measurement and valuation of presenteeism in economic 
evaluations, these findings provide valuable information for researchers and policy makers. 
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One of the issues that emerge from this review is that there is a scarcity of economic 
evaluation studies incorporating aspects of presenteeism, the effects of presenteeism on 
team productivity, and effects of work compensation mechanisms. In light of the significant 
costs associated with reduced productivity, economic evaluation results could be severely 
underestimated where effects of reduced productivity and associated work-related 
compensation mechanisms are not taken into account. The results indicated that 
productivity costs ranged from 28% to 85% of the total costs associated with various 
diseases, and therefore deserve more attention. Regardless of the lack of a standardised 
method estimating presenteeism related costs, empirical economic evaluation studies 
including presenteeism costs are needed. Increased transparency in the calculations and 
methods used in quantifying and generating these monetary estimates should be 
encouraged to ensure sound and rigorous methods are used.  
 
The results from this review provide some support for exploring applications of single-item 
global presenteeism questions as they may offer potential advantages in collecting 
presenteeism estimates at reduced costs, with more simplicity and reduced burden. 
However, more research on these measures needs to be undertaken as their validity as 
standalone measures has not been identified. No attempts have been made to compare 
output from commonly used standardised questionnaires and standalone single-item 
presenteeism questionnaires. Further research on this area is also recommended.  
 
A further key issue that emerges from this review is the limited application of the friction 
cost approach in valuing presenteeism. This is an important issue for further research to 
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foster consistency of methods used to estimate absenteeism. Studies investigating 
applications of the friction cost approach in valuing presenteeism could take into account 
the impact of incorporating compensation mechanisms and multiplier effects due to 
presenteeism. Other potential areas of research, although beyond the scope of this thesis, 
include investigating the impact of different recall periods on presenteeism estimates when 
measuring presenteeism and extrapolation approaches for productivity loss estimates 
obtained in short-term periods.  
 
 
In conclusion, there is potential for further methodological and empirical developments in 
measuring and valuing presenteeism. Currently, the number of studies including 
presenteeism costs in economic evaluation remains small and monetary generation 
approaches vary widely. The findings here have provided a systematic review assessing 
presenteeism costs in practice. They have revealed important gaps in measurement, 
valuation and incorporation of these costs in economic evaluations and the significant 
economic burden associated with presenteeism. One of the most important issues is the lack 
of any evidence on the validity and responsiveness of a single-item presenteeism question in 
specific disease conditions, and the general lack of the impact of presenteeism related costs 
on cost-effectiveness results. Obtaining better evidence on these areas is thus one of the 
major foci of this thesis. 
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CHAPTER FIVE  
   
This chapter provides an overview of the clinical area of low back pain. The chapter explores 
the nature, aetiology, prevalence and incidence of the condition as well as the risk factors 
associated with its occurrence and development. The approaches used to manage non-
specific low back pain are discussed, with reference to current national guidelines. A review 
of literature on the management of non-specific low back pain and evidence for the cost-
effectiveness of existing interventions is then provided and discussed. The economic burden 
of the illness is presented, with a particular focus on total societal costs in the UK and 
internationally. Finally, an overview of the data sets to be used in this thesis is provided. 
 
 
Back pain is a common disorder affecting nearly five million people each year within the UK 
and is one of the most common reasons for general practice consultations (Hay et al., 2008; 
Foster et al., 2010). The condition is associated with significant resource use, absenteeism, 
and long-term disability, with serious implications for individuals, families and society at 
large (van Tulder and Waddell, 2005). 
 
Low back pain is defined as pain, discomfort, stiffness in the lower back region with or 
without referred leg pain (van Tulder et al., 2002; NICE, 2009a). Low back pain is classified 
into either non-specific (simple) or specific back pain. Non-specific low back pain is pain, 
soreness, tension or stiffness in the lower back that cannot be associated with any specific 
identifiable cause (Weiner and Nordin, 2010; NICE, 2009a). Most often, non-specific low 
104 
 
back pain is characterised by disability and pain (Koes et al., 2006). Simple back pain 
normally lasts for a period of between 6 weeks and 12 months. On the other hand, specific 
low back pain is associated with particular identifiable conditions such as hernia, 
osteoporosis, and rheumatoid arthritis (Krismer and van Tulder, 2007; Cohen et al., 2008). 
The majority of low back pain sufferers experience some form of non-specific low back pain 
(Koes et al., 2006). This thesis is based on two datasets reporting the outcome and cost data 




5.3.1 Types of non-specific low back pain (NSLBP)    
There are three types of non-specific low back pain: acute, sub-acute and chronic. This 
categorisation relates to the duration of the condition (Krismer and van Tulder, 2007). Acute 
non-specific LBP is pain that lasts for less than 6 weeks while sub-acute non-specific LBP lasts 
for between 6 weeks and 12 weeks (van Tulder et al., 2002). Back pain that persists beyond 
12 weeks is classified as chronic LBP (van Tulder et al., 2002). Chronic non-specific LBP 
sufferers, if not managed properly, can end up with significant disabling long-term pain and 
disability (Adams, 1997). In most cases, however, non-specific low back pain resolves quickly, 
with 90% of patients ceasing consultations within 4 - 12 weeks (Croft, 1998).   
 
5.3.2 Prevalence of low back pain  
Low back pain is a very common problem among adults in all age groups and prevalence 
rates tend to increase with age and among working age adults (van Tulder et al., 2002; 
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Dionne et al., 2006). The prevalence however decreases in population groups after 
retirement (Dionne et al., 2006). 
 
There is no general consensus on the prevalence, although many studies have been 
conducted to assess prevalence rates, with similar findings from different countries and 
settings. Differences in prevalence rates arise from the definition of low back pain used, the 
study design, and the way in which the data was collected (Jones and Macfarlane, 2005). 
Moreover, there are inherent challenges in estimating incidence rates of low back pain since 
the cumulative incidence of first back pain episodes is often high by early adulthood (Dionne 
et al., 2006). As such, the majority of studies have investigated prevalence of low back pain 
as either a period (e.g., one, two years or life time) or point estimates (i.e., at a specific time 
point) (Hoy et al., 2010b).  
 
Estimates of point, one year and life-time prevalence vary considerably between studies and 
countries. International comparisons show point prevalence rates ranging from 12% to 30%, 
12-month prevalence ranging from 50% to 67%, and life-time prevalence ranging from 10% 
to 80% (Cassidy et al., 1998; Koes et al., 2006; Mortimer et al., 2006; Ihlebaek et al., 2006; 
Hoy et al., 2012). Low back pain has been reported to be more prevalent among females and 
adults aged 40 years and over (Hoy et al., 2012). Prevalence rates also tend to vary by 
country. For example, the point prevalence was 50% in France (Rossignol et al., 2009), 68% 
in Australia (Walker et al., 2004), and 34-39% in the UK (Hillman et al., 1996). The life-time 
prevalence was estimated at 61% in the UK (Hillman et al., 1996), 20-69% in Canada (Cassidy 
et al., 1998), 61% in Norway and 70% in Sweden (Ihlebaek et al., 2006).  
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In the UK population one-year prevalence was on average 40% (Hillman et al., 1996; DOH, 
1999), one month prevalence was 29% (Macfarlane et al., 2012), and point estimates 19% to 
40% (Hillman et al., 1996; Macfarlane et al., 2012). Two UK studies suggest there are no 
significant differences in prevalence rates between men and women, with prevalence rates 
of 29% and 27% (Macfarlane et al., 2012), and 34% and 37% (Croft, 1998) respectively. The 
high prevalence rates from the various studies and countries demonstrate the importance of 
the condition. 
 
5.3.3 Incidence of low back pain  
The estimates from literature show that one year incidence rates among patients reporting a 
first ever episode of low back pain ranged from 6% to 15%, while those for any episode 
ranged from 2% to 36% (Hoy et al., 2012). Studies specific to the United Kingdom have 
reported first ever episode incidence rates ranging from 3% to 6% (Papageorgiou et al., 1996; 
Croft, 1998; Waxman et al., 2000). 
 
5.3.4 Identification of low back pain  
One of the main challenges in back pain management is the uncertainty related to the 
diagnosis of low back pain patients, particularly in the case of non-specific low back pain 
(Deyo and Phillips, 1996). The assessment of back pain involves the use of a classification 
system focussed on screening for ‘red flags’ (indicators for potential serious conditions), 
neurological problems, and identification of possible psychosocial and workplace risk factors 
(van Tulder et al., 2002). This classification system enables the distinction between specific 
or non-specific low back pain conditions in order to determine appropriate management 
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strategies of low back pain and to identify the most appropriate options for treating 
individuals (Weiner and Nordin, 2010). Box 5.1 below provides a summary of the most 













Modified from Koes et al., 2006 and Cohen et al., 2008 
 
5.3.5 Aetiology of low back pain  
In addition to prevalence, incidence and identification, epidemiological researchers have 
provided evidence examining the risk factors associated with occurrence and chronicity of 
low back pain (Macfarlane et al., 2006). Current models attempting to identify the cause of 
low back pain involve an interaction of various factors that can be classified into individual, 
psychosocial and occupational factors as presented and discussed below.   
Box 5.1: Red flag conditions indicating possible underlying spinal pathology or nerve root 
problems  
Red flags 
 Non-mechanical pain (unrelated to time or activity) 
 Non-responsive to care 
 Thoracic pain 
 Widespread neurological symptoms 
 Weakness in limbs 
 Pain at multiple sites 
 Previous history of carcinoma, steroids, HIV 
 Feeling unwell 
 Unexplained weight loss 
 Structural spinal deformity 
 Osteoporosis 
 
Indicators for nerve root problems 
 
 Unilateral leg pain  
 Severe lower extremity pain 
 Radiates to foot or toes 
 Abnormal deep tendon reflexes 
 Numbness and paraesthesia in same distribution 
 Straight leg raising test induces more leg pain 




5.3.5.1 Individual factors 
Although results from studies tend to vary, research demonstrates that the most common 
individual factors associated with development of low back pain include social demographic 
factors such as age, gender, occupation, and education status. Other individual factors 
reported in the literature include smoking, levels of physical activity, obesity, pain radiating 
in leg, and poor strength of back muscles (Macfarlane et al., 2006; van Tulder et al., 2002). 
The initial occurrence of LBP often takes place between the ages of 20 and 40 (Adams, 1997).  
 
The literature indicates that the evidence relating to smoking is inconclusive with some 
finding weak associations between smoking and the occurrence of low back pain (Leboeuf-
Yde, 1999) and others finding strong associations, particularly among young adults (Shiri et 
al., 2010). Similarly, the evidence supporting gender differences in LBP sufferers is relatively 
mixed with some epidemiological studies reporting higher LBP estimates among women 
(McIntosh et al., 2000; Macfarlane et al., 2006), and others finding weak evidence to support 
gender differences among LBP sufferers (Turner et al., 2000; Hayden et al., 2005).    
 
5.3.5.2 Psychosocial factors 
The relationship between back pain, psychological and psychosocial factors has been 
investigated in epidemiological studies investigating predictors of low back pain onset or 
poor outcomes (Breen et al., 2005; Macfarlane et al., 2006). Studies show that the most 
common psychosocial risk factors leading to LBP occurrence and long-term back pain 
conditions include avoidance of activities based on fear (fear avoidance), depression, beliefs 
about pain, emotional instability, anxiety, cognitive dysfunction, mental distress and long-
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term multiple physical disorders (somatisation). Fear avoidance has been found to be a key 
psychological factor significantly associated with disability in long- term back pain conditions 
(McIntosh et al., 2000; Pincus et al., 2002; Grotle et al., 2010). 
 
There is also evidence showing that depression and distress increase the risk of long-term 
LBP disability, especially in the early stages (Pincus et al., 2002). Moreover psychological 
distress has been linked to the persistence and development of chronic back pain (Linton 
and Nordin, 2006), as well as to delays in returning to work among low back pain sufferers 
(Crook et al., 2002). Further evidence among primary care consulters in the UK has shown 
that having negative perceptions about the low back pain condition, depression and distress 
are significant predictors of poor low back pain outcome in the long run (Foster et al., 2008). 
 
5.3.5.3 Occupational factors   
Low back pain injuries have been associated with disability, lost work days and significant 
cost to the work place (Freburger et al., 2009). As a result, researchers have focused on 
identifying various aspects of work and the work environment that are likely to influence the 
risk of back pain development. The most common occupational risk factors associated with 
individuals developing low back pain include physical jobs that involve frequent bending, 
twisting, physically heavy manual work, sedentary work, static postures and vibrations 
(Punnett and Wegman, 2004). The evidence shows increased risk of long-term absence from 
work resulting from physical factors of lifting, carrying, and pulling heavy weights and loads 




Occupational psychological related factors such as job stress, job dissatisfaction, 
unemployment and lack of social support at work are also associated with an increased risk 
of the future occurrence of back pain as well as persistence in low back pain (Hoy et al., 
2010a; Shaw et al., 2009). Moreover, persistent low back pain has been strongly associated 
with high job demands, dissatisfaction at the work place (Thomas et al., 1999; Macfarlane et 
al., 2009), and with unemployment among low back pain sufferers (Dunn et al., 2011). 
 
 
5.4.1 Introduction   
The management of low back pain is a key aspect of reducing the economic burden of illness 
to society. Currently, there is no clear cut approach for the treatment and management of 
non-specific low back pain, particularly in individuals with pain and disability lasting more 
than 6 weeks (NICE, 2009a). There is, however, more clarity about the management of acute 
low back pain (i.e. pain lasting less than six weeks) among back pain patients in the existing 
national treatment guidelines. In most cases, the strategy employed aims to ensure 
prevention and targeted management of the condition in order to prevent long-term 
disability.  
 
The ‘stepped up’ care model has been adopted into most of national clinical guidelines (Koes 
et al., 2006; Airaksinen et al., 2006; NICE, 2009a). This model was proposed by Von Korff as a 
system for the management of low back pain in primary care (von Korff, 1999). The theory 
underlying this model is that patients are first introduced to the low-intensive, low-cost 
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interventions, and then moved onto to more intensive, costly or complex interventions 
depending on their response to treatment (Von Korff and Moore, 2001).  
 
5.4.2 An overview of current national treatment guidelines 
The development of national and international guidelines for clinical management of low 
back pain (Airaksinen et al., 2006; van Tulder et al., 2006a; Chou et al., 2007; NICE, 2009a; 
Koes et al., 2010) has been guided by evidence from the numerous randomised clinical trials, 
and cost-effectiveness studies that have been conducted on the management of the illness. 
In most of these guidelines, the recommendations for managing each condition have 
involved applications of the Von Korff ‘stepped up’ care model (Von Korff and Moore, 2001). 
In brief, the current available treatments for non-specific low back pain from the national 
guidelines cited above can be summarised as:  
 
 Early management which involves advising back pain sufferers to stay active and the 
provision of evidence-based educational materials for self-management of LBP; 
 In addition, individuals are also provided with medications such as paracetamol, non-
steroidal anti-inflammatory drugs (NSAIDs), opioids as well as antidepressants and 
muscle relaxants if deemed necessary; 
 For persistent non-specific low back pain, alternative interventions such as spinal 
manipulation, exercises, physiotherapy, mobilisation, cognitive behaviour therapy 





The consensus in most national guidelines in managing chronic or long-term LBP is to 
consider interventions such as combined behavioural therapy, invasive procedures and, in 
some cases, surgical treatment (van Tulder et al., 2006a; Airaksinen et al., 2006; NICE, 2009a; 
Koes et al., 2010). The following section presents and compares the existing treatment and 
management strategies for low back pain, with a consideration of clinical and cost-
effectiveness evidence for these interventions.  
 
5.4.3 Currently available interventions for managing non-specific low back pain 
5.4.3.1 Information and education materials for self-care 
Early management involves providing patients with education and information in relation to 
the nature, causes and impact of the condition to promote self-management strategies. The 
Back Book is one such patient educational material that was produced in the UK to provide 
patients with specific advice on how to cope with back pain in daily life (Burton et al., 1999). 
Such education resources as the Back Book are recommended because they provide 
complementary advice to clinicians and are relatively inexpensive.  
 
There is evidence to suggest that the provision of educational materials alongside other 
interventions such as exercising improves overall patient beliefs and clinical outcomes 
(Burton et al., 1999; Little et al., 2001; Chou et al., 2007). Furthermore, evidence on the 
effectiveness of Back schools and other educational interventions shows that these are more 
effective than interventions such as spinal manipulation, and advice when provided in an 
occupational setting and alongside exercise programmes (Heymans et al., 2004; May, 2010). 
Others have, however, found that advice and educational programmes may influence 
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aspects of behaviour but are not effective in improving low back pain function in patients 
with chronic low back pain (Roberts et al., 2002; Engers et al., 2008).  
 
The advice to avoid bed rest and stay active has been associated with long-term 
improvement of outcomes, particularly among acute patients (van Tulder et al., 2006b). 
Advice to rest in bed compared to staying active has been found to have no effect on low 
back pain and in some instances has been associated with small harmful outcomes for acute 
low back pain patients. (Hagen et al., 2000; Dahm et al., 2010). 
 
The economic evidence on education and advice interventions is largely inconclusive. Advice 
and educational material interventions have been reported as being more cost-effective 
when provided alongside cognitive behavioural therapy (Lamb et al., 2010b), in a combined 
multidisciplinary programme including acupuncture, exercises, dietary advice, and a back 
care book (Herman et al., 2008) than when used alone. However, there is some evidence 
indicating that advice to patients is a more cost-effective strategy than physiotherapy when 
provided in routine primary care practice (Rivero-Arias et al., 2006).  
 
5.4.3.2 Pharmacological interventions  
Pharmacological interventions are often considered as a means of providing acute and 
chronic low back pain patients with short-term pain relief alongside advice to stay active 
(NICE, 2009a; Koes et al., 2010). Such medications include paracetamol, non-steroidal anti-
inflammatory drugs, antidepressants, muscle relaxants, and opioids. National guidelines 
from the UK (NICE, 2009a), the USA (Chou et al., 2007) and the Netherlands (van Tulder et al., 
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2006a) all recommend use of opioids, muscle-relaxants and anti-depressants in addition to 
commonly prescribed NSAIDs. 
 
The evidence shows the effectiveness of NSAIDs and opioids when compared to paracetamol 
in providing short-term relief in patients with non-specific chronic low back pain, but are 
associated with more adverse side-effects in comparison to paracetamol (Roelofs et al., 
2008). Moreover, there is no significant difference in pain relief between NSAIDs and 
paracetamol, although paracetamol tends to have fewer side effects (Roelofs et al., 2008). 
Similarly, muscle relaxants should be used with caution as they are associated with 
significant adverse effects yet are effective in the management of non-specific low back pain 
(van Tulder et al., 2003). 
 
Economic evidence comparing the cost-effectiveness of pharmacological interventions in the 
management of low back pain remains scarce in the UK and internationally. However, a 
study in the US assessing the resource utilisation patterns of chronic low back pain patients 
found that opioids comprised a major cost component of the health plan for chronic low 
back pain patients (Vogt et al., 2005).  
 
5.4.3.3 Interventions involving exercise programmes and advice 
Various forms of exercise are often recommended alongside advice for patients to stay 
active particularly for people experiencing persistent non-specific low back pain (NICE, 
2009a). The evidence shows programmes involving physical exercises alone are associated 
with improvements in pain and functionality outcomes (Hayden et al., 2005). Muscle 
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strengthening and stretching exercises were in particular found to be the best type of 
exercise therapy. On the other hand, advice to stay active through exercises is associated 
with only small benefits in pain and functional improvement when applied to acute low back 
pain suffers (Dahm et al., 2010). 
 
The economic evidence shows  that a combination of GP prescription exercises and the 
Alexander technique sessions are a cost-effective strategy when compared to massage 
therapies (Hollinghurst et al., 2008). Furthermore, exercise programmes have been found to 
be cost-effective when provided in addition to current practice (U. K. Beam Trial, 2004), and 
cost-effective when provided in combination with education and cognitive therapy in 
chronic low back pain patients (Johnson et al., 2007).  
 
5.4.3.4 Alternative manual and physiotherapy treatments 
A wide range of physical treatments such as spinal manipulation or mobilisation, 
physiotherapy, acupuncture and massage have been recommended for treating patients 
with persistent low back pain (Koes et al., 2006). The evidence concerning the effectiveness 
of these interventions appears to be diverse.  There is evidence showing massage therapy is 
more effective when compared with joint mobilisation, acupuncture, physical therapy and 
self-care education, particularly if massage treatments are combined with exercise and 
education strategies (Furlan et al., 2009). On the other hand, spinal manipulation and 
mobilisation treatments are associated with some short-term functional improvement in 
treatment of acute low back pain patients (BEAM, 2004) but not for chronic low back pain 
sufferers (Bronfort et al., 2004; Rubinstein et al., 2011).  
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Studies investigating the effectiveness of acupuncture have found insufficient evidence of 
the effectiveness of acupuncture interventions among acute non-specific low back pain 
patients, and some evidence of short-term pain relief among non-specific chronic low back 
pain sufferers (Furlan et al., 2009). However, acupuncture therapy showed some evidence of 
effectiveness in providing pain relief and improved outcome when provided alongside other 
treatment interventions in chronic but not in acute low back pain patients (Furlan et al., 
2005).  
 
There is economic evidence comparing strategies involving physiotherapy, pain management, 
spinal manipulation, acupuncture, exercise and behavioural counselling. The literature 
shows that physiotherapy treatment is cost-effective for treating low back pain when 
compared to pain management programmes (Whitehurst et al., 2007) but less cost-effective 
when compared to advice from a physiotherapist (Rivero-Arias et al., 2006). In treating 
patients with persistent chronic low back pain, traditional acupuncture care alongside 
conventional primary care interventions was found to be a cost-effective strategy in 
reducing long-term pain compared to usual care from a GP (Thomas et al., 2005).  
Further work on spinal manipulation shows that treatment has been found to be cost-
effective when provided alone or as an add on strategy to current practice within primary 
care (U. K. Beam Trial, 2004). In contrast, massage interventions have been found not be 
cost-effective when compared to advice , exercise or conventional care (Hollinghurst et al., 
2008). However, a combination of massage, exercise and behavioural counselling improved 




Treatment strategies in the management of persistent non-specific low back pain in the 
United Kingdom involving acupuncture have been found to be highly cost-effective from a 
societal perspective when compared to usual GP care (Ratcliffe et al., 2006) and, in Germany, 
relatively cost-effective when provided in addition to routine practice (Witt et al., 2006). In 
both studies, the additional costs associated with acupuncture were worth the benefits 
accrued for chronic non-specific low back pain patients.  
 
5.4.3.5 Psychological treatments   
Psychological treatment interventions involve a combination of cognitive behavioural 
interventions and self-management programmes (NICE, 2009a). Cognitive behavioural 
therapy in particular has often been used in treating patients with chronic non-specific low 
back pain (van Tulder and Waddell, 2005). Social and psychological factors have been found 
to increase functional disability in low back pain sufferers, hence the need for behavioural 
therapy and multidisciplinary interventions (Henschke et al., 2010). Recent clinical guidelines 
have therefore stressed the importance of providing psychological interventions in 
combination with other interventions (NICE, 2009a). Cognitive Behavioural Treatment (CBT) 
includes a combination of cognitive and behavioural techniques with the aim of enabling 
patients to better manage and respond to their pain and condition (Weiner and Nordin, 
2010) . CBT has been found to be particularly effective for chronic low back pain (Koes et al., 
2006).  
 
In general, there appears to be minimal difference in functional status and behavioural 
outcomes between behavioural therapy interventions and commonly used therapies such as 
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group exercises for pain in chronic low back pain patients, particularly in the long-term 
(Henschke et al., 2010). Similar evidence was reported in a clinical trial within a general 
practice setting offering CBT alongside education and active exercise interventions (Johnson 
et al., 2007). However, a large trial involving 56 general practices found both short and long-
term benefits associated with CBT both in acute and chronic low back pain patients (Lamb et 
al., 2010a). 
 
Combined treatments involving CBT aspects have been found to be superior to short-term 
pain relief interventions such as Back schools, advice and physiotherapy (Henschke et al., 
2010). Moderate evidence in short-term and long-term effectiveness has been found when 
behavioural therapy interventions are combined with exercises and back schools (Ostelo et 
al., 2005). 
 
In addition to the clinical evidence, short-term and long-term cost-effectiveness of CBT 
compared to active management has been shown among chronic low back pain patients 
(Lamb et al., 2010a).  
 
Additional health economic evidence on psychological interventions found that a pain 
management programme incorporating cognitive-behavioural techniques was a highly cost-
effective alternative to conventional outpatient physiotherapy or spinal manipulation 
intervention (Critchley et al., 2007). Additionally, cognitive behavioural interventions were 
found to be highly cost-effective when compared to current practice offering advice to low 
back pain patients in primary care (Lamb et al., 2010b). However, a physical therapy 
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(McKenzie approach) intervention was found to be more cost-effective than a brief 
physiotherapy pain management programme using cognitive behavioural principles (Manca 
et al., 2007).  Thus, cognitive behavioural therapy appears to be a viable option for managing 
patients with chronic low back pain when compared to some of the common primary care 
interventions, but this might not be the most cost-effective option. 
 
5.4.3.6 Summary 
In summary, the literature shows that pain management programmes, cognitive behavioural 
approaches, exercise, spinal manipulation, acupuncture, and physiotherapy offer cost-
effective options to health service providers particularly when combined together. The 
evidence on advice and educational interventions when provided alone is inconclusive and 
these appear to be best offered alongside other interventions. However, massage therapies 
appear not to be cost-effective, especially when provided as a separate intervention. More 
health economics evidence is needed on the cost-effectiveness of pharmacological 
interventions when provided alongside other acute and chronic pain management strategies.  
 
5.4.4 Subgrouping of low back pain patients  
Individuals developing low back pain have often been treated as a homogenous group 
without taking into consideration differences in underlying individual patient risk factors and 
characteristics (Wand and O'Connell, 2008). Clinical studies evaluating effectiveness of 
alternative treatments of low back pain patients often report small mean health benefits 
associated with non-specific low back pain interventions (BEAM, 2004; van Tulder et al., 
2006b; Hay et al., 2008).  
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This observed, small, mean benefit could possibly be explained in light of recent 
advancements in the subgrouping of non-specific low back pain patients. It has been 
suggested that the assumptions of homogeneity in treating non-specific low back pain could 
potentially lead to the allocation of treatments that are not appropriate for patients 
diagnosed in this way (Boersma and Linton, 2005; Foster et al., 2008). Researchers have 
therefore developed ways to identify subgroups of patients who are likely to benefit from 
targeted treatment interventions as well as subgrouping tools as potential guides to decision 
making (Brennan et al., 2006; Hill et al., 2008; Kamper et al., 2010). These tools and 
measures have been implemented in clinical trials to assess the effectiveness of low back 
pain treatment interventions among patient subgroups.  
 
For example, a recent randomised trial conducted within primary care general practices in 
the UK assessed the effectiveness of stratified care compared with current practice that does 
not involve stratification of low back patients (Hill et al., 2011). Using a validated 
subgrouping tool (Hill et al., 2008) – the STarT Back Screening Tool - patients in the trial were 
classified into one of three groups: ‘low risk’, ‘medium risk’ and ‘high risk’ based on a various 
factors associated with the development of back pain chronicity. The findings demonstrated 
that the stratified intervention approach which involved screening for risk factors and 
targeting treatment for specific subgroups of patients resulted in higher health gains and 
significant improvements in the primary outcome (disability) for patients with back pain 
when compared to the non-stratified approach. The study showed that without screening 
approaches to guide treatment allocations for back pain patients, patients in the ‘medium 
risk’ and ‘high risk’ groups could be denied access to the most appropriate treatments. 
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Similar research has been carried out to assess the implementation of a subgrouping and 
targeted treatment system within routine care practice  producing similar findings (Foster et 
al., 2010). 
 
In summary, it appears that the clinical assessment and management of non-specific low 
back pain should involve a stepped up care model approach in order to differentiate 
between simple low back pain patient conditions and potential serious back pain conditions. 
In this approach, management for low risk patients uses simple, low cost interventions such 
as advice and education and some medication and then moves on to more complex 
treatments such as exercises, massages, spinal manipulation, acupuncture, and cognitive 
behavioural therapy with increasing risk.  
 
 
Low back pain is a common and costly condition according to the reported point prevalence 
rates ranging from 19% to 40% in the UK (Hillman et al., 1996; Macfarlane et al., 2012). 
Moreover, it has been estimated that 80% of working adults will experience back pain at 
some stage in their life (Palmer et al., 2000). The condition imposes a significant 
socioeconomic burden on the UK and internationally. Identifying the cost burden of low back 
pain through cost-of-illness studies provides important information for policy makers when 
planning (Dagenais et al., 2008).  
 
Back pain has been linked with costs of over £1 billion in treating the different types of back 
pain each year within the NHS (NICE, 2009b). A significant proportion of the economic 
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burden of low back pain is associated with costs to society through sickness absence from 
work as well as reduced productivity at work due to back pain illness. Work productivity loss 
due to back pain illness has been estimated at around 4.9 million working days per year (HSE, 
2003/2004). Moreover, because of high prevalence rates, back pain affects many working 
age individuals hence contributing to economic loss in the society. The following section 
therefore provides an overview of cost of illness estimates for back pain in the UK and 




5.6.1 Economic burden of low back pain internationally 
Internationally, back pain is linked with significant costs wherever estimates of the condition 
have been quantified. A number of cost-of-illness studies reporting associated economic 
costs of low back pain in various countries have been identified internationally, with the 
results consistently showing relatively high indirect costs compared to direct costs (Dagenais 
et al., 2008; Maetzel and Li, 2002). There are variations in the studies, which makes it 
difficult to compare costs across multiple countries. Costing approaches from these 
countries tend to vary by perspective (whether healthcare or societal), costing method (top 
down approach or bottom up approach), indirect cost method (human capital or friction cost 
approach), sources of data and the time when the study was conducted. Table 5.1 provides a 
summary of cost-of-illness studies that have reported full societal costs including both direct 
and direct costs of low back pain from different countries. Costs were converted to UK 
pound sterling (£) using original exchange rates (http://www.hmrc.gov.uk/exrate/). The 
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original price years of the estimates were recalculated to 2005 prices using CPI index data 
from the World Bank (http://data.worldbank.org/indicator/FP.CPI.TOTL?page=1). 
 
Table 5:1 Selected cost-of-illness national total cost estimates for low back pain 
Author/study 
year 
Country Price year Total costs (In 
billions)* 
Total Cost (2005 
prices)** 
% indirect costs 
(Boonen et al., 
2005) 

































1998 6.7 to 12.3 7.35, 13.56 41% to 87% 
(Shinohara et al., 
1998) 
Japan 1994 0.04 
 
0.04 55% 
(van Zundert and 
van Kleef, 2005) 
Belgium 1999 0.78 
 
0.88 84% 
(Walker et al., 
2003) 
Australia 2001 3.29 
 
3.66 89% 
(Wieser et al., 
2011) 
Switzerland 2005 2.2 to 2.9 2.2, 2.9 46% to 61.4% 
**Costs were expressed in 2005 price year costs using CPI data from the World Bank  
* costs reported in original price years and expressed in UK pound sterling (£)  
 
5.6.2 Costs of low back pain internationally 
Cost-of-illness studies reporting both direct and indirect cost estimates of low back pain 
were identified from Australia, Belgium, Japan, Netherlands, Korea, Sweden, and Switzerland 
(Table 5.1). In the nine societal cost-of-illness studies identified, mean indirect costs 
accounted for 34% (Netherlands) to 93% (Sweden) of total disease burden costs, suggesting 
that indirect costs comprise the majority of total societal LBP costs. The largest societal costs 
of LBP were observed in the United Kingdom, with costs ranging from £7bn to £14bn based 
on estimates from the friction cost approach and the human capital method. This was 
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followed by the study in Australia that found the societal costs of LBP to be £3.7bn in the 
2005 estimated costs.  
 
The corresponding estimates in Sweden ranged from £1.2bn to £3.1bn. Studies in 
Switzerland (Wieser et al., 2011), the Netherlands (Boonen et al., 2005), and Belgium (van 
Zundert and van Kleef, 2005) reported total societal costs ranging from £0.88bn to £2.9bn. 
The international comparison showed that the societal costs of LBP in Japan were smaller in 
comparison to costs reported from all other countries with reported costs of £0.04bn. The 
study by Wieser et al., (2011) estimated total costs in Switzerland of £2.9bn when using the 
human capital method and only £2.1bn using the friction cost approach, assuming a friction 
period of 22 weeks. This estimate was between 1.6% and 2.3% of the GDP. Similarly, costs 
from the Netherlands were calculated using the friction cost approach, assuming a friction 
period of three months. 
 
5.6.3 Cost of back pain in the UK 
Few attempts have been made to estimate the cost-of-illness of low back pain in the UK. 
These demonstrate clearly that low back pain poses a major economic burden to the UK, 
with total societal costs ranging from £1.2 to £12.3bn. For example, a prevalence based 
study report estimated the cost of back pain to the NHS at between £265 million and £382 
million in 1992 (Klaber-Moffett et al., 1995). The corresponding costs incorporating 
productivity losses were estimated to range between £1.2bn and £1.74bn. The estimates 
reported in the study could however have been underestimated as the work absence days 
were based on a percentage of certified incapacity days (Klaber-Moffett et al., 1995).  
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Another UK study assessed the economic burden of LBP imposed on patients, the healthcare 
system and society as a whole in the UK using a combination of prevalence estimates, 
epidemiological, service utilisation and unit cost data from various sources (Maniadakis and 
Gray, 2000). This was a prevalence based study, estimating the annual cost of back pain in 
the UK in 1998. The findings indicated that the overall cost of back pain in 1998 was £12.3bn 
based on the human capital method (HCM) and £6.7bn using the friction cost approach 
(FCA). The total direct costs associated with care and treatment of back pain were £1.63bn, 
35% of which comprised services provided by the private sector. Indirect cost of lost 
productivity due to incapacity to work was estimated at £3.44bn and £9.1bn using the FCA 
and the HCM respectively. The direct cost was estimated at £1.6 billion, while the cost of 
private care services was estimated at £565m. Estimates from this study were updated to 
2005 costs in order to facilitate international comparisons (Table 5.1).   
 
5.6.4 Comparison of low back pain with costs of other diseases  
The important finding from the cost-of-illness studies in LBP is that indirect costs heavily 
outweigh the direct costs of healthcare. A comparison of LBP costs with other disorders in 
the UK shows similar findings. It is interesting to note that the back pain is more costly than 
other disorders such as depression, mental health, obesity and COPD. A lack of common 
methodology and cost components, however, makes comparisons across disease areas 
difficult. Nevertheless, the economic and social costs associated with mental health 
conditions in England have been estimated at around £77bn in 2003 (Sainsbury Centre for 
Mental Health, 2003). The corresponding amount in 2009 was estimated at £105bn with 
productivity costs comprising 29% of the total costs (Sainsbury Centre for Mental Health, 
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2010). In another study, the total costs of obesity to the UK were estimated to be over £2bn, 
with productivity costs accounting for 80% of the total costs (Vlad, 2003). Another 
investigation showed that chronic obstructive pulmonary disease places a significant burden 
on the healthcare system with total direct costs of £800 million and indirect costs of around 
£3bn (NICE, 2011). In the clinical area of depression, studies have reported total societal 
costs of £9bn, with productivity loss comprising over 90% of the total costs (Thomas and 
Morris, 2003) . 
 
 
To address the question of how to incorporate productivity costs within economic evaluation 
studies, the empirical work of this thesis is based on studies designed to compare a stratified 
primary care management intervention with current practice in low back pain patients. In 
brief, this comprised two studies (Table 5.2). The first, investigated the effectiveness of a 
stratified management intervention compared with a non-stratified current practice in 
reducing long-term disability from low back pain in a randomised controlled trial (STarT Back; 
(Hill et al., 2011)). The second investigated the impact of introducing and managing the 
stratified management treatment intervention approach in primary care based on a 
prospective, population based, before and after study design in routine practice (IMPaCT 
Back study; (Foster et al., 2010)). Across both studies, patients consulting for low back pain 
in general practices were invited to attend an assessment clinic from which eligible patients 
were identified. Assessments were carried out by means of questionnaires. The STarT Back 
study was granted ethical approval by the North Staffordshire Local Research Ethics 
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Committee, while ethical approval for the IMPaCT Back study was obtained from the 
Cheshire Local NHS Research Ethics Committee. 
 
Table 5:2 Summary of the data sets and study design 
Study Design Aim  
Intervention study 1:  
STarT Back RCT  
(n=851) 
To assess the effectiveness of a stratified primary care back 
pain management intervention with matched treatment 
intervention against a non-stratified current best practice. 
Intervention study 2:  
IMPaCT Back Study  
(n = 927) 
To implement a stratified management intervention care 
system for the evaluation and management of LBP patients 




5.7.1. Intervention Study 1: The STarT Back trial 
5.7.1.1 Aims and objectives   
This first intervention study which provided effectiveness data had the following aims and 
objectives. The main aim of the study was to assess the overall effectiveness of the stratified 
primary care back pain management intervention with targeted treatment options against 
non-stratified current best practice. 
 
Secondary objectives of the study included:  
1. To test whether, for the low-risk patients, minimum treatment provided non-inferior 
clinical outcomes to current best practice care 
2. To test whether, for medium-risk patients, systematic referral to physiotherapy led to 
better clinical outcomes than did current best care 
3. To test whether, for high-risk patients, systematic referral to psychologically 




Full details of the study methodology are reported in the study protocol and clinical study 
(Hay et al., 2008; Hill et al., 2011). An overview of the methods is provided in the next 
section. 
 
5.7.1.2 Study population 
The STarT Back study comprised low back pain consulters, aged 18 years and over, with a 
consultation of low back pain, identified from 10 general practices within the Keele General 
Practice Research Partnership, England (Hill et al., 2011). Eligibility was based on patients 
consulting for non-specific low back pain (i.e. excluding potentially serious pathology such as 
inflammatory arthritis, malignancy, and serious co-morbidity, pregnancy-related low back 
pain, personality disorders, individuals receiving care for a current back pain episode and 
those having had spinal surgery in the last 6 months (Hay et al., 2008). 
 
Patients were recruited between the period of June 2007 and November 2008, with low 
back pain sufferers identified from searching GP patients’ electronic data records. All 
patients identified were mailed a letter requesting them to make contact for an 
appointment at an assessment back pain clinic. Appointments were set up for patients who 
contacted the study team and details of the trial were explained during the appointment. 
Those consenting to participate in the study were taken through a process of completing 
written consent for participation in the study. 1573 individuals were identified as being 
eligible from the 10 general practices and, of these, 851 were included in the study. Patients 
were randomised to the interventions by a computer generated stratified block 
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randomisation. Stratification was carried out based on the STarT Back screening tool risk 
subgroup (Hay et al., 2008).  
 
5.7.1.3 Study design 
The design of the study was a pragmatic randomised controlled trial over a period of 12 
months; a total of 851 patients were randomised to either receive stratified primary care 
management (intervention, n = 568) or current best practice (control group, n = 283, in line 
with the standard physiotherapy usually provided). Consequently study participants were 
followed up at 3 months, 6 months and 12 months during the study period after the baseline 
assessment.  
 
5.7.1.4 Study Interventions  
The STarT Back trial interventions included an initial 30-minute physiotherapy evaluation 
with advice and education on physical activities and exercises for all patients. In the control 
group, the decision about additional treatment was determined by the physiotherapist, 
without having any knowledge of the patient group classifications. In the intervention group 
(stratified management), however, decisions about additional treatment were based on the 
STarT Back tool risk group classifications. High-risk patients were provided with additional 
psychologically inclined physiotherapy interventions aimed at addressing psychosocial 
factors affecting back pain recovery. Medium-risk patients were assigned to physiotherapy 
interventions aimed at addressing pain-related symptoms and physical functions; no further 




5.7.1.5 Outcome measures  
The main clinical outcome measure was the 24-item Roland Morris Disability Questionnaire 
(RMDQ; scores ranging from 0-24; high scores indicating severe disability) (Roland and 
Morris, 1983). Utility was assessed using QALYs derived from the EuroQol EQ-5D measure 
(Dolan, 1997). Work-related outcomes included days off work in the past 12 months, and 
reduced productivity at work in the past 30 days due to low back pain illness.  
 
5.7.2. Intervention Study 2: The IMPaCT Back study 
5.7.2.1 Aims and objectives  
The second intervention study was the IMPaCT Back study (IMplementation study to 
improve Patient Care through Targeted treatment for Back pain). This was a quality 
improvement study that was designed to extend the stratified management approach within 
routine care in a primary care setting. The primary aim of the IMPaCT Back study was to 
assess whether the STarT Back model of stratified care for LBP could be implemented in 
routine primary care (Foster et al., 2010).  
  
Secondary objectives of the study included:  
1. Improve patients' clinical outcomes at 2 and 6 months follow-up; 
2. Provide evidence for the sustainability of this care system. 
 
5.7.2.2 Study population   
The IMPaCT Back study recruited patients from 7 GP practices in the UK. The practices were 
selected with a balance of urban, semi-rural, rural and small, medium sized general practices. 
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Eligibility for the study included adult patients aged 18 years and over consulting for non-
specific low back pain. Similar to the STarT Back Trial, exclusion of study patients was based 
on specific identifiable causes (‘red flags’) such as inflammatory arthritis, pregnancy, 
malignancy, recent surgery on back pain and patients already receiving physiotherapy 
treatment for the current back pain episode (Foster et al., 2010). 
 
5.7.2.3 Study design and interventions.   
A detailed account of the study interventions is reported in the study protocol (Foster et al., 
2010). Briefly, the study was a prospective observational cohort study with a before and 
after study design involving three phases in routine primary care. A summary of the 
interventions from the study is provided below. 
 
Phase 1 included provision of usual primary care for all patients, which included an option 
for referral to other healthcare services such as physiotherapy. Subgrouping for targeted 
treatment for low back pain patients was not included. In phase 1, clinical outcomes of 
patients in a baseline period of 6 months were obtained as well as attitudes and behaviours 
of general practitioners (GP’s). 
 
In the 2nd phase of the study, a diverse set of interventions aimed at improving the quality of 
the health system including educational courses, mentoring support, regular feedback 
sessions, and systems to support the subgrouping for targeted treatment in primary care 
was implemented. The multi-component quality improvement intervention included 
incorporating the subgrouping tool in physiotherapy and GP sessions within the primary care 
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system in order to classify patients as being of low-risk, medium-risk or high-risk of poor 
outcome.  
 
Phase 3 involved the same procedure as at baseline for patients and GPs recruited during a 
12 month period following the roll-out of the new subgrouping and targeted care system. 
Data were collected to assess changes in patients’ clinical outcomes and healthcare resource 
use, and healthcare professionals’ back pain-related attitudes and behaviours after 
implementation of the stratified care and subgrouping intervention. In this phase, healthcare 
practitioners used the STarT Back tool as introduced in the phase 2 implementation of the 
quality improvement intervention.   
  
  
This chapter has provided an overview of low back pain, presenting the nature, prevalence 
and management of the condition. The literature shows that non-specific low back pain is a 
common disorder, impacting patient morbidity and leading to significant productivity costs 
to individuals and society. This chapter has also reviewed economic evaluation studies of low 
back pain interventions and cost-of-illness studies in low back pain sufferers. The cost-of-
illness literature demonstrates the magnitude of the economic burden of low back pain to 
society for various countries.  
 
Policy makers worldwide have acknowledged the importance of low back pain by developing 
clinical guidelines (van Tulder et al., 2006a; Chou et al., 2007; Airaksinen et al., 2006; NICE, 
2009a). The novel approaches to subgrouping and stratified management care discussed in 
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this chapter have been found to improve the clinical management of low back pain, and they 
could potentially help in reducing the economic burden. The low back pain clinical area and 
study datasets discussed in this chapter will be used as case studies for the empirical work 
conducted later in this thesis. Before that, however, the next chapter focuses on generating 









CHAPTER SIX  
 
The overall aim of this chapter is to further develop the friction cost approach for use in the 
UK. Two areas are covered. The first focuses on generating specific data on vacancy 
durations, hence friction periods, that can be used in practical applications of the friction 
cost approach in valuing productivity costs within economic evaluations in a UK context. The 
second is to compare methods for capturing time off work. The next section of this chapter 
covers the rationale for the work. This is followed by information about the data and 
background. The methods and results of (i) investigations into estimating friction periods for 
the UK and (ii) comparability between sickness certification records and self-report data in 
estimating time off work are then explored. Finally, the discussion focuses on the 
implications of these findings and their application for work in the forthcoming chapters.  
 
 
The literature reviews presented in Chapters Three and Four show that few studies have 
applied the friction cost approach within economic evaluations in the UK. This is mainly 
attributed to the absence of reliable relevant data necessary for its application, with 
particular reference to a lack of information about the friction period, for which there are no 
reliable estimates within the UK (Koopmanschap et al., 1995; Pritchard and Sculpher, 2000). 
The duration of a vacancy has been suggested as a proxy for estimating a friction period 
(Brouwer and Koopmanschap, 2005). This is the period employers take to successfully fill an 
employment vacancy (van Ours and Ridder, 1991). However, few studies have empirically 
investigated vacancy durations, particularly within the UK. To date, only four studies in the 
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UK, (Beaumont, 1978; Roper, 1988; Adams et al., 2002; Andrews et al., 2008) have explored 
different aspects of vacancy data, and these do not provide the sort of information required 
to estimate the friction period for use in productivity cost valuations. Of these studies, 
Andrews et al., (2008) analysed computerised career service data using econometric 
modelling (Andrews et al., 2008). Their findings showed an average vacancy duration of four 
weeks; however this was limited to a youth population. In a duration of four weeks, a model 
by Adams et al., (2002), that considered employees mostly from the financial and services 
industries, found that 63 per cent of vacancies had been filled, and only 8 per cent of the 
vacancies were unfilled within a period of 12 weeks. Elsewhere, using vacancy data from UK 
survey of employers, Roper (1988) assessed the effect of recruitment methods on vacancy 
durations. Their results showed that the method of recruitment affects the length of vacancy 
durations. Neither of these studies however provides the detailed specific vacancy duration 
information required to estimate a mean friction period necessary for valuing lost 
productivity when using the friction cost approach. Moreover the data used in these studies 
are relatively old (1985-1992 for Adams et al., (2002), 1996-1997 for Andrews et al., (2008) 
and data from the 1970’s for both Beaumont (1978) and Roper (1988)) and do not accurately 
illustrate the prevailing labour market conditions. Clearly this is an under-researched area 
within the UK.  
 
Economic evaluations often use a single average friction period when valuing productivity 
costs. However, the use of an average friction period ignores differences between types of 
employees in the labour market, which could potentially lead to inaccurate estimation of 
productivity costs (Koopmanschap and Rutten, 1996; Koopmanschap et al., 1995). The 
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impact of using more detailed friction periods therefore remains uncertain. A stratification 
of friction periods by individual subgroups based on education status has been conducted 
(Koopmanschap et al., 1995), but as yet, there has not been a stratification based on 
occupational status. However, occupational status is often collected in economic evaluation 
studies and is clearly more directly relevant to vacancy durations and hence friction periods 
(Andrews et al., 2008). Estimation of friction periods by occupational status would clearly 
provide an advance on the information currently available. 
  
  
To accurately estimate more detailed friction periods for the UK, data on the average length 
of time to fill a vacancy were surveyed from four sources for the period 2007-2011. The 
initial data search involved surveying the office of National Statistics (ONS) using a 
questionnaire, as has been done in previous countries, for example the Netherlands when 
obtaining vacancy duration statistics. This was followed by a survey from the Chartered 
Institute of Professional Development (CIPD), the largest human resource professional body 
in the UK. From the CIPD library and information services department, a third data source, 
i.e. DLA Piper LLP that collects relevant data on vacancy duration data was also identified. 
Finally, vacancy duration data were purposively collected from the University of Birmingham 
as part of a primary data collection exploration process. In each case, the data collected 






These data sources are briefly described below:    
1) DLA Piper LLP (DLA)  
DLA Piper LLP is a global services legal organisation. It works with various local, national and 
global organisations and also operates throughout the public sector, working with central 
governments, local governments, universities and housing associations. The organisation has 
offices throughout Asia, Europe, Australia, the Middle East and the United States. It offers a 
human resource (HR) measurement and benchmarking service that collects performance 
data on a range of indicators from over 400 contributing organisations. 
     
2) Chartered Institute of Personnel and Development (CIPD)  
The Chartered Institute of Personnel and Development is the world’s largest chartered HR 
and professional body. It is an internationally recognised organisation that supports and 
develops individuals responsible for managing and developing people within human 
resources. The organisation collects HR vacancy statistics data through annual surveys.   
  
3) Office of National Statistics (ONS)   
The Office of National Statistics is a key source of national statistics in the UK. It is the UK’s 
largest independent producer of official statistics, and is also the recognised national 
statistical institute of the UK. ONS works with various organisations in the UK and provides a 
leading role in the development of national and international good practice in the 
production of official statistics. The organisation collects a range of work performance 




4) University of Birmingham (UoB)  
The University of Birmingham is one of UK’s leading universities founded in 1900 and 
associated with excellence in research and teaching. The organisation is a very large 
employer with over 5000 staff from a broad range of occupations. The university maintains a 
database with HR vacancy statistics through the Human Resources statistics department.  
 
Data from these four sources were used to estimate detailed friction periods stratified 
according to different occupational level categories. Each of the data sources included, 
however, slightly different questions, categorised occupational levels differently and 
provided data from different time points which necessitated adjustments to make the data 
more comparable. A detailed description of each data source and the approaches for dealing 
with differences in the dataset used are described in the methodology.  
 
  
The methodology is organised as follows: section 6.4.1 defines the meaning of vacancy 
duration for the purpose of the research, and explains how adjustments were made to 
ensure the same definition was used across all data sources. Section 6.4.2 then describes the 
relationship between the occupational titles of participants in the study datasets and an 
established international standard occupational classification. In section 6.4.3, a detailed 
description of the data sources and the underlying matching processes with the standard 
occupational classification is described. A description of the necessary adjustments carried 
out for each source to make it generalisable at firm and national level is then provided in 
section 6.4.4. Finally, sections 6.4.5 and 6.4.6 provide an overview of the work-related 
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questionnaire used in the study and the process of identifying a friction period occurrence in 
the datasets.  
 
6.4.1 Standardising vacancy duration definition   
Data from the different sources were collected at firm-level based on slightly different 
vacancy duration definitions and occupational categorisations. The standard period 
considered for the survey was the average period taken to fill a vacancy, from when a 
vacancy is raised to when an individual starts working. To ensure comparability, an 
additional period, in line with previous literature, was added to the values from those data 
sources that did not cover the survey duration from when a vacancy is raised to when an 
individual starts work. Since there is no known estimate for the time lags involved before a 
vacancy is raised as well as the extra time lags for a successful replacement employee to 
start work in the UK, an average period of 4 weeks was adopted from a study in the 
Netherlands that used this period (Koopmanschap et al., 1995).  
 
6.4.2 Occupational categories  
In the STarT Back trial (SBT) and IMPaCT Back study (IBS), respondents were asked to report 
whether they were employed at baseline and follow-up as well as to record their current job 
title. The job title captured for each individual was used to assign responders to specific 
categories according to shared characteristics based on the Standard Occupational 
Classification 2000 (SOC, 2000). As the thesis was focused on valuing productivity costs of 
individuals in paid employment, final classifications used in categorising the friction period 
were based on the SOC 2000 which is limited to employed individuals. The SOC 2000 is a 
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classification that can be applied to all paid jobs performed by economically active 
individuals in the UK (SOC, 2000). Other standard classifications widely used in the United 
Kingdom include the Standard Industrial Classification (SIC) and National Statistics Socio-
economic Classification (NS-SEC). The SOC 2000, which focuses on employed individuals, was 
used here to link categories of employed individuals with the Annual Survey of Hours and 
Earnings (ASHE) carried out by the Office of National Statistics (ONS). The ASHE is a labour 
market and earnings survey based on a sample of UK employees that provides information 
about the earnings and hours paid for employees within different occupations in industries 
by age groups and regions (ASHE, 2008). The ASHE is based on the SOC classification system 
and so was a particularly useful classification to use.  
The following major groups of the SOC 2000 were considered:  
a) Managers and senior officials  
b) Professional occupations  
c) Associate professional and technical occupations  
d) Administrative and secretarial occupations  
e) Skilled trade occupations  
f) Personal service occupations  
g) Sales and customer service occupations  
h) Process, plant and machine operatives  
i) Elementary occupations.  
 
As the different data sources asked slightly different questions, and were categorised 
differently, the following final occupational category levels were identified and summarised 
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for this thesis following adjustments as described in the descriptions of the data sources. 
   
i) “Managerial and professional” or “operations and support” for DLA Piper LLP 
ii) “Managers and senior managers” or “professional occupations”, “Administrative, 
secretarial and technical professions” or “services” (including sales, customer, 
and personal staff) or “elementary occupations” for the three remaining data 
sources including the ONS, CIPD and UoB.  
 
6.4.3 Measuring the average duration to fill a vacancy – Data sources  
To estimate friction periods for the UK, vacancy duration statistics were obtained from a 
number of sources described in the next section. The following data sources were identified 
and are described in more detail including the questions asked, the duration covered, the 
nature of data collected and how it was categorised.  
 
6.4.3.1 DLA PIPER’S HR Bench marker Statistics (2009-2011) 
The DLA Piper UK LLP data analysed in this study were collected by annual vacancy surveys 
as part of the organisation’s HR bench marker research (DLA PIPER, 2012). The HR bench 
marker is a human resource service involving over 400 participating organisations, which 
enables organisations to compare their performance on indicators such as vacancy duration 
and absence rates. For this analysis, recruitment data obtained were used to generate 
trends data for the period 2009 to 2011. Data from the survey comprised both public and 
private sector organisations with the latter comprising slightly over 40%. The data were 
collected based on two categories of employees: i) managerial/professional ii) 
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operational/support. Measures of average, median, upper and lower quartiles were then 
estimated from the reporting organisations for each category. Respondents in the survey 
were asked to estimate the number of working days taken to fill a vacancy (from vacancy 
notification to job offer)(DLA PIPER, 2012). 
 
The SOC 2000 classification was collapsed into the two levels for which vacancy duration 
data were available from DLA piper according to Figure 6.1. The 9 classes represent the 
original SOC 2000 classification. To standardise the duration from when a vacancy is raised 
to when an individual reports to their work place, the data were adjusted by adding in a 
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6.4.3.2 Chartered Institute of Personnel and Development (CIPD) - Annual surveys (2007 - 
2009) 
The CIPD data analysed in this research were collected by annual surveys assessing the 
average time and costs required to fill a vacancy in the UK. Specifically, the data were 
obtained from the Recruitment, Retention, and Turnover Survey Reports that show trends of 
how organisations recruit and maintain personnel within the UK (CIPD, 2009; CIPD, 2008; 
CIPD, 2007). In the surveys, questionnaires were sent out to HR professionals in private, 
public and voluntary sectors.  
 
The specific wording used in the CIPD surveys is presented below:  
“What is the average number of weeks to fill a vacancy?” 
 
Data were available only for the period 2007-2009 and subsequent surveys from 2010 no 
longer collect statistics on filling job vacancies. The SOC 2000 classification system was 




















Figure 6:2 Collapsing the Standard Occupational Classification 2000 (SOC 2000) into the CIPD Dataset 
 
6.4.3.3 Office of National Statistics (ONS)   
Vacancy duration data were also obtained from the ONS, which generates independent 
information on the UK labour economy. These data mainly comprised vacancy outflows by 
duration and occupation, based on the Jobcentre Plus vacancy statistics. Jobcentre Plus, a 
public employment service attached to the Department of Work and Pensions (DWP), 
provides services that link people to work and helps employers to fill vacancies (Bukowski et 
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al., 2010). The data were obtained through the ONS official labour statistics database known 
as Nomis (http://www.nomisweb.co.uk/default.asp) and summarised.  
 
Nomis is a service provided by the Office for National Statistics (ONS), which provides free 
access to comprehensive and updated UK labour market statistics. The database provides 
various categories of data including the measure on vacancy outflows used here. Vacancy 
outflows are the number of jobs that have been filled or withdrawn from the market by the 
Jobcentre Plus during a specified period. A vacancy is considered as filled if a client is 
awarded a job as a result of the Jobcentre Plus recommending that client to the vacancy.  
 
The sample used in this analysis covers the period January 2007 to October 2011 with the 
exception of data from September 2010 that were withdrawn due to inconsistencies in the 
data sources. Similarly to the DLA Piper data, these data were standardised to the duration 
from when a vacancy is raised to when an individual reports to their work place by adding in 
a one month duration, which covers the period from offer date to a starting date 
(Koopmanschap et al., 1995). Similarly, the SOC 2000 classification system was collapsed into 
five category levels by mapping their work characteristics onto the data obtained from ONS 
as in Figure 6.2.  
 
6.4.3.4 University of Birmingham   
As a final data source, which can be viewed as an exploratory exercise into primary data 
collection of vacancy duration statistics, data were also collected from an organisation 
within a research and academic context. This enabled the estimation of friction periods for 
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academic and research occupations that are potentially not available through the other data 
sources used. These estimates were surveyed and obtained from the University of 
Birmingham, Human Resources (HR) statistics department. The University of Birmingham 
employs over 5000 staff. The vacancy duration statistics generated included the duration 
from when a vacancy is advertised to the actual start date. The SOC 2000 classification 
system was categorised into five levels based on the data obtained from the University as in 
Figure 6.2.  
 
6.4.4 Weighting friction period estimates for national level data 
The friction period values obtained from the sample data from the four data sources were 
weighted to adjust for the proportion of jobs in each occupational class at the population 
level, to make the overall friction period estimate representative of the UK population. 
Sample weights comprising the total number of jobs in each occupation class for each year, 
from the ONS covering the period 2007-2011, were used to adjust the friction period values 
from the sample data to values of the population. The ONS labour force survey 
(http://www.ons.gov.uk/ons/search/index.html?newquery=all+in+employment) data were 
considered appropriate for this adjustment as they provide the largest annual 
comprehensive national estimates of jobs across the entire UK economy. Results are 
presented for the un-adjusted and adjusted friction periods.  
 
Weighting of the sample datasets involved a weighted average statistical analysis of the 
occupational categories data. Consider e different occupational categories, and let f1, f2…, fe 




   
Here,  
 wi represents the weighting factor based on the total UK national vacancies by 
occupation  
 fi represents the estimated values of friction periods in the different occupational 
categories 
  corresponds to the weighted mean duration of a friction period for the UK  
 
6.4.5 Work-related questionnaire used in the studies 
In both the SBT and IBS, information on absenteeism and presenteeism was collected 
through a postal questionnaire. In addition to back pain and quality of life related questions, 
respondents were also asked a number of employment and demographic questions 
including gender, age, job title, and current job status. Specifically, respondents were also 
asked to report on whether they had experienced absenteeism from work during the study 
reporting period. If so, they were asked to record the duration of the absenteeism. Then, 
they were asked to report the extent to which back pain affected their performance at work 







6.4.6 Identifying a friction period in the data sets 
To determine the frequency of friction periods, data on work absence and disability were 
sought from the two study datasets. In accordance with previous research (Koopmanschap 
et al., 1995; Koopmanschap and Rutten, 1996), a friction period is considered in a situation 
where there is:  
i) Immediate death  
ii) Absence from work that resulted in an individual having to stop work due to a 
work-related disability and hence the need for them to be replaced at their 
workplace  
iii) Absence from work longer than the friction period.  
 
However, because of the structuring of the work questions in the study datasets, the 
duration of specific individual episodes of work absence could not be obtained. A more 
accurate extraction of this information could have been achieved had the retrospective work 
questions been structured in a more specific way to capture the frequency of absence 
episodes and the duration of each episode or through the use of detailed patient diaries 
documenting absence days (Stewart et al., 2000). This informed part of the methodological 
work undertaken and is presented in the following subsection as part of this research – 
assessing the feasibility of using sickness certification records to identify length of sickness 







6.5.1 Vacancy duration  
The average vacancy duration for the period 2007-2011 ranged from 2 months to 3.2 
months after adjusting the period to national level values (See Figure 6.3). The overall 
average adjusted friction period was 2.7 months.  
 
 
Figure 6:3 All organisations – Summary of friction period estimates for UK in months (number), by 
occupational level 
DLA - DLA Piper LLP consultancy firm  
CIPD Chartered institute for Professional Development 
ONS Office of National Statistics 
 UoB - University of Birmingham 
 ALL - Average of all organisations 
UFP – Unadjusted friction period, AFP Friction period adjusted for national vacancy stocks by occupation, AFP* Friction period adjusted for 






Details of vacancy duration estimates for the individual data sources are shown in Tables 6.1 
to 6.4 and Figures 6.3 to 6.7. More specifically, the results showed higher maximum vacancy 
durations in the UoB (range: 2.5 to 5.6) and CIPD (range: 1.5 to 4.2) individual data sets; 
relatively lower vacancy duration ranges were observed in the DLA piper LLP dataset (range: 
3.0 to 3.6 – including additional correction for time lags in starting a new job) and the ONS 
dataset (range: 2.3 to 2.7 – including additional correction for time lags in starting a new job). 
The additional adjustment for these data sets was to standardise the data collection period 
to include the period when an individual accepts a job up to the point of actually starting 
work.  
 
As Tables 6.1 to 6.4 show, there were differences between the friction period range values 
from the statistics generated from the different data sources.  
 
Table 6:1 Friction period estimates for UK in months (number), by occupational level, for 2009-2011 – DLA 
Piper dataset 
Year Occupational Classification 
Average (median; LQ - UQ) 
 ALL 1 2 
2009 2.3 (2.0;1.5-1.8) 2.6 (2.3;1.5-3.1) 1.9 (1.5;1.2-1.8) 
2010 2.2 (2.0;1.4-2.7) 2.6 (2.4;1.6-3.1) 2.0 (1.7;1.3-2.3) 
2011 2.3 (2.0;1.5-2.7) 2.5 (2.3;1.5-3.1) 2.0 (1.7;1.3-2.4) 
Unadjusted values 2.2 (2.0;1.5-2.4) 2.5 (2.3;1.5-3.1) 1.9 (1.6;1.2-2.1) 
Adjusted for national UK 
vacancy values 
2.0 2.6 2.0 
Overall adjusted* 3.0 3.6 3.0 
ALL. All employees, 
 1. Managerial/Professional,  
2. Operational/Support  






Figure 6:4 DLA Piper – Summary of friction period estimates for UK in months (number), by two occupational 
level categories (2009-2011)  
1 Managerial/Professional  
2 Operational/Support 
ALL Average of all organisations 
 UFP – Unadjusted friction period 
 AFP Friction period adjusted for national vacancy stocks by occupation 
AFP* Friction period adjusted for national vacancy stocks by occupation and average duration to take up job vacancy  
 
Table 6:2 Friction period estimates for UK in months (number), by occupational level, for 2007-2009 CIPD 
Year Occupational classification  Average(n) 
 1 2 3 4 5 
2007 4.1 (761) 3.2 (814) 1.7 (797) 1.9 (678) 1.5 (611) 
2008 4.1 (723) 3.0 (733) 1.7 (737) 1.9 (670) 1.5 (642) 
2009 4.3 (703) 3.1 (720) 1.6 (717) 1.8 (657) 1.5 (633) 
ALL 4.2 3.1 1.7 1.9 1.5 
Adjusted for national 
UK vacancy values 
4.2 3.1 1.7 1.9 1.5 
1. Senior managers/directors 
 2. Managers and professionals  
3. Administrative, secretarial and technical  
4. Services (customer, personal, protective and sales)  





Figure 6:5 Summary of friction period estimates for UK in months (number), by two occupational level 
categories (2007-2009) 
ALL Average of all organisations. UFP – Unadjusted friction period, AFP Friction period adjusted for national vacancy stocks  
1. Senior managers/directors  
2. Managers and professionals  
3. Administrative, secretarial and technical  
4. Services (customer, personal, protective and sales)  
5. Manual/craft workers 
 
Table 6:3 Friction period estimates for UK in months, by occupational level, for 2007-2011 (Based on 
vacancies filled by job centre plus and alternative recruitment channels) ONS 
Year Occupational level (Average) 
 1 2 3 4 5 
2007 1.6 1.7 1.4 1.9 1.4 
2008 1.6 1.9 1.4 1.8 1.4 
2009 2.0 1.8 1.2 1.7 1.2 
2010 1.4 1.5 1.2 1.6 1.3 
2011 1.3 1.4 1.2 1.5 1.2 
ALL 1.6 1.6 1.3 1.7 1.3 
Adjusted for national 
UK vacancy values 
1.6 1.7 1.3 1.7 1.3 
Adjusted Overall* 2.6 2.7 2.3 2.7 2.3 
1: Managers and Senior Officials  
2: Professional Occupations/Associate Professional and Technical Occupations  
3: Administrative and Secretarial Occupations/Skilled Trades Occupations/ Process, Plant and Machine Operatives  
4: Personal Service Occupations/Sales and Customer Service occupations 





Figure 6:6 Summary of friction period estimates for UK in months (number), by two occupational level 
categories (2007-2011) 
ALL- Average of all organisations. UFP – Unadjusted friction period, AFP Friction period adjusted for national vacancy stocks.  
Managers and Senior Officials   
2: Professional Occupations/Associate Professional and Technical Occupations  
3: Administrative and Secretarial Occupations/Skilled Trades Occupations/ Process, Plant and Machine Operatives 
4: Personal Service Occupations/Sales and Customer Service occupations  
5: Elementary Occupations. AFP* Friction period adjusted for national vacancy stocks by occupation and average duration to take up job 
vacancy for DLA. 
 
Table 6:4 Estimated friction period in months, by occupational level, for 2009-2011 (Based on vacancies filled 
by the University of Birmingham) UoB 
Year Occupational Classification (average) 
 1 2 3 4 5 
2009 5.0 3.9 2.9 2.9 2.1 
2010 6.6 5.2 3.2 2.9 2.3 
2011 6.0 4.3 3.0 2.4 3.0 
ALL 5.8 4.4 3.0 2.7 2.5 
Adjusted for national UK 
vacancy values 
5.6 4.5 3.0 2.7 2.5 
1. Managers, Senior officials, Directors  
2. Professional and technical occupations  
3. Administration, Skilled trade  
4. Services 





Figure 6:7 UoB – Summary of friction period estimates for UK in months, by five level occupational categories 
(2007-2009) 
ALL - Average of all organisations. UFP - Unadjusted friction period, AFP - Friction period adjusted for national vacancy stocks.  
1: Managers and Senior Officials, 
2: Professional Occupations/Associate Professional and Technical Occupations,  
3: Administrative and Secretarial Occupations/Skilled Trades Occupations/ Process, Plant and Machine Operatives,  
4: Personal Service Occupations/Sales and Customer Service occupations,  
5: Elementary Occupations.   
AFP* Friction period adjusted for national vacancy stocks by occupation and average duration to take up job vacancy for DLA. UoB 











In the UK, general practitioners (GPs) play a key role in the sickness certification process as part of 
their contractual role (Hussey et al., 2004). GPs will normally issue a fit note, formerly a doctor’s sick 
note (sickness certificate) for an illness lasting more than one week based on their expert judgement 
of a patient’s capacity to work and the probable duration of sick leave required (Morrison, 2011). 
However, patients could potentially return to work at an earlier date than agreed with the GP. The 
'fit note' replaced the doctor's sick note on 6 April 2010 (DWP, 2013). Additionally patients can self-
certify sickness for an absence period of 7 days or less as GPs are not required to issue a fit note 
before seven days of absence have elapsed (DWP, 2013). However, self-certified absence is not 
documented in GP certification databases. Prospective investigations exploring how sickness absence 
due to illness using GP issued sickness certificates (fit note) could provide additional data to estimate 
episodes of work absence due to sickness. Nevertheless, knowledge about the comparability of GP 
sickness certification records and self-reported absence methods remains very limited (Wynne-Jones 
et al., 2008).   
 
A secondary analysis was carried out for a sample of respondents in the SBT and IBS datasets 
who consented to having data from their sickness absence records collected from the 
reviewed general practitioner database. This analysis was to assess the feasibility of using 
sickness certification records to estimate time off work due to sickness in economic 
evaluations. A secondary purpose was to explore the use of sickness certification records to 
identify the frequency and duration of work absence episodes when applying the friction 
cost approach. It was hypothesized that such data could be used to assess incidences and 
durations of back pain sickness episodes, in an economic evaluation setting, in the absence 
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of detailed patient self-reported data that clarified the duration of individual detailed 
episodes of time off work. 
 
This exploration involved comparing: i) incidence of sickness absence based on a self-report 
questionnaire data and GP certification records; ii) sickness absence duration data by 
combining the total duration of each episode listed in the medical certificates and self-
reported absence days.  
 
6.6.1 Population of the sample  
Study participants (SBT n=295; IBS n=256) who gave their consent for review of their 
sickness certification records were included in the study. In addition to the self-report postal 
questionnaire including work absence completed by participants in the two datasets, back 
pain related sickness certificates were extracted from the primary care registry and 
consultations databases in the Keele GP research partnership. Data on certification 
information showing patients who received sickness certification were linked to time off 
work data from the SBT and IBS data sets using a unique individual identification number 
and Read codes. Read codes comprising levels of process, symptom and morbidity codes 
were used to identify the type of sickness certificate, alongside the corresponding 
consultation data (Hiscock and Ritchie, 2001; Wynne-Jones et al., 2009).  
 
The certification database included information about patients who had sick leave spells of 7 
days or more. Sickness certificates issued during these periods were matched with self-
reported work absences.  
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6.6.2 Measurement and analysis  
The main measures in this investigation were the occurrence of an absence episode and the 
associated length of absence in the self-report and sickness certification data sources. For 
each of these data sources, the reported time off and their associated lengths were 
reviewed. Agreement of sickness certificates with absence records was based on a set of 
criteria in Figure 6.8 below adopted from Wynne-Jones et al., (2008), pg 116.  
 Direct match 
No reported work absence and no sickness certificate 
A reported work absence >7days and a sickness certificate 
 
Consistent match 
A reported work absence of <7 days and a sickness certificate 
A reported work absence of <7 days and no sickness certificate 
 
Mis-match 
No reported work absence and a sickness certificate 
A reported work absence of >7 days and no sickness certificate 
Figure 6:8 Criteria used in marching the self-report and GP sickness certification data sources 
Further analysis on the primary self-reported and sickness certification data was carried out 
using the inter-rater agreement kappa statistic (Altman, 1995) to evaluate the magnitude of 
agreement between the two data sources. The kappa assesses the measure of agreement 
between two variables while adjusting for agreement by chance. The kappa statistic ranges 
from -1 to 1. In this study therefore, a higher kappa statistic reflected a higher degree of 
agreement between self-reported time off work and sickness certification records. It has 
been proposed that the strength of agreement measured by a Kappa statistic can be graded 
as < 0.20 = poor; 0.21 – 0.40 = fair; 0.41 – 0.60 = moderate; 0.61 to 0.80 = good; 0.81 – 1 = 
Very good (Altman, 1995).    
      
A secondary analysis was carried out to evaluate the magnitude of agreement between the 
two data sources excluding self-reported days off work of less than 7 days. This was done to 
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ensure that the same definition was used across the two data sources since sickness 
certification data does not include time off work episodes of less than 7 days.  
  
  
6.7.1 Characteristics of the data sources  
The SBT included 836 patients who provided consent to have their records reviewed, of 
whom 516 (62%) were employed at baseline and 295 (35%) were employed at 12 months. 
The IBS dataset included 728 patients who provided consent to have their records reviewed, 
of whom 551 (59%) were employed at baseline and 256 (35%) were employed at 6 months. 
The mean age of the 295 in the SBT was 46 (range: 18-69); 56% female. Similarly, in the IBS, 
the mean age of the 256 in the SBT was 48 (range: 19-72); 59% were female.   
 
6.7.2 Summary of self-reported absence and sickness certificates measures 
As shown in Tables 6.5 and 6.6, approximately 25% of the respondents in both datasets 
reported having had an absence from work episode (26 % and 25 % for SBT and IBS 
respectively). On the other hand, few participants in both studies reported receiving a 
sickness certification during the study period (7 % and 7 % for SBT and IBS respectively).  
 
Table 6:5 Self-reported absence from work for employment patients 
Self-reported Absence Number Percent Number Percent 
STarT Back Trial (n=295) 
12 months recall 
IMPaCT Back Study(n=256) 
6 months recall 
Yes 78 26% 67 25% 





Table 6:6 Sickness certificates issued during study period 
Sickness certificate Number Percent Number Percent 
STarT Back Trial (n=295)  
12 months period 
IMPaCT Back study (n=256)  
6 months period 
Yes 21 7% 17 7% 
No 274 93% 239 93% 
 
6.7.3 Overall agreement between the electronic medical records and self-report  
Table 6.7 presents data on matching of self-reported work absence periods with sickness 
certification records from the GP certification database. Relatively similar agreement levels 
were observed in the two study datasets. Among employed individuals, 73% and 72% (for 
SBT and IBS respectively) had direct matches, where a reported absence greater than 7 days 
was associated with a sickness certificate and no sickness certificate was recorded for 
records without a reported absence. However, a relatively high mismatch rate of 15% and 13% 
was observed for the SBT and IBS databases respectively. 
 
A significant proportion of the inconsistent matches were found to be self-reported work 
absence days greater than seven days, which warranted a sickness certification but had no 
record of a sickness certificate. A hand search of the consultation free text showed the 
certificates were not documented in the electronic database and therefore could not be 
matched. The remaining minority of records (3% and 3% for the SBT and IBS) were reported 
sickness certification records for which no self-reported work absence was given. Thus the 
results seem to imply that agreement between self-reported and sickness certification 





Table 6:7 Agreement of self-reported work absence with sickness certificates for the study datasets 
Sickness absence (SA) 
according to Self-report 
record 
STarT Back(12 months recall) 
 n = 295 
IMPaCT Back(6 months recall) 
n =255 
SA based on certification database - Sickness Certificate 
Yes No Yes No 
Yes 10 68 10 54 
No 11 206 7 184 
 Sickness certificates matching categorized self-reported work absence period 
< 7 days 0** 36** 0** 29** 
> 7 days 10* 32*** 9* 25*** 
No 11*** 206* 7*** 184* 










*Direct Match **Possible Match ***Inconsistent Match  
 
6.7.4 Association between self-report and sickness certification absence episodes 
using the inter rater kappa 
Kappa statistics obtained for the overall sample of employed patients were 0.085 (SE: 0.044; 
p < 0.05) and 0.158 (SE: 0.048; p < 0.001) for the SBT and IBS datasets respectively. The 
observed values demonstrated a poor (k < 0.20) level of agreement according to the 
classification system by Altman, (1995).   
     
The corresponding kappa values excluding self-reported time off work values less than 7 
days were 0.2074( SE: 0.570; p < 0.001) and 0.292 (SE:0.061; p < 0.001). The adjusted 
datasets demonstrated a fair (0.21 < k < 0.4) level of agreement between the two data 
sources.  Overall, the additional analysis on the primary data variables shows further 





6.8.1 Estimation of a friction period for the UK  
This chapter aimed to contribute to knowledge on the application of the friction cost 
approach by estimating a length of friction period for the UK, and also more detailed friction 
periods stratified by occupational level categories. Vacancy duration estimates were 
collected from a number of organisations and used to estimate the length of a friction period 
in the UK. The overall average duration of a friction period incorporating all data sources was 
2.7 months. National vacancy duration statistics estimated from DLA Piper LLP, the Office of 
National Statistics, Chartered Institute of Professional Development and the University of 
Birmingham in the UK, show friction periods for all occupations combined as ranging 
between 2.0 to 3.2 months. The findings showed wide variations in the friction period across 
occupational categories in some of the data sources (see Figure 6.3 to 6.7), highlighting the 
need to assess the impact of using more detailed friction period values in economic 
evaluation studies applying the friction cost approach. Friction period estimates were 
summarised in three formats including: i) an overall average friction period for all 
occupational categories adjusted to national-level estimates ii) a friction period for two 
levels of occupational categories, iii) a friction period for each dataset split into five 
occupational level categories. Such an analysis has not been performed before.   
 
The results provide insight into the range of vacancy duration estimates from different data 
sources, and the variations in friction periods between occupational categories. The findings 
show differences in vacancy duration and hence friction periods between occupational 
classifications with higher occupational levels including senior managers, professional and 
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technical occupations, showing longer friction periods compared to lower level occupations 
including skilled, services and elementary occupations. The results reflect higher 
unemployment for lower level occupational categories and a longer friction period needed 
to employ higher level occupational workers. Higher level occupational category jobs such as 
senior managers and professional occupations generally have a smaller pool of individuals to 
choose from, which might result in longer recruitment periods compared to lower category 
occupational jobs and this could have influenced this variation. In addition, such occupations 
might have longer notice to leave periods for their employees. Indeed the data set from the 
University of Birmingham showed higher job notice period estimates of six to twelve weeks 
for this category of employees. 
 
Slightly lower estimates were observed in the unadjusted ONS and DLA piper LLP datasets 
which could be attributed to the absence of the period between a job offer and the actual 
start date from these datasets. Currently, there is no reliable information available in the UK 
about the average duration between individuals accepting a job offer and starting 
employment. Therefore, this estimate was sought from published literature in other 
countries. Previous researchers have used an average duration of four weeks to allow for 
this period (Koopmanschap and Rutten, 1996; Hanly et al., 2012). The additional findings 
from the University of Birmingham dataset agreed with previous estimates in the 
Netherlands showing broadly similar estimates of three to five weeks for the average period 
between accepting a job offer and starting work (Koopmanschap et al., 1995). In contrast, 
higher estimates (six to twelve weeks) were observed for occupations specific to academic 
and research related occupations.    
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To date, there is little evidence on friction period estimates within the UK. Studies that have 
used the friction cost approach have reported a friction period of about 90 days (Maniadakis 
and Gray, 2000) and 180 days (Lewis et al., 2007) without providing detailed information on 
the sources of the friction period estimates.  
 
Few researchers have studied vacancy durations or provided comprehensive estimates of 
vacancy durations (Beaumont, 1978; Roper, 1988; van Ours and Ridder, 1991; Erdogan-Ciftci 
and Koopmanschap, 2011). Van Ours and Ridder used a statistical model analysing grouped 
vacancy duration data to estimate vacancy durations according to education level for two 
occupations (van Ours and Ridder, 1991). The data used in the model were based on a 
sample of data from a survey. They found that, in general, employers need more time to fill 
vacancies that require higher educational levels and vacancy durations are more responsive 
at higher educational levels. However, the duration data used in this model were limited 
only to the period of the survey.  
 
Further work by Koopmanschap et al., (1995) in the Netherlands, followed van Ours' model 
by using completed vacancy durations by education level for 1988 and 1990 to estimate 
vacancy durations. The analysis was based on quarterly data on the number of vacancies and 
the uncompleted vacancy durations from a large number of Dutch firms (Koopmanschap et 
al., 1995). This study added an additional period to allow for the time taken in raising a 
vacancy as well as the time in between filling a vacancy and an individual starting work. A 
recent conference abstract reported estimated vacancy durations in 2009 for the 
Netherlands, Belgium, Germany, France, the UK, Norway and Sweden as ranging between 
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40-80 days using a combination of national aggregate stock and time series data on 
vacancies (Erdogan-Ciftci and Koopmanschap, 2011).   
 
The research within this Chapter shows that the average friction period is broadly similar to 
the overall average friction period from these studies as well as from studies as discussed in 
Chapter Three of this thesis. Nevertheless, this research differs in a number of ways. Firstly, 
they study either a cross-section of vacancy durations or patterns of vacancy durations and 
vacancy flows. This research considers both approaches from a variety of data sets and 
hence the findings here complement and strengthen these studies. Secondly, they study 
either average vacancy durations or vacancy durations by education level. This research 
considers variations in vacancy stocks at UK national level and vacancy durations are split 
into occupational categories of the labour market which has not been performed before and 
therefore provides more detailed vacancy duration values and hence friction periods. Overall, 
the vacancy durations from the four sources provide estimates that can be used in the 
application of the friction cost approach within the UK. Consequently, if friction periods 
differ according to occupational levels as has been shown by the vacancy duration estimates 
presented here, then the current practice of using a single friction period for the labour 
market could potentially have an impact on overall friction related costs and on overall cost-
effectiveness estimates.  
 
The analysis presented here has some strengths and limitations. One strength of the current 
study was the diverse range of data sources from which vacancy duration data for various 
levels of occupational categories were collected for the UK. In addition, the datasets were 
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adjusted to national level estimates for the different occupational categories based on data 
from the office of National Statistics. A limitation of the study is that data were obtained 
from different sources that applied different methods in collecting the vacancy duration 
estimates. Ideally, a comprehensive survey covering the various occupational categories 
would provide more rigorous friction period estimates but this was beyond the scope of this 
work and the available resources. However, the selection of data sources included in this 
study span a range of occupational categories at different levels.  
 
Moreover, the data were adjusted to national level data using aggregate vacancy statistics 
comparable to national UK values. Another drawback of this study is that the friction period 
results were categorised based on a broadly classified occupational classification system. A 
more detailed analysis could have been presented if the respondent’s occupational status 
had been coded at a more detailed occupational level classification. This could have been 
achieved through more precise structuring of work questions on the individual 
questionnaires in order to obtain extra information such as whether the respondent is self-
employed, is an employee, the size of the organisation, and supervisory status. However, 
obtaining these extra data could potentially come at a cost of reduced response rates.  
A further limitation with the data sources used is that they only presented limited summary 
data thus limiting the presentation of more detailed information such as standard deviation 
and other measures of dispersion. However, limited data on medians, Lower quartile and 




Given that very few economic evaluation studies have applied the friction cost approach, 
mainly due to uncertainties in estimating a friction period (Hanley et al., 2012), these 
findings provide estimates that will guide future work and research in the application of the 
friction cost approach in the UK. Furthermore, in current practice of economic evaluations 
using the friction period, an overall average friction period is commonly used and often 
depends on the availability of data. The results from this study can be used to further 
develop standard friction period estimates for different occupational categories within the 
UK. In the current practice and reporting of economic evaluations, it is not often possible to 
identify the validity and source of friction period estimates used. Finally, the lack of readily 
available empirical data could potentially be one of the main reasons the friction cost 
approach has rarely been used in the United Kingdom. Data presented here and 
methodological aspects discussed, can therefore help to overcome some of these drawbacks 
as well as stimulate further research. 
 
6.8.2 Feasibility of using sickness certification records in identifying friction periods  
A second aim was to contribute to the scarce research on comparability between sickness 
certification data from GP records and self-report work-related data. This investigation is 
one of the first comparisons of self-reports and sickness certification records in a clinical trial 
and cohort analysis setting within the United Kingdom. The motivation for this investigation 
was to explore how to use retrospective sickness absence data from datasets that have not 
collected durations of individual episodes in order to estimate the occurrence of friction 
periods within economic evaluation studies. This is especially necessary when valuing 
productivity costs using the friction cost approach.  
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The results show that, although self-reports and electronic sickness certification records are 
comparable, the discrepancies found between the two data sources were much higher than 
were typically found in other studies. For example, the only study identified that compared 
self-reports with sickness certification records by Wynne-Jones et al., (2008) reported a 95% 
match of sickness certification medical records with self-reported records. However, this 
may be due to the recall period considered in that study. In comparison to the investigation 
in this thesis that compared self-reported absences over a period of 6 and 12 months, their 
study compared sickness certification records with self-reported time off work over a much 
shorter recall period of 2 weeks. Previous research has shown that recall periods longer than 
3 months are subject to potential errors of recall bias (Severens et al., 2000). However, there 
is also potential overestimation when extrapolating work absence data collected over 
shorter periods of time, making a trade-off necessary, unless it is feasible to collect detailed 
data over a longer period of time (Braakman-Jansen et al., 2012). 
 
Most of the research investigating agreement between resource utilisation data sources has 
focused on comparing self-reports with the healthcare provider or employee healthcare 
databases. One such study in the UK (Ferrie et al., 2005), found relatively good agreement 
between incidence and duration of self-reported work absence data over 12 months when 
compared with employee recorded sickness absence. In contrast, others (van Poppel et al., 
2002; Grovle et al., 2012) reported poor agreement between self-reports and sickness 
absence database records for periods as low as 3 months. Although relatively good accuracy 
of data on the duration of sickness absence has been shown in employment sickness 
absence registers, practical challenges in accessing these data exist particularly within a 
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clinical trial setting where employee data would be required from many different 
organisations.  
 
The feasibility study presented in this thesis investigating the role of sickness certification 
records in assessing work absence in comparison to self-report was based on sickness 
certification data extracted alongside a large clinical trial and cohort study within primary 
care, with a diverse set of patients captured in the certification registry. Nevertheless, there 
were inherent problems with the sickness certification and consultation data. The main 
limitation of this investigation was the lack of information on the duration of sickness 
certificates and therefore reliable conclusions cannot be made on the differences in the 
magnitude of work absence between the two data sources. Further examination of the 
manually prepared sickness certification records, indicated that the most important source 
of discrepancy appeared to be the failure to accurately document certificates issued and the 
associated length of the sickness certificate. As a result, it was also not possible to use the 
sickness certification records to identify individual sickness episodes linked to self-reported 
time off work. In addition, one can question the quality and completeness of the database or 
the data extracted as the additional data had to be manually extracted from consultation 
medical notes.  
 
However, care was taken to review all the relevant certification, consultation data sets and 
consultation free text for back pain related diagnoses and dates of sickness certificates. A 
further limitation was that, where included, it was not possible to identify whether an 
170 
 
individual would spend the entire certified period away from work or might potentially 
return to work before the certified period expired.  
 
These limitations mainly stem from the nature of the sickness certification system in the UK. 
Currently patients can self-certify sickness for an absence period of 7 days or less and would 
only be legally required to obtain a doctors fit for work note, formerly a sickness certificate, 
after an illness of more than 7 days. Additionally, doctors who issue sickness certificates are 
not mandated to record the duration of the sickness certification or to obtain information as 
regards to when individuals return from a sickness certification period.  
 
Overall, it is evident from the findings in this chapter that sickness certification data in the 
UK often lacks information on the duration of sickness absence. Based on these findings, it 
would appear that medical certification data is not tailored for health economic research as 
data on key aspects such as duration of absence and occupation are not always accurately 
documented. However, because this analysis focused on a specific population, it cannot be 
assumed to be representative of the entire UK population. A wider exploration with a larger 
set of practices might be warranted to further explain the relationships between self-reports 
and sickness certification records.  
 
From the findings in this investigation, time off work self-reports are potentially a more 
accurate data source than are sickness absence records and offer the best possibility for 
assessing time off work in economic evaluation studies, unless the certification recording 
system systematically improves to capture all sickness certifications and their associated 
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durations. On the other hand, self-reports are subject to possible recall bias and non-
response issues, and when used  there are possibilities of under-reporting absence episodes 
especially over longer periods of time leading to underestimation of productivity costs. 
Conversely, there are also possibilities of overestimating productivity loss as a result of poor 
recall and inclusion of sickness absence episodes falling outside the relevant study period. A 
further complication is that sickness absence self-reports normally do not include data on 
the duration of specific sickness episodes unless specifically requested from the onset. For 
economic evaluation studies estimating productivity costs based on the friction cost 
approach and using self-reports, the tendency to ignore the capture of specific absence 
episodes should therefore be taken into account at the design stage to the study.  
 
In the absence of duration data on episodes of work absence, a pragmatic approach was 
taken in this thesis assuming that the self-reported sickness absence comprised a single 
sickness absence episode. This sort of assumption may be more accurate in chronic diseases 
like back pain associated with both episodic and long periods of work absence, than for 
some other conditions.  
 
   
This chapter has provided data about friction period estimates in the UK from different data 
sources and employment category levels. The findings showed vacancy durations, hence 
friction periods, differ between employment category levels and that this pattern is 
relatively similar across different data sources. A greater length of the average friction 
period was observed for higher occupational level jobs. This reflects that the friction period 
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is sensitive to occupational level categories and the associated productivity losses may vary 
when more detailed friction periods are used. Obviously more research (a wider survey 
covering various occupational categories across different sectors) could be conducted to see 
if similar results are found, but the empirical work presented in this chapter will contributes 
to the debate on using the friction cost approach and knowledge as to how researchers can 
use more detailed friction periods when valuing productivity costs. An unanticipated 
conclusion is that the average friction period estimated has not changed considerably over 
recent years, despite the change in economic conditions. 
 
The results also showed significant discrepancies between self-report records and sickness 
certification records. It also appears that the current medical certification registry does not 
accurately capture the duration of sickness certifications and therefore cannot be used to 
identify individual absence episodes, which are necessary in valuing productivity costs when 
using the friction cost approach. Medical certification records therefore do not provide a 
more practical solution to common challenges with self-reports in economic evaluation 
studies. Additional research (covering a more diverse set of GP practices) could be carried 
out to provide more insight into the comparability of self-reports with sickness certification 
data, but it is hoped that the results here generate an increased interest in reviewing GP 
certification records and a way forward for their use in economic evaluation research. The 
findings in this chapter highlight the difficulties in obtaining accurate information on the 
length of a sickness period in current economic evaluation research. Greater involvement of 
economists in the design of data collection instruments could provide more detailed and 
accurate data on friction periods. Chapter Eight assesses the potential impact of using more 
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detailed friction periods within an economic evaluation carried out from a societal 
perspective. The next chapter reports empirical work assessing the construct validity and 

























   
The overall aim of this chapter is to evaluate alternative methods used in the measurement 
of lost productivity with particular emphasis on reduced productivity at work. The inclusion 
of a single-item standalone question and a set of work and demographic questions in the 
STarT Back Trial and IMPaCT Back Cohort facilitated an exploratory investigation of the 
construct validity of the single-item presenteeism question. In this chapter, a rationale for 
assessing the validity of the single-item presenteeism question among low back pain 
sufferers is provided. This is followed by a brief overview of literature on psychometric 
properties of reduced productivity measures. Next, the methods and results of the validity 
and responsiveness of the single-item presenteeism measure are explored and presented. 
Finally, the discussion focuses on the implications of these findings and their application for 
work in the subsequent chapter. 
 
 
The literature review in Chapter Four of this thesis shows that the concept of presenteeism 
has received relatively little attention in comparison to absence from work, particularly 
within economic evaluation studies. The evidence from the review in Chapter Four shows 
that presenteeism costs comprise 28% to 85% of total costs of disease, and were often 
greater than absenteeism costs. It is therefore important that presenteeism is measured 
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appropriately within economic evaluation studies. However, the methodological challenges 
in the measurement and valuation of presenteeism have meant that these costs are treated 
with caution within economic evaluation research (Brooks et al., 2010)  
 
A range of tools have been developed to measure presenteeism as identified in Chapter Four 
of the thesis, and their psychometric properties of feasibility, reliability, and validity have 
been reported in previous reviews (Lofland et al., 2004; Beaton et al., 2009; Prasad et al., 
2004; Mattke et al., 2007; Tang et al., 2009). The majority of such tools use multi-item 
presenteeism questions which have the drawback of being associated with difficulties in 
interpretation, increased responder burden, and the potential risk of asking irrelevant 
questions for certain occupations (Bowling, 2005). Conversely, the advantages of tools 
incorporating single-item questions, namely simplicity, ease of interpretation and reduced 
burden, come at the expense of obtaining more detailed information and potentially 
reducing sensitivity to change (Bowling, 2005).  
 
This chapter investigates the validity of a single-item presenteeism question (SIPQ) as a 
standalone measure outside standard presenteeism questionnaires obtaining information 
over a period of 30 days. The SIPQ is a numeric rating scale asking respondents to rate their 
job performance over a specified period of time on a scale of 0 to 10. It was adapted from 
the standardised World Health Organisation Health and Work Performance (HPQ) 
questionnaire (Kessler et al., 2003). The HPQ single question asks respondents to rate their 
overall performance on days worked during the past 4 weeks. The wording from this 
question was adapted for a low back pain population group and to ask about a 30 day period 
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(Figure 7.1). A similar question is incorporated in the Work Productivity and Activity 
Impairment (WPAI) standardised questionnaire with a shorter recall period of seven days 
(Reilly et al., 1993).  
 
Overall, few presenteeism measures have been evaluated within the context of back pain 
(Lerner et al., 2001; Beaton and Kennedy, 2005; Hagberg et al., 2002). The HPQ tool has 
been evaluated in chronic diseases such as arthritis, depression, chronic headaches and 
asthma, but not among back pain patients (Kessler et al., 2004). Similarly, the WPAI measure 
has been validated in a variety of diseases (Reilly et al., 2003; Reilly et al., 2004; Wahlqvist et 
al., 2007; Reilly et al., 2008; Reilly et al., 2010) but not yet among back pain patients. Such a 
validation is important because back pain is a common disorder affecting the working age 
population (Wynne-Jones, 2008), and is a leading reason for working individuals who consult 
their general practitioner in countries such as the United Kingdom (UK) (Foster et al., 2010). 
Practical methods of assessing the costs of reduced productivity, particularly when an 
economic evaluation is from a societal perspective, are needed in determining the full 
economic burden of back pain (Loeppke et al., 2007).  
 
This chapter therefore reports: 
 1) An assessment of the validity of using a single-item presenteeism question in measuring 
at work reduced productivity due to back pain related symptoms with a 30 day recall period 
in two UK studies 
2) An assessment of the responsiveness of the single-item presenteeism question for which 




Psychometric testing has been widely used to measure subjective concepts such as health 
perception and attitudes, and has been used in measurement constructions, and the testing 
of established health status measures such as the SF-36 health survey, and EQ-5D (Harrison 
et al., 2010; Boonen et al., 2007). A range of criteria is  used in assessing the performance of 
measures within the psychometric literature including reliability, validity and responsiveness 
(Brazier et al., 1999). Reliability is used to assess both random and systematic error inherent 
in any measurement (Streiner and Norman, 2006).  
 
Responsiveness is defined as an instrument’s ability to detect a meaningful or clinically 
important difference when changes occur over time (Lindeboom et al., 2005). The validity of 
an instrument assesses if an instrument is able to measure what it is supposed to measure 
within that particular situation (Streiner and Norman, 2006). There are different types of 
validity including content validity, criterion validity and construct validity. Content validity 
refers to the instrument’s ability to measure all related characteristics of what is being 
measured (Brazier et al., 1999). Criterion validity assesses the association of a measure with 
some other alternative measure, usually a gold-standard measure within the area of study 
(Streiner and Norman, 2006). Alternatively, construct validity assesses whether the 
relationship between the scores of a measure and other measures or concepts being 
investigated correlates as hypothesized (Streiner and Norman, 2006). As there is currently 
no gold standard for assessing presenteeism, construct validity rather than criterion validity 





7.4.1 Study population and design  
Data were obtained from the Subgrouping for Targeted Treatment (STarT) Back Trial (Hill et 
al., 2011) and the IMplementation study to improve Patient Care through Targeted 
treatment for back pain (IMPaCT) Back Study (Foster et al., 2010) as described in Chapter 
Five. Briefly, The STarT Back Trial (SBT) was a primary care, multicentre, pragmatic 
randomised controlled trial investigating subgrouping for targeted treatment versus current 
best care (non-targeted) physiotherapy. The IMPaCT Back study (IBS) was a quality 
improvement cohort study investigating a new care system of subgrouping and targeting 
treatment for low back pain patients in routine primary care services. 
 
7.4.2 Patient reported outcome measures      
Patients completed self-administered questionnaires at baseline and at defined subsequent 
time-points throughout both studies. These questionnaires are summarised in Table 7.1 





Table 7:1 Summary of patient outcomes and instruments used in the SBT and IBS Studies 
Construct Outcome measure/Instrument Summary description of instrument 
Disability Roland Morris disability 
questionnaire (RMDQ) 
A 24 item questionnaire scoring 0 or 1. Higher 
scores represent high disability levels 
Generic HRQOL EuroQol (EQ-5D) A multi-attribute generic health utility index with 
Mobility, self-care, usual activities, pain/discomfort, 
anxiety/depression. Higher scores represent better 
HR-QOL 
Generic Health Status 
measure 
SF-12 A shorter version of the SF-36 with a subset of 
questions from the SF-36 measure. It covers both 
physical (PC-12) and mental (MC -12) summary 
aspects.  
Pain Severity Numeric rating scale 
 
An 11 point scale anchored by ‘no pain’ (0) to ‘pain 
as bad as could be’ (10). (past 2 weeks, usual pain, 
and present time) 
Psychological health – Pain 
fear 
Tampa Scale for 
Kinesiophobia(TSK) 
A 17-item scale scored on a 4-point Likert scale 
anchored by 1 "strongly disagree" to 4 "strongly 
agree. Higher scores represent greater 
Kinesiophobia levels 
Generic psychological health 
- Anxiety and Depression 
The Hospital Anxiety and 
Depression questionnaire 
(HAD) 
A 14 item measure of generalised anxiety (7 items) 
and depression (7 items). Higher scores represent 
higher anxiety and depression problems 
Pain catastrophising   Pain catastrophising scale (PCS)  A 13- item measure each with a 5 point scale 
ranging ‘Not at all’ to ‘all the time’. Higher scores 
represent greater Catastrophising 
Change in health status Global change numeric scale A global question with a 6 point scoring scale 
anchored by ‘completely recovered’ to ‘much 
worse’ (6) 
All items included in the START Back and IMPaCT Back databases except for the education component not collected in the IMPaCT Back 
cohort 
 
7.4.2.1 The single-item presenteeism question   
A single-item question asked respondents to estimate their reduced productivity at work 
due to back pain over the past 30 days. The question, administered at baseline and follow-up, 
comprised a single question presented on an 11-point Likert-type scale anchored by ‘Not at 
all’ (0) and ‘The worst you can imagine’ (10). Higher scores indicate a greater impact of back 
pain on work performance. The measure was used to assess the impact of back pain on work 




 “To what extent has back pain affected your performance at work over the past 30 
days? Please rate this on a 0-10 scale, where 0 is ‘Not at all’ and 10 is ‘The worst 
you can imagine’.” (Please cross one box) 
              Not at all 
        The worst you can 
imagine 
 0 1 2 3 4 5 6 7 8 9 10 
 
Figure 7:1 The Single-Item Presenteeism Question wording 
 
7.4.2.2 Roland- Morris Disability Questionnaire (RMDQ)   
Disability was measured using the RMDQ (Roland and Morris, 1983). The RMDQ is a self-
administered 24-item questionnaire with yes/no items specifically related to physical 
functions. A RMDQ summary score is obtained by adding the items checked. The final score 
ranges between 0 (no disability) to 24 (severe disability). The psychometric properties of the 
RMDQ have been established in low back pain patients (Roland and Morris, 1983). 
 
7.4.2.3 EuroQol (EQ-5D)  
Health status was assessed using the EQ-5D. The EQ-5D is a self-completed generic health 
status measure with 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression) and with index values based on value sets elicited from a sample of the 
UK adult population (Dolan et al., 1996). Each dimension has 3 levels of severity. Scores in 
the UK value set range from -0.59 (worst) to 1.0 (perfect health) (Dolan, 1997). Higher scores 
indicate better HR-QOL outcomes. The established and validated 3 level version was used 
here. The EQ-5D has been found to be valid and responsive in low back pain patients 
(Obradovic et al., 2013). 
181 
 
7.4.2.4 SF-12   
Functional well-being and the general well-being of patients was measured using the SF-12 
(version 2).The SF-12 (v2) is a shorter version of the generic SF-36 health profile instrument 
(Ware et al., 1996). The SF-12 generates two summary measures: the physical (PCS-12) and 
mental (MCS-12) component summaries from the 12 questions. SF-12 scores range between 
0 and 100, with higher scores indicating better quality of life (HR-QOL). The SF-12 has been 
found to be valid and responsive in low back pain sufferers (Obradovic et al., 2013).  
 
7.4.2.5 Numerical rating scale (NRS) for back pain activity  
The back pain is an 11 point numerical rating scale is a scale that allows individuals to rate 
their pain from 0 (no pain) to 10 (Pain as bad as could be) (Childs et al., 2005). Questions are 
focused on the intensity of least painful back pain in the last 2 weeks and the intensity of 
back pain at the present time using the NRS.  
 
7.4.2.6 Tampa Scale for Kinesiophobia (TSK)   
The TSK is used to assess fear of movement (Kinesiophobia) in pain sufferers (Hudes, 2011). 
The instrument is a 17-item self-completion questionnaire with each item scored on a 4-
point Likert scale with scores ranging from 1 "strongly disagree" to 4 "strongly agree" (Feleus et al., 
2007). The Overall scores range from 17 to 68, with higher scores indicating increasing 
degrees of Kinesiophobia. The TSK has been shown to be valid in low back pain sufferers 





7.4.2.7 Anxiety and Depression Scale (HADS)  
The HADS was used to assess anxiety and depression in back pain patients. The HADS is a 14-
item self-report measure used to assess anxiety (7 items) and depression (7 items) (Snaith, 
2003). Each item is scored on a 4-point Likert scale with maximum subscale scores of 21 
indicating the highest levels of depression and anxiety.   
  
7.4.2.8 The Pain Catastrophising Scale (PCS)  
Catastrophising involves worrying about negative outcomes from a situation (Turner et al., 
2001). The patients’ use of catastrophising strategies to cope with pain was assessed using 
the PCS which contains 13 questions on thoughts or feelings. Each question is asked on a 5 
point scale from 0 (‘not at all’) to 4 (‘all the time’) and scores are summed to provide a total 
score (Sullivan et al., 1995). Scores range from 0 (lowest) to 52 (highest level of pain 
catastrophising) (Snaith, 2003). 
 
7.4.2.9 Global change question  
A global retrospective assessment question of treatment effect was used to assess the 
patients’ perception of the overall change in their back pain condition. A 6-point Likert scale 
anchored by ‘completely recovered’ and ‘much worse’ was used and collapsed into a 
dichotomous variable with two categories ‘improved’ (completely recovered to better) and 
‘not improved’ (no change to much worse). The variable was used as an external anchor for 
evaluation of responsiveness as in previous validation studies (Beaton and Kennedy, 2005; 




7.4.3 Analysis  
Alpha was set at .05 unless otherwise stated. All statistical analyses detailed below were 
carried out using STATA software version 12 and SPSS software version 19. A priori 
hypotheses were established and presented after each construct. Analysis was restricted to 
the employed population for whom data on presenteeism were collected as part of the data 
sets. A paired (samples) t-test based on matched individuals was used to test for the 
difference in reduced productivity between responders employed at baseline and follow-up. 
 
7.4.4 Validity  
Construct validity of the SIPQ was assessed by providing evidence of convergent and 
divergent validity. Convergent and divergent validity were tested by exploring whether the 
presenteeism tool was correlated with measures hypothesized to be related (convergent) or 
unrelated (divergent). Evidence of convergent validity was established by a significant and 
strong correlation between measures based on stated prior hypothesis (Marra et al., 2005), 
while divergent validity was determined by an insignificant and weak correlation between 
measures (Streiner and Norman, 2006).  
 
Correlation analysis was conducted between the presenteeism measure, and standard 
reference constructs included in both studies for pain (NRS), disability (RMDQ), fear 
avoidance (TSK), anxiety and depression (HADS), Catastrophising (PCS) and quality of life (SF-
12, EQ-5D). The measure was also correlated against non-clinical variables including age, 
education, gender and patient risk group. Correlation coefficients were calculated using 
Pearson’s correlations for normally distributed data and Spearman’s rank correlations for 
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non-normal data. Correlations were classified as very strong ( 8.0r ), strong 
( 8.06.0 r ), moderate ( 6.04.0 r ), weak ( 4.02.0 r ), or absent ( 2.00.0 r ) 
(Aggarwal et al., 2009). Correlations were performed for interval scores in evaluating for 
cross-sectional validity. 
 
Previous validation studies have shown productivity loss to be related to disease severity 
and quality of life (Prasad et al., 2004; Reilly et al., 2010). A number of a priori hypotheses of 
expected relationships were therefore developed and tested. It was hypothesized that the 
SIPQ would be highly correlated with: 1) pain intensity and severity 2) disability 3) disease 
specific measures and 4) quality of life. SIPQ was further hypothesised to be moderately 
correlated with fear and avoidance (measured by the TSK) and depression/anxiety 
(measured by the HADS). Such associations would reflect convergent validity of the SIPQ. In 
contrast, previous research has demonstrated that age, gender and education have 
relatively little impact on sickness presenteeism (Aronsson et al., 2000). A further hypothesis 
was that there would be an insignificant correlation between the SIPQ and these variables. 
Evidence in this context would reflect divergent validity of the SIPQ.  
 
7.4.4.1 Presenteeism scores and EQ-5D   
 Lower levels of quality of life in back pain patients have been associated with efficiency loss 
and absenteeism (Lamers et al., 2005). Correlation analysis was therefore used to explore 
the relationship between presenteeism and EQ-5D at baseline and follow-up. The SIPQ was 
expected to be highly correlated with the EQ-5D. 
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7.4.4.2 Presenteeism scores and general health scores  
Investigations were also carried out to compare the dimensions within the SF-12 such as 
physical limitations, psychological health problems at work, and general health satisfaction. 
Since pain in the lower-back generally affects physical health to a greater extent than mental 
health (Riddle et al., 2001), presenteeism was expected to be highly correlated with the 
physical summary component (PCS).  
  
7.4.4.3 Presenteeism scores and disability    
Previous studies have associated back pain with chronic illness which leads to disability and 
impairment at work (Croft, 1998; Mallen et al., 2007; Lin et al., 2011). The SIPQ was 
therefore hypothesised to be highly correlated with the disease specific RMDQ. This 
measure was also expected to be more highly correlated with the RMDQ than with the 
generic EQ-5D measure as disease specific measures have been known to have overall 
greater responsiveness than generic instruments (Taylor et al., 1999).  
 
7.4.4.4 Presenteeism scores and pain characteristics of pain intensity and severity  
Pain intensity (or pain severity) has been reported as a predictive factor for poor prognosis 
among musculoskeletal patients (Mallen et al., 2007). These characteristics have been 
associated with self-reported reduced productivity (Hagberg et al., 2002; Mannion et al., 
2009). The SIPQ was therefore hypothesised to be highly correlated with pain intensity and it 
was also hypothesised that the severity of back pain would be associated with significantly 




7.4.4.5 Presenteeism scores and psychological health  
Evidence of the influence of psychological factors, such as fear avoidance and anxiety, on 
back pain related reduced productivity has been conflicting. Some have found no impact of 
depression or anxiety on reduced productivity (Hagberg et al., 2002) while others found that 
fear avoidance beliefs about work and physical activities were significantly associated with 
both work absence and reduced productivity (Mannion et al., 2009). It was hypothesized 
that the SIPQ would be moderately correlated with fear and avoidance (measured by the 
TSK) and depression/anxiety (measured by the HADS).  
    
7.4.4.6 Presenteeism and other factors – age, gender, education  
Previous research has demonstrated that age, gender and education have relatively little 
impact on sickness presenteeism (Aronsson et al., 2000). It was therefore hypothesised that 
there would be an insignificant correlation between the SIPQ and these variables. 
   
Discriminant validity of the presenteeism measure was tested using the known-group 
validity method by assessing the ability of the SIPQ to discriminate between pre-defined 
groups that were expected to differ (Streiner and Norman, 2006). Patients were categorised 
into subgroups of low risk, medium risk and high risk based on the presence of risk factors 
for chronicity, in order to identify patients at risk of work absence due to back pain sickness 
for targeted treatment. Using pre-defined groups from the validated STarT Back tool (Hill et 
al., 2008), it was hypothesised that the SIPQ would discriminate among known groups by 
showing greater presenteeism in patients thought to have more severe back pain (i.e. the 
‘high risk’ group and ‘medium risk’ group, compared to the ‘low risk’) (P < .05). Sensitivity to 
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the known differences was assessed using analysis of variance (ANOVA) with adjustments for 
multiple testing based on the Bonferroni correction method (Bland and Altman, 1995). 
Furthermore, using t-tests, known-group validity was also assessed by comparing participants 
who had improved in their back pain condition with those who had not improved according 
to a global response question and a change in RMDQ score described in the responsiveness 
analysis detailed below. A priori hypothesis was that the SIPQ would discriminate among 
patients classified into these known-groups. 
 
7.4.5 Responsiveness and sensitivity to change 
Responsiveness of the SIPQ was also assessed to investigate the ability of the tool to detect 
changes over time. A responsive measure is able to detect minimal important changes in 
patients (either improved or worsened) over time (Revicki et al., 2006). A minimal 
meaningful improvement is the smallest difference that is perceived as a significant change 
in the health condition of patients (Streiner and Norman, 2006). For this analysis, 
comparisons between the SIPQ and other instruments were performed for two patient 
groups: those who perceived their health as having improved between baseline and follow-
up, and those who considered their health as having not improved. The change in health was 
established from two indicators with the following items for assessing changes in health: (i) 
patient perceived change in back pain condition over time (patient rated global score 
question); and (ii) change in percentage RMDQ score (clinical endpoint).  
 
The external patient global rating of change (GRC) question in health status was used to map 
change scores to changes in clinical measures (Revicki et al., 2006): a RMDQ > 30% change is 
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considered an appropriate threshold for assessing patient improvement in health among 
back pain patients (Jordan et al., 2006). Responses from the GRC question were given on a 6-
point scale ranging from 1 “completely recovered” to 6 “much worse”. Respondents who 
scored 1, 2 or 3 were classified as having improved, and those scoring 4, 5 or 6 were 
considered not to have had any improvement. Similarly, respondents with a RMDQ > 30% 
change were classified as having improved, and those individuals with < 30 % change as not 
having had any improvement. 
 
In quantifying and examining responsiveness, two analytical approaches were used:  
I. correlation analysis  
II. statistical 
In the correlation approach, correlation analysis was conducted between the presenteeism 
measures and the two external indicators for assessing change as in the construct validity 
analysis above. It was hypothesised that at least moderate correlations would indicate 
responsiveness of the measure. Once groups of low back pain sufferers were identified as 
either improved or non-improved based on the external indicators, statistical analysis was 
then used to further examine responsiveness.  
 
In the statistical analysis approach (Hays and Revicki, 2005), statistical significance of the 
differences in the mean presenteeism change scores between ‘improved’ and ‘non-
improved’ groups was established using the student t-test statistic. Distribution-based 
methods were applied based on statistical properties of the presenteeism measure. These 
methods included: (i) effect size (SES) (mean change divided by the standard deviation of the 
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baseline score) (Kazis et al., 1989); and (ii) standardised response mean (SRM) (mean change 
divided by the standard deviation of the change score) (Cohen, 1988). Anchor based testing 
included the Guyatt responsiveness index (GRI) (mean change in ‘improved’ subjects divided 
by the standard deviation of change in ‘non-improved’ subjects) (Guyatt et al., 1987; Yost 
and Eton, 2005). Responsiveness of the measure was categorized as small when less than 0.5, 
moderate when between 0.5 and 0.8, and large when greater than 0.8 (Cohen, 1988). A 
priori hypotheses were that large ESs and SRMs for the SIPQ would be observed for patients 
who had improved and that small ESs and SRMs would be observed for patients who had not 
improved, as previous studies showed lower values for subgroups of patients who had not 
improved in self-reported measures (Beaton et al., 2010). 
 
Longitudinal construct validity assesses the extent to which change over time correlates with 
other indicators of change. Responsiveness was further measured through correlation 
analyses of change scores of the SIPQ with change scores of other constructs (as described in 
the construct validity assessment detailed above); only patients employed both at baseline 
and follow-up were included. A priori hypotheses were that low correlations (.30 < r <.50) 
would be observed between the change scores of the SIPQ and change scores of the pain, 









7.5.1 Participant Characteristics 
The back pain patient samples are described for employed patients in Table 7.2. The SBT 
sample included 851 patients, of whom 62% (n = 524) were employed. 275 (53%) of these 
patients reported taking time off work in the past 12 months. Only 285 responders reported 
being employed both at baseline and follow-up. The IBS included 922 patients, of whom 60% 
(551) were employed at baseline; 243 (44%) of these patients reported taking time off in the 
past 12 months (Table 7.2). Overall, 281 responders reported being employed both at 
baseline and follow-up (the IBS was characterised with a lower response rate than the SBT).  
 
Table 7:2 Characteristics of patients employed at baseline assessment. 
 STarT Back ( N
a


















Absenteeism  524 275 53% 547 243 44% 
Gender (Female ) 524 292 56% 551 301 55% 
Age 524 43.69 11.34 551 46.80 11.20 
RMDQ 524 8.79 5.40 551 7.93 5.70 
EQ-5D 517 0.60 0.27 546 0.65 0.29 
SF-12 PCS 522 
 
39 10.08 546 41.74 10.57 
SF-12 MCS 522 48.69 10.79 546 49.93 10.49 
Pain intensity – Present 
time 
522 6.34 2.32 549 4.26 2.76 
Pain intensity- Past 2 
weeks 
521 4.48 2.49 550 5.72 2.72 
Average pain severity 518 4.88 1.97 548 4.99 2.54 
SIPQ score (reduced 
productivity at work) 
520 4.82 3.00 530 4.47 3.01 
a represents participant who self-reported being employed at baseline; RMDQ Roland Morris disability questionnaire, SD Standard 
deviation, PCS Physical component summary scale, MCS Mental component summary scale, STarT: Subgrouping for Targeted Treatment, 
IMPaCT: Implementation study to improve Patient Care through Targeted treatment  





7.5.2 Distribution of responses across the 11 points of the SIPQ  
Overall, scores for the SIPQ were distributed across the whole scale in both studies as shown 
in Figure 7.2, suggesting a capacity for broad discrimination between different intensities of 
presenteeism.  At follow-up, several participants reported presenteeism scores distributed 
between the numbers 0 (not pain at all) and 5. The SBT sample included 520 and 292 
patients (for baseline and follow-up respectively) who responded to the SIPQ, of whom 60% 
and 89% (for baseline and follow-up) reported numerical scores distributed between 
numbers, 0 and 5. A similar trend was observed in the IBS dataset which included 530 and 
279 patients (at baseline and follow-up respectively) who responded to the SIPQ, of whom 
61% and 86% (for baseline and follow-up) reported a numerical score between the numbers 
0 and 5. 
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7.5.3 Reduced Productivity – Presenteeism  
The difference in mean reduced productivity between patients employed at baseline and 
follow-up was calculated alongside the 95% confidence intervals (CI). This resulted in a mean 
difference of 2.46 (CI 2.09 to 2.82: P <0.001) and 2.25 (CI 1.87 to 2.61: P <0.001) for SBT and 
IBS respectively (Table 7.3). In both studies, the differences between the patients employed 
at baseline and follow-up were statistically significant (P<0.001) (Table 7.3). 
 
Table 7:3 Reduced productivity for patients with back pain at baseline and Follow-up 
STUDY Measure n
a














patients baseline and 












patients baseline and 










values for reduced productivity changes calculated for data available at both baseline and follow-up 
 
7.5.4 Construct Validity  
Presenteeism was positively correlated with pain, psychological health (fear avoidance, 
anxiety depression, and catastrophising), disability, risk group categorization and time off 
work; and negatively correlated with quality of life (Table 7.4). Furthermore, the Spearman 
rank correlation between presenteeism and EQ-5D dimensions, risk group and time off work 
due to back pain showed a significant correlation. There was strong evidence of an 
association between reduced productivity and quality of life, disability, pain intensity and 
pain severity attributes as hypothesised. In addition, weak to moderate associations were 
193 
 
observed between presenteeism and the general psychological measures (Table 7.4) and the 
anxiety and self-care dimensions of the EQ-5D. The highest correlations were observed 
between the SIPQ and physical summary component of the SF-12, the ‘usual activities’, and 
the ‘pain’ components of the EQ-5D ( 66.029.0 r ) and in the disease specific measures 
related to disability ( 70.055.0 r ) and pain ( 77.038.0 r ) (Table 7.4). There was 
evidence of a weak association between the SIPQ and the mental health component 
( 001.0;29.021.0 Pr ) (See Table 7.4). 
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Table 7:4 Construct validity: correlations between the SIPQ and other constructs at baseline and follow-up 












Pain Dimensions     
Average pain severity 0.54 (P<0.001) 0.77 (P<0.001) 0.53 (P<0.001) 0.70 (P<0.001) 
Intensity of back experience 
at present time 
0.44 (P<0.001) 0.76 (P<0.001) 0.44 (P<0.001) 0.65 (P<0.001) 
Psychological health     
Anxiety (HAD) 0.23 (P<0.001) 0.39 (P<0.001) 0.34 (P<0.001) 0.42 (P<0.001) 
Depression (HAD) 0.35 (P<0.001) 0.47 (P<0.001) 0.45 (P<0.001) 0.53 (P<0.001) 
Catastrophising (PCS) 0.35 (P<0.001) 0.56 (P<0.001) N/A N/A 
Pain related fears (TSK) 0.34 (P<0.001) 0.40 (P<0.001) 0.35 (P<0.001) 0.42 (P<0.001) 
Disability     
RMDQ score disability 0.53 (P<0.001) 0.70 (P<0.001) 0.54 (P<0.001) 0.70 (P<0.001) 
SF-12 Dimensions     
physical component 
summary (SF-12 v2) 
-0.56 (P<0.001) -0.66 (P<0.001) -0.55 (P<0.001) -0.58 (P<0.001) 
Mental component summary 
(SF-12 v2) 
-0.21 (P<0.001) -0.28 (P<0.001) -0.29 (P<0.001) -0.29 (P<0.001) 
General health -0.54 (P<0.001) -0.62 (P<0.001) -0.57 (P<0.001) -0.59 (P<0.001) 
Age -0.01 0.03 -0.09 -0.03 
Education 0.04 0.01 N/A N/A 
Gender 0.02 0.04 0.03 -0.01 
Measurement  (Spearman’s 
Ranks Correlation) 
    
EQ-5D     
EQ-5D mobility 0.34 (P<0.001) 0.44 (P<0.001) 0.34 (P<0.001) 0.39 (P<0.001) 
EQ-5D self-care 0.22 (P<0.001) 0.27 (P<0.001) 0.26 (P<0.001) 0.22 (P<0.001) 
EQ-5D usual activities 0.36 (P<0.001) 0.50 (P<0.001) 0.43 (P<0.001) 0.51 (P<0.001) 
EQ-5D pain 0.29 (P<0.001) 0.58 (P<0.001) 0.36 (P<0.001) 0.54 (P<0.001) 
EQ-5D anxiety 0.14 (P<0.001) 0.27 (P<0.001) 0.22 (P<0.001) 0.32 (P<0.001) 
EuroQol EQ-5D -0.44 (P<0.001) -0.60 (P<0.001) -0.46 (P<0.001) -0.62 (P<0.001) 
Others     
Risk Group 0.49 (P<0.001) 0.41 (P<0.001) 0.47 (P<0.001) 0.49 (P<0.001) 
Time off work 0.39 (P<0.001) 0.43 (P<0.001) 0.40 (P<0.001) 0.15 (P<0.05) 
SIPQ Single-Item presenteeism question, RMDQ Roland Morris disability questionnaire, SD Standard deviation, HAD Hospital Anxiety and 
depression scale PCS Pain Catastrophising Scale, TSK Tampa Scale for Kinesiophobia, STarT: Subgrouping for Targeted Treatment, IMPaCT: 




The single-item presenteeism scores correlated positively with education (r = 0.04 for SBT) 
and gender (r = 0.02, r = 0.03 baseline for SBT and IBS respectively) and negatively with age 
(r = -0.01, r = 0.03 for SBT and r = -0.09, r = -0.03 for IBS) (Table 7.4). These weak and 
insignificant relationships between the presenteeism tool and these variables (education, 
gender and age) showed divergent validity (Table 7.4).      
  
  
The results of discriminant validity are summarised in Tables 7.5. At follow-up in both studies, 
mean scores of the SIPQ could differentiate between patient risk groups. The findings at 
baseline show that ‘high risk’ patients have statistically significant higher presenteeism than 
‘medium risk’ and ‘low risk patients’ (P < 0.001) (Table 7.5). There was a significant 
difference between the medium and low risk groups and the high-risk and low risk groups 
after correcting for multiple testing. Similarly, mean scores of the SIPQ could differentiate 
between improved patients and patients who had not improved according to the global 
change question and RMDQ change score indicator. The findings showed that ‘improved’ 
patients have statistically significant higher mean presenteeism changes than ‘non-improved’ 
patients according to the global change to back pain (SBT: 3.25 versus 0.71, IBS: 2.85 versus 
0.76; p<0.001) and the RMDQ score indicator (SBT: 3.16 versus 0.82; p<0.001, IBS: 3.22 







Table 7:5 Known-group validity of the SIPQ among risk groups at baseline and follow-up 
STarT Back Trial IMPaCT Back Study 


































































SIPQ Single-item presenteeism question, SD Standard deviation, Diff Difference, STarT: Subgrouping for Targeted Treatment, IMPaCT: 
Implementation study to improve Patient Care through Targeted treatment  
 
 
Additionally, longitudinal construct validity examined using correlations between change 
scores in reduced productivity and change scores from selected constructs in both studies 
showed similar findings. The strongest association with presenteeism was observed with 
RMDQ scores and the SF-12 physical summary dimension (Table 7.6).  However, low to 
moderate associations were observed between the SIPQ and the pain and HR-QOL measures.  
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Table 7:6 Longitudinal construct validity correlations between the SIPQ and pain, disability, psychological, 
general and quality of life measures 
Measurement  
 








Pain Dimensions   
Intensity of back experience at present time (N=275;261)* 0.52 (P < 0.001) 0.34 (P < 0.001) 
Psychological health   
Pain related fears (TSK) (N=277;259)* 0.27 (P < 0.001) 0.23 (P < 0.001) 
HADS – Anxiety(N=279;261)* 0.22 (P < 0.001) 0.26 (P < 0.001) 
HADS – Depression(N=279;261)* 0.36 (P < 0.001) 0.30 (P < 0.001) 
Disability   
RMDQ –disability(N=283;262)* 0.54 (P < 0.001) 0.54 (P < 0.001) 
EQ-5D Dimensions   
EuroQol EQ-5D(N=270;255)* -0.36 (P < 0.001) -0.31(P < 0.001) 
SF-12 Dimensions   
physical component summary  
(SF-12 v2)(N=277;256)* 
-0.50 (P < 0.001) -0.51 (P < 0.001) 
Mental component summary  
(SF-12 v2) (N=277;256)* 
-0.15 (P < 0.001) -0.08 
General health (N=253)* -0.46 (P < 0.001) -0.09 
Perceived change in Back pain   
Global change @12 months(N=278 , N=262)** -0.38 (P < 0.001) -0.30 (P < 0.001) 
Change in RMDQ (RMDQ>30%)(N=283, N=242)** 0.55 (P < 0.001) 0.54 (P < 0.001) 
** Spearman’s ranks correlation; *Pearson’s correlation coefficient; a Patients employed at baseline and follow-up with relevant data, (N)  
represents numbers of participants at base-line and follow-up in the STarT Back Trial and IMPACT Back Study respectively, SIPQ Single-Item 
presenteeism question, RMDQ Roland Morris disability questionnaire SD Standard deviation, HAD Hospital Anxiety and depression scale, 
PCS Pain Catastrophising Scale, TSK Tampa Scale for Kinesiophobia STarT: Subgrouping for Targeted Treatment, IMPaCT: Implementation 
study to improve Patient Care through Targeted treatment  N represents numbers at follow-up in the SBT and IBS studies. 
The responsiveness analysis is based on a subsample of patients employed at baseline and follow-up, 283 for the SBT and 262 for the IBS 
dataset. 
 
7.5.5 Responsiveness  
A total of 283 patients employed both at baseline and follow-up in the SBT were included in 
the responsiveness analysis based on the global change in back pain variable (See Table 7.6). 
A total of 188 (68%) of all the employed patients reported an improvement in their back pain 
condition (See Table 7.7). In the IBS, 262 of the employed patients both at baseline and at 
follow-up were included in the responsiveness analysis (See Table 7.6). Of these, 186 
reported an improvement in their back pain condition based on the global assessment 
question (See Table 7.7). Change in SIPQ showed statistically significant associations with 
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measures assessing improvement in back pain (Table 7.7). The majority of patients showed a 
significant improvement in back pain condition at follow-up as determined by both the 
global response change in the back pain question and the RMDQ > 30% change score. As 
anticipated, the improved patients group had a significant reduction in work impairment 
compared with the non-improved patients group (Table 7.7).  
 
Effect size statistics in the overall SIPQ scores were large (SBT dataset – SES = 0.83, 
SRM=0.76, IBS dataset - SES = 0.76, SRM=0.74). Similarly, the effect size statistics from the 
subgroup of patients with improvement in back pain based on SIPQ scores were large (1.01 
to 1.18) in both studies compared to those for patients reporting no improvement (SRMs: 
0.24-0.28) – giving anchor-based GRI statistics of 1.12 and 0.94 (SBT and IBS respectively) 
(See Table 7.7). Patients classified as ‘not improved’ demonstrated small improvements in 
their presenteeism scores although the SRM values show these improvements were very 
small. 
Table 7:7 Responsiveness of the SIPQ change scores by proxy measures (given by global change in condition 
of back pain variable and RMDQ>30% criterion) 
 STarT Back Trial IMPaCT Back Study 







Global change in condition       
Improved  188 3.25 (2.76) 1.18 186 2.85 (2.81) 1.01 
Not improved  90 0.71 (2.91) 0.24 76 0.76 (3.03) 0.25 
RMDQ Change       
Improved  198 3.16 (2.94) 1.07 152 3.22 (2.83) 1.14 
Not improved 85 0.82 (2.95) 0.28 90 0.68 (2.83) 0.24 
SIPQ Single-Item presenteeism question, RMDQ Roland Morris disability questionnaire, SD Standard deviation, SRM Standardised response 
mean, STarT: Subgrouping for Targeted Treatment, IMPaCT: Implementation study to improve Patient Care through Targeted treatment. 





Similarly, the SIPQ was able to detect changes in back pain patients according to the 
transitional global change questionnaire that assessed transition of patient condition from 
“no change” to “better”, “much better” or “completely recovered” and from “no change” to 
“worse” or “much worse”. As anticipated, patients reporting their back pain condition as 
‘completely recovered’ and ‘much better’ had a significant reduction in work impairment 
when compared with patients self-reporting as ‘worse’ and ‘much worse’ (Table 7.8).   
  
Table 7:8 Mean change in presenteeism for the single-item question among back pain patients based on the 
change in back pain condition 6 point severity question. 
Global change in severity pain 
question 








Completely Recovered 36 -4.36 (3.11) 38 -3.61 (2.78) 
Much better 90 -3.53 (2.86) 92 -3.23 (2.73) 
Better  62 -2.19 (2.53) 56 -1.71 (2.68) 
No change 70 -1.28 (2.55) 46 -1.26 (2.61) 
Worse 15 1.00 (2.24) 28 -0.04 (3.64) 
Much worse  5 2.20 (3.49) 2 0.50 (2.12) 
a change in back pain between baseline and follow-up in the 6 point back pain change scale measure 
 
  
This chapter has reported on the first study to examine the validity and responsiveness of 
the single-item presenteeism question as a stand-alone measure for estimating 
presenteeism among low back pain sufferers. There has been an increased number of 
presenteeism instruments developed in the literature. This, to a large extent, has been 
driven by the significant costs associated with reduced productivity, hence necessitating the 
need for practical tools assessing the impact of illness on productivity at the workplace. The 
review in Chapter Four of this thesis identified a diverse set of multi-dimensional 
instruments as well as standalone global single-item questions from costing literature. The 
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validity of standalone questions used outside of standard presenteeism instruments in these 
costing studies, however, has not been reported among low back pain sufferers.  
 
This study demonstrated the construct validity and responsiveness to change in worker 
productivity of the single-item response question (the SIPQ). The study substantiated most 
of the theorised constructs underpinning the SIPQ in relation to existing measures, 
suggesting that the presenteeism tool is measuring what it is expected to measure. When 
testing for convergent validity, the strongest relationships were observed between the 
presenteeism measure and pain, disability, and SF-12 physical component scales. 
Furthermore, divergent validity was established as the presenteeism question was as 
anticipated, not statistically significantly correlated with constructs of age, gender and 
education. Known-group validity of the single-item presenteeism tool was also established, 
as the tool was able to differentiate between presenteeism changes among subgroups of 
patients based on patient risk groups (low risk, medium risk, and high risk), and observed 
patient response to the intervention (improvement or not).   
 
The responsiveness to change in worker productivity of the single-item response question 
was also confirmed. The SIPQ was found to be highly responsive, showing ability to 
discriminate between subgroups of patients and changes in their health conditions according 
to pre-defined anchors (patient rated global change and clinical end point: RMDQ > 30% 
indicators of change). Estimates of effect size indicators from the overall and pre-defined 




The results in this study generally agreed with previous validation studies that have found 
strong relationships between work productivity, disease severity, pain and quality of life in a 
range of conditions (Reilly et al., 2008; Giovannetti et al., 2009; Zhang et al., 2010a). On the 
other hand, the findings regarding the association between presenteeism and psychological 
measures were inconclusive. Chronic back pain is known to be commonly associated with 
the impaired ability to perform physical roles (Lin et al., 2011), but there is less clear 
evidence, generally, on the influence of psychological factors such as fear avoidance and 
anxiety. Some studies have found that the effect of depression or anxiety on reduced 
productivity could not be ascertained (Hagberg et al., 2002) and others report that fear 
avoidance beliefs about work and physical activity due to back pain are significantly 
associated with both work absence and reduced productivity (Mannion et al., 2009). As 
hypothesised, the results presented in this chapter show significant but weak associations 
between the SIPQ and psychological assessment measures. Further, the results in this 
investigation agreed with a previous study that investigated the validity of a single-item 
question against a multi-item work ability index questionnaire used to assess work ability 
among women on long-term sick leave (Ahlstrom et al., 2010). There was a strong 
association between both measures, and the predictive value of health-related quality of life 
and sick leave was similar in both tools. 
  
In the study presented here, the strongest associations are observed between the SIPQ and 
the physical summary component of the SF-12; the ‘usual activities’, and the ‘pain’ 
components of the EQ-5D; and in disease specific measures related to disability and pain. 
Similar findings were observed in the longitudinal construct validity analysis. Although there 
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is currently no gold standard for the assessment of statistically significant meaningful 
changes (Pengel et al., 2004), responsiveness of the measure was shown based on two proxy 
measures assessing improvement in back pain condition. These approaches have been used 
in prior psychometric studies (Beurskens et al., 1996; Beaton and Kennedy, 2005; Coelho et 
al., 2008). All statistical measures applied showed responsiveness of the SIPQ. 
  
The study has both strengths and limitations. The major strength of the study is that the 
analysed data were from two large empirical datasets which contained other measures 
alongside which to validate the SIPQ, and thus enabled comparative analysis across the two 
studies. Furthermore, the data have been analysed using a number of well-established 
statistical methods for measuring validity and responsiveness. The analysis was not, however, 
able to cross-validate the SIPQ against multi-item presenteeism tools. This would be an 
avenue for further research and could be achieved by comparison of the SIPQ with other 
commonly used multi-item instruments such as the Work Limitations Questionnaire, the 
Work Productivity and Activity Impairment questionnaire and the Stanford Presenteeism 
Scale. Although some studies have compared across presenteeism measures (Ozminkowski 
et al., 2004; Tang et al., 2009; Beaton et al., 2010; Zhang et al., 2010b; Louise et al., 2012), 
none have, as yet, focussed on the comparison of these measures with a SIPQ. One study, 
however, has compared the Work Ability Index against a single-item question assessing work 
ability among women on long-term sick leave (Ahlstrom et al., 2010). Such studies would be 
important in providing greater insight into the comparability of productivity loss estimates 
from single and multi-item presenteeism tools. Moreover, the results presented here only 
focus on low back pain sufferers, and therefore cannot be generalised.   
203 
 
The significance of back pain related costs of absenteeism and presenteeism augments the 
importance of initiatives towards the further development of presenteeism measurement 
and valuation instruments. The SIPQ in particular potentially offers various benefits for those 
wishing to investigate presenteeism given the brevity, simplicity, and efficiency of the 
measure and its potential applicability to diverse occupations since it does not ask job-
specific questions as in the majority of the current multi-item measures. Moreover, the SIPQ 
can be incorporated into clinical study questionnaires without imposing a significant burden 
on both the respondent and researcher. This is in contrast to many of the self-report multi-
item presenteeism questions used for economic evaluation that are often less practical and 
quite lengthy. 
  
This study has shown the validity and responsiveness to change of the single-item 
presenteeism question among back pain patients, which warrants further research in other 
disease areas and translation into practice. Nevertheless, there is still the need for further 
studies undertaking concurrent validation of the SIPQ alongside other commonly used multi-
item instruments such as the Work Limitations Questionnaire and Stanford Presenteeism 
Scale. A previous study compared psychometric properties of four presenteeism measures in 
workers with shoulder or elbow disorders, reporting the existence of theoretical differences 
in what the tools measure (Tang et al., 2009). Further research is therefore needed to 
provide more insight into the comparability of productivity loss estimates from single and 






The findings presented in this chapter show the validity and responsiveness of the single-
item presenteeism question. Standardised validated presenteeism measures are necessary if 
the impact of disease on work productivity is to be accurately quantified and incorporated 
within economic analysis studies. While potentially less precise and limited in obtaining 
more detailed information than multi-item measurement scales, the SIPQ demonstrates 
good construct validity and responsiveness, and offers noticeable benefits within 
musculoskeletal research across diverse populations. It is also able to discriminate between 
specific patient groups, is responsive to change, and is feasible to use in the context of back 
pain. Construct validity and responsiveness are, however, best confirmed through evidence 
from various studies. The SIPQ should therefore be validated in other studies to investigate if 
the results obtained here will be replicated. Subsequently the SIPQ scores from both studies 
will be used to generate presenteeism costs. In the next chapter, these are included as part 






In Chapters Six and Seven, estimates of the length of a friction period relevant for the United 
Kingdom (UK), and an assessment of the construct validity and responsiveness of a single-
item presenteeism question were presented and discussed. In this chapter, economic 
evaluations of the stratified care intervention conducted alongside the STarT Back Trial (SBT) 
(Hill et al., 2011) and IMPaCT Back Study (IBS) (Foster et al., 2010) are presented, with the 
aim of illustrating the application of the friction cost approach in economic evaluation 
studies. This includes how the friction cost approach can be used to value absenteeism and 
presenteeism, using multiple friction period estimates and adjusting costs for the effects of 
productivity loss on team productivity. 
 
The burden of low back pain has been clearly established in Chapter Five. Stratified primary 
care management, which employs screening tools to allocate patients to risk-defined groups, 
has been proposed as a means of ensuring optimal treatment of LBP (Hay et al., 2008; Hill et 
al., 2011). The cost-effectiveness of such interventions from a societal perspective however 
remains unclear. Information on societal costs is useful to support broader decision making 






Few studies have attempted to investigate the extent to which inclusion and exclusion of 
productivity costs affects the true total societal costs in this area. A cost-utility analysis was 
previously performed alongside the STarT Back clinical trial reported by Hill et al., (2011) and 
further analysis was performed within risk-defined subgroup analysis and reported by 
Whitehurst et al., (2012). The studies showed that, from a healthcare perspective, the 
stratified management approach was a highly cost-effective intervention among LBP 
patients in general, and across all risk-defined subgroups (Hill et al., 2011; Whitehurst et al., 
2012). The cost-utility analysis for the IMPaCT Back study has not yet been reported. 
However, the limitation of these economic analysis studies is that they were performed from 
the conventional UK healthcare perspective, although there are strong arguments in favour 
of adopting a broader societal perspective (Drummond et al., 2005; Drummond and Rutten, 
2008). 
 
The economic analyses studies in this chapter were therefore performed using a societal 
perspective to investigate the impact of including productivity costs estimated using a FCA 
on economic evaluation results, and focusing on aspects of lost productivity such as 
absenteeism, presenteeism, and multiplier effects (related to effects of productivity loss on 








The aims of this chapter therefore are to:  
(i) assess the impact of including productivity costs of absenteeism, presenteeism 
and multiplier effects in cost-effectiveness analyses (investigated through two 
cost-utility studies comparing the stratified management intervention with non-
stratified current practice overall and within risk-defined subgroups);  
(ii) assess the impact of using more detailed length of friction period values when 
valuing productivity costs using the friction cost approach on cost-effectiveness 
results (assessed through friction period estimates stratified by occupational 
levels obtained from four different UK data sources). 
 
Productivity costs are generated based on various cost valuation models of the friction cost 
approach. The chapter also illustrates practical applications of the findings from empirical 
studies investigating detailed friction period estimates for the UK and the validated SIPQ tool 
described in Chapters Six and Seven within an economic evaluation setting. Subsections of 
this chapter describe the approaches used to generate productivity costs, and the methods, 
findings, and conclusions from the economic analysis studies. 
 
 
8.2.1 Work-related outcomes  
Data on absenteeism and presenteeism were collected among patients in paid employment 
at baseline and follow-up (6 months for IBS, and 12 months for SBT). Participants were asked 
about their work status (full time/part-time/not working) and their current/previous 
occupation. The occupation of each participant was then classified according to the SOC 
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2000 classifications and wages assigned, based on the Annual Survey of Hours and Earnings, 
2008 as described in Chapter Six. Social security benefits such as sick pay, unemployment 
benefits and disability pay were excluded from the evaluation as these were considered to 
be transfer payments, rather than lost productivity as recommended for societal perspective 
evaluations (Brouwer et al., 2001; van den Hout, 2010).  
 
Absenteeism was based on self-reported duration of back-pain related work absence, by 
asking respondents whether they had taken time off work as a result of their back pain 
problem and if so, the number of days off work during the study period. Presenteeism was 
assessed by asking participants in paid employment the extent to which back pain had 
affected their performance at work during the past month using the SIPQ validated in 
Chapter Seven of this thesis. In the base-case analysis, the impact of including the costs of 
lost productivity (i.e. absenteeism, presenteeism, and multiplier effects) was investigated in 
the economic analysis. 
  
8.2.2 Valuation of productivity costs    
In the base-case analysis, the valuation of lost productivity was carried out using the friction 
cost approach. Detailed methods for the models used in estimating productivity costs using 
the friction cost approach are described below. For comparison purposes, productivity costs 
were also recalculated using the more conventional approach of using the friction cost 
approach to value absenteeism and the human capital method to value presenteeism as part 




Wage-related multiplier estimates were used to account for potential differences in job 
characteristics of team work, substitution, and time sensitivity of output across different job 
classifications as a result of productivity loss. In order to do this, the occupational wage was 
adjusted using an occupational weighted multiplier.  The multiplier values used were 
obtained from a published study conducted in the UK among early RA patients enrolled in 
the Early Rheumatoid Arthritis Network (ERAN) cohort (Zhang et al., 2012).  
 
The multiplier is defined as, “the cost of an absence as a proportion (often greater than one) 
of the absent worker’s daily wage”, (Nicholson et al., 2006) (p 112). The study by Zhang et al., 
(2012) generated multipliers for selected professions in the UK that were used for these 
economic evaluations. The occupational classes from the IBS and SBT were mapped as 
closely as possible to those of Zhang et al., (2012) in order to obtain multipliers relevant for 
the evaluations in this thesis. The values ranged from 1.0 (elementary occupations) to 4.68 
(managers) in absenteeism and from 1.0 to 2.78 for presenteeism (See Table 8.1).  
 
Table 8:1 Average multiplier estimates per job category for Absenteeism and presenteeism 








Manager 5 4.68 15 2.78 
Professionals 7 1.97 8 1.40 
Technicians 7 1.78 10 1.55 
Clerk 6 1.27 7 1.25 
Services and 
sales 
5 1.07 12 1.08 
Craft 1 1.63 2 1.31 
Operators 2 2.00 2 2.13 
Elementary 
occupations 
1 1.00 1 1.00 




8.2.2.1 Valuation of Absenteeism 
The questions on work absence used in the study data sets involved asking respondents 
whether they had experienced absence from work during the study period (6 months for IBS 
and 12 months for SBT).  
 
Absenteeism based on the Human capital method 
For comparison purposes with the friction cost approach, absenteeism costs were first 
calculated using the human capital method by multiplying the work absence time due to 
back pain by the gross national wage-rate for each occupation stratified by age and gender 
and excluding adjustments for multiplier effects based on the model below:  
 
Equation 8.1  
hwtPC **  
 Here, PC represents absenteeism related costs valued using the human capital 
method.  
 t represents self-reported time off work (in days).  
 w represents the gross national wage-rate per hour stratified by age and gender  
 h represents the number of hours worked per day. 
 
Absenteeism using the friction cost approach including multiplier effects 
In the base-case analysis, productivity costs were valued, based on the friction cost approach 
for different cost scenarios, which are described in the next section. Additionally, 
productivity costs were adjusted for the impact of work absence on team productivity 
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(multiplier effects). The cost scenarios generated in this chapter are based on the friction 
period data obtained from DLA Piper UK (DLA), the Chartered Institute of Personnel and 
Development (CIPD), the Office of National Statistics (ONS) and the University of 
Birmingham (UoB), as described and reported in Chapter Six of this thesis. The results are 
therefore presented for five cost scenarios generated by the friction cost approach: i) 
scenario 1 applies a single friction period ii) scenario 2 applies a two occupational level 
friction period from the DLA dataset iii) scenarios three, four and five apply five occupational 
level friction periods from the CIPD, ONS and UoB datasets. 
 
In cost scenario 1, productivity costs were estimated using the average friction period (found 
to be 2.7 months for the UK in Chapter Seven) while incorporating multiplier effects. The 
estimation of labour costs was based on age-adjusted and sex-adjusted wage-rates. Time off 
work due to back pain during the study period was multiplied by the labour wage-rate and 
an elasticity value of 0.8. The elasticity value was to take into account work compensations 
in the short-term as recommended by the Dutch costing manual (Hakkaart-van Roijen L et al., 
2010), and based on the employee’s length of absence. The length of absence was 
categorised into short-term absence (less than the friction period) and long-term absence 
(greater than the friction period). The elasticity value was then applied to the short-term 
absences. The friction costs for this period were therefore assumed to be 80% of wage costs.  
 
The elasticity value is often used as an adjustment factor to account for compensation at the 
work place, for instance in situations where labour reserves exist within an organisation or 
where the individual makes up for lost work time on their return to work (Koopmanschap et 
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al., 1995; Hanly et al., 2012). In the literature, and as demonstrated in Chapter Three of this 
thesis, a value of 0.8 has often been used to represent 80% productivity loss during the 
friction period.  The productivity cost calculation is illustrated in Equation 8.2: 
 
Equation 8.2 
lhwtPC ***  
 Here, PC represents absenteeism related costs valued using the friction cost 
approach.  
 t represents the individual’s self-reported time off work (days) (based on a uniform 
friction period of 2.7 months) 
 w represents the gross national wage-rate per hour stratified by age and gender for 
an occupation adjusted for multiplier effects. 
 h represents the number of hours worked per day. 
 l represents the elasticity value 
 
A variant of this cost model, comprising scenarios 2 to 5, involved using friction periods 
stratified by occupational classification from the four data sets as described in Chapter Six of 








Absenteeism – without accounting for multiplier effects  
In the regular friction cost approach, absenteeism was estimated as commonly done using 
the same equation as above but without taking into account any multiplier effects. This was 
then used as part of the sensitivity analysis.  
 
8.2.2.2 Valuation of Presenteeism   
Reduced productivity was measured using the SIPQ. Respondents were asked to rate how 
much back pain had affected their overall work performance over a period of 30 days. The 
self-reported reduced productivity score was then translated into productivity loss by 
multiplying the self-reported presenteeism score by the actual number of days worked for 





 Here, R represents productivity loss in relation to presenteeism over the past 30 days  
 r represents the self-estimated level of back pain related reduced productivity during 
the past 30 days obtained at follow-up. 
 d represents the actual days at work for each individual - estimated as overall days 
worked less absence from work days due to sickness.  
 
Productivity losses resulting from reduced productivity at work were then converted into 




Presenteeism valuation: Using the friction cost approach including multiplier effects 
In the friction cost approach, incorporated in scenarios 1 to 5, presenteeism related 
productivity loss was calculated by multiplying reduced productivity loss (in days) by the 
gross daily wage-rate and the elasticity value of 0.8 adjusted for potential internal 
compensations and the values extrapolated over the study periods. The details are shown in 
equation 8.4:  
Equation 8.4 
lwRC hh **  
 Here, Ch represents presenteeism costs due to back pain over the past 30 days. 
 Rh represents back pain related productivity loss while working (including number 
of days and hours per day)  
 w represents the gross national wage-rate per day stratified by age and gender for 
an occupation adjusted for multiplier effects. 
 l represents the elasticity value 
 
Presenteeism valuation: Using the human capital method and excluding multiplier effects 
In the conventional human capital method, approach 2, reduced productivity was calculated 
using the human capital method and excluding multiplier effects as commonly done by 
multiplying the estimated productivity loss in days by the age-sex dependent average wage 






wRC hh *  
 Here, Ch represents presenteeism costs due to back pain over the past 30 days. 
 R represents back pain related productivity loss while working.  
 w represents the UK national wage rate.  
 
 
8.3.1 Study design 
A cost-effectiveness analysis was performed alongside a pragmatic multi-centre randomised 
controlled trial carried out over a period of 12 months, including 851 participants (568 
assigned to the stratified primary care management intervention and 283 to the non-
stratified current best practice). Details of the trial were given in Chapter Five of this thesis. 
The economic analysis was undertaken from a broader societal perspective, including both 
healthcare and productivity costs.  
 
8.3.2 Outcomes for economic analysis 
Health outcome and work-related data were collected through self-reported questionnaires. 
Outcome data were collected at baseline, 4 months and 12 months. Work-related data 






8.3.3 Health outcomes 
The pre-specified outcomes for the economic analysis were change in physical factors for 
chronicity as measured by the Roland Morris Disability Questionnaire (RMDQ) and change in 
overall health status on the EQ-5D measure (Dolan, 1997). The EQ-5D responses were then 
used to generate Quality Adjusted Life Years (QALYs) using area-under-the-curve analysis 
across the study duration (Manca et al., 2005).  
 
8.3.4 Healthcare resource use and costs  
Resource use information was extracted from the study questionnaires and included 
consultations, other healthcare professional consultations, prescriptions, hospital based 
procedures and out-of-pocket expenditures. A telephone call at twelve months was used to 
obtain additional data for patients not responding to the questionnaire. Costs were included 
by multiplying resource use data with United Kingdom (UK) unit cost estimates, expressed in 
2008/2009 average prices. This base year was used for comparability with the initial cost-
effectiveness analyses. All costs within the healthcare sector were included regardless of 
whether they were borne by the government or privately by patients. Details of the relevant 










8.4.1 Study design 
The IBS economic evaluation was performed alongside a prospective, population-based, 
quality improvement before and after study over a period of 6 months. The study included 
922 participants, comprising 368 in phase 1 strategy (before intervention) and 554 in phase 
3 strategy (after stratified intervention). Details of the study were given in Chapter Five. 
Similar to the STarT Back trial methods described above, the economic analysis conducted 
here was performed from a societal perspective.    
 
8.4.2 Outcomes for economic analysis 
Health outcome data were collected at baseline, 2 months and 6 months using self-reported 
questionnaires. Data regarding employment status, work absence (absenteeism) and 
presenteeism were collected at baseline and 6 months. Health resource use data were 
collected using a six months self-reported questionnaire.  
 
8.4.3 Health outcomes  
Similar health outcomes to the SBT design were collected over a shorter period (6 months). 
The EQ-5D responses were then used to generate Quality Adjusted Life Years (QALYs) 






8.4.4 Healthcare resource use and costs 
Resource use information was extracted from a combination of medical record reviews and 
the six month self-report questionnaire, and included hospital stays, outpatient 
appointments, hospital visits, medication, over the counter treatments, health visits with the 
NHS and private practice. Unit costs assigned to these resources were obtained from 
published sources reflecting UK national averages. A telephone call at 6 months was used to 
obtain additional data for non-responders. For patients who provided permission for medical 
records to be reviewed, records were anonymously retrieved to gain further insight into self-
reported absence reports reported in the 6 month questionnaire. Details of the relevant IBS 
resource use and unit cost data are reported in Appendix C.2 
 
 
Analysis was conducted based on the intention-to-treat principle. Details of other aspects 
including handling of missing data, costing and uncertainty analysis are included in the 
following sections.  
 
8.5.1 Missing data 
The multiple imputation method was used to impute missing data. The technique is used to 
replace each missing variable with a set number of possible values (Briggs et al., 2003). In 
both studies, five estimates for each missing variable were generated using a multivariate 
normal model (Whitehurst et al., 2012). The overall mean of the five estimated values was 
then used as the imputed observation included in the analysis. Imputation was carried out 
on both the costs and outcomes.  
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8.5.2 Exploring variations in cost and work outcomes between groups 
Costs and outcomes were calculated for overall and risk-group analysis, and defined as 
means and standard deviations (SD) for costs and effects per patient per year. Bootstrap 
methods were applied to generate difference in mean costs and QALYs between the 
treatment groups (Barber and Thompson, 2000). Confidence intervals for costs were 
generated using the bias-corrected and accelerated bootstrapping method (1000 
replications) (Barber and Thompson, 2000).  
 
Cost valuation scenarios were presented for disaggregated costs of: i) healthcare costs with 
both absenteeism and presenteeism adjusted for multiplier effects ii) healthcare costs with 
both absenteeism and presenteeism excluding multiplier effects. Statistical analysis was 
performed using STATA 12 and SPSS 19.   
 
8.5.3 Cost-Utility analysis  
Incremental cost-effectiveness ratios (ICERs) were generated as the additional costs 
(difference in costs) divided by additional benefits (difference in QALYs gained) of the study 
intervention within each risk-defined subgroup and for the overall patient group.  
 
Costs relating to absenteeism, presenteeism and multiplier effects of productivity loss on 
team work were included in the calculations alongside direct healthcare costs. In order to 
generate appropriate incremental QALY values, between-group imbalances were accounted 
for using linear regression analysis to adjust for baseline EQ-5D, RMDQ scores, age, gender 
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and duration of pain at baseline. Given the time horizon of the cohort study (6 months) and 
randomised trial (12 months), no discounting was performed.  
 
To account for uncertainty, a bootstrap approach based on 5000 replicates was used to 
generate the data used to produce cost effectiveness acceptability curves (CEACs) at 
different willingness-to-pay values. A comparison of costs and effects was illustrated 
graphically in the form of cost-effectiveness planes (CE plane) (van Hout et al., 1994; Briggs 
and Fenn, 1998). The horizontal axis showed the difference in the costs between the 
treatment arms (in this case stratified management minus usual practice), while the vertical 
axis showed the difference in effects.  
 
The decision on whether the ICER obtained is acceptable often depends on the maximum 
amount that the decision maker is willing to pay for an additional QALY. The probability that 
the stratified care intervention for low back pain intervention is cost-effective at different 
values of the maximum acceptable ratio to society (willingness to pay values) was plotted as 
a CEAC (Fenwick and Byford, 2005). ICERs were generated from a societal perspective based 
on friction cost approach valuation models for different willingness-to-pay values. To assess 
the impact of using more detailed friction periods, CEACs were also generated for friction 
periods varying by occupation levels. In the subgroup analyses, the probability curves for the 






8.5.4 Sensitivity Analysis  
A number of sensitivity analyses were performed to assess the impact of assumptions made 
during the analyses on the overall friction related costs. The first sensitivity analysis included 
using the conventional approach of incorporating productivity costs, i.e., using the friction 
cost approach for valuing absenteeism and the human capital method for valuing 
presenteeism and excluding multiplier effects. This aimed to assess possible differences 
between the two approaches. In the second sensitivity analysis, the elasticity factor was 
adjusted from 0.8 in the base case analysis to 1 in the sensitivity analysis. No published 
estimate of an elasticity factor currently exists for the United Kingdom. Therefore, in the 
absence of a published elasticity value, an assumption was made to use a value of 1 as done 
in a previous UK study (Hanly et al., 2012). In the final analysis, combined multiplier values 
from the UK study (Zhang et al., 2012) and a previous US study (Pauly et al., 2008) were 














8.6.1 Study population  
Following the multiple imputation procedure on the SBT study dataset, a total of 851 
participants in the study were included in the base-case analysis; 568 in the intervention 
group and 283 in the control group. 567 (67%) of these patients provided cost utilisation 
data at 12 months, 386 in the intervention group and 181 in the control group. The resource 
use data are provided for the overall sample and for each risk-defined subgroup in Tables 8.2 
to 8.3.  
 
8.6.2 Work-related outcomes  
The mean work-related resource per patient shows a consistent pattern of lower 
productivity loss in patients treated with stratified management (Table 8.2). Approximately 
23% of the patients in the intervention group and 34% in the usual practice group reported 
having time off work at the 12 month follow-up period. The overall absence from work for 
the intervention group was 4.43 days compared to 12.18 days in the control group, a 
difference of 7.75 days (95% CI -14.2 to -1.31; p = 0.01). For the case of presenteeism, the 
stratified management intervention was associated with a productivity loss of 46.5 days 
compared to 53.2 days in the control group, a difference of 6.75 days (95% C: -20.4 to 6.89 ; 
p = 0.33).  
 
In the subgroup analysis, a significant difference in lost days was observed in the medium-
risk-defined subgroup (4.13 days versus 18.44 days for stratified and usual practice 
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respectively) but not in the high-risk (9.85 days versus 10.57 days) and low-risk groups (0.37 
days versus 3.0 days). 
 
Table 8:2 Comparison of overall work-related outcomes for participants in paid employment between the 







Stratified care  
(n = 200) 
Usual care 
(n = 98) 
Overall Analysis 
 
n/mean %/SD n/mean %/SD  
Work-related outcomes – HCM 
Time off work due to low back pain: (n, 
%) 
46 23% 33  34%  
Absenteeism days 
4.4 21.2 12.2 35.1 -7.75 
(-14.2 to -1.3) 
Back-pain related absenteeism cost 
447 2126.2    1113  3424.4 -69 
(-1362.1 to 25.2) 
Presenteeism days 
46.5 54.4 53.2 59.7 -6.75 
(-20.4 to 6.89) 
Back-pain related presenteeism cost 
3524 4480.2     4274  5222.5 -750 
(-1924.93 to 424.60) 
Work-related outcomes – FCA 
Back-pain related absenteeism cost      
Scenario 1 461 1760.4 1179 3598.4 -717 
(-1334.4,-100.6) 
Scenario 2 457 1733.8 1275 4119.0 -818 
(-1493.4,-141.8) 
Scenario 3 407 1460.5 1171 3664.6 -763 
(-1356.4,-170.2) 
Scenario 4 461 1760.4 1272 4101.3 -811 
(-1486.0,-134.3) 
Scenario 5 433 1586.2 1082 3156.6 -649 
(-1194.8,-103.2) 
Back-pain related presenteeism cost  4411 5510.1 5618 6896.4 -991 
(-2344.9, 363.6) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB. 
*The estimation of productivity loss focussed on the subsample of respondents in paid employment at 12 months for SBT (298/567). 
 
8.6.3 Productivity Costs: The human capital method  
The findings in Table 8.2 show that the overall mean costs based on the human capital 
method were lower in the stratified management group (intervention) than in the current 
practice group (control). The overall mean absenteeism costs were £447 in the stratified 
management group and £1113 in the current practice group, a difference of £669. For 
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presenteeism, the corresponding productivity loss was £3524 and £4274 for the intervention 
and control groups respectively, a difference of £750 (See Table 8.2). 
 
8.6.4 Productivity costs: Methodological applications of the friction cost approach 
In the overall analyses, the results in Table 8.2 indicate that adjusting productivity costs for 
multiplier effects leads to estimates of productivity costs that are higher than the more 
traditional human capital method. The observed mean costs in the stratified care 
intervention were between £407 and £461 depending on the occupational friction period 
level used compared with over £1000 in the current practice groups (Table 8.2).  
 
In the subgroup analysis, large and significant cost differences between stratified care and 
usual care were observed in the medium-risk group compared to other risk-groups. 
Moreover, mean productivity losses were higher in the medium-risk and low-risk categories 
for the stratified management care intervention. However, in the high-risk category, the 
control was associated with lower mean productivity costs compared to the stratified 
management care intervention (Table 8.3). As shown in Table 8.3, the results of the overall 
analysis were replicated in the subgroup analysis. In addition, there were no significant 








Table 8:3 Comparison of risk-group work-related outcomes for participants in paid employment between the 







Stratified care  




Low-risk n/mean %/SD mean SD  
Time off work due to low back pain: (n, %) 8 12.3% 5 17.2%  
Back-pain related absenteeism cost      
Scenario 1 47 160.1 199 836.3 -152 
(-368.5,63.9) 
Scenario 2 47 160.1 199 836.3 -152 
(-368.5,63.9) 
Scenario 3 47 160.1 219 945.0 -172 
(-414.9,69.7) 
Scenario 4 
47 160.1 199 836.3 -152 
(-368.5,63.9) 
Scenario 5 
47 160.1 199 836.3 -152 
(-368.5,63.9) 
Back-pain related presenteeism cost  3123 4235.7 5270 8367.1 -2146 
(-4785.6,492.0) 
Medium-risk (n = 81) (n = 48)  
Time off work due to low back pain (n, %) 22 27.1% 20 41.7%  
Back-pain related absenteeism cost      
Scenario 1 422 1741.4 1870 4725.9 -1448 
(-2604.1,-292.6) 
Scenario 2 401 1607.4 2104 5660.3 -1703 
(-3034.8,-371.5) 
Scenario 3 336 1166.4 1878 5002.4 -1541 
(-2695.2,-388.7) 
Scenario 4 
406 1647.1 2098 5637.6 -1691 
(-3022.3, -361.7) 
Scenario 5 
369 1380.0 1709 4267.3 -1340 
(-2361.4,-319.3) 
Back-pain related presenteeism cost 4845 5329.8 5902 6322.5 -105 
(-3130.2,1055.7) 
High-risk (n = 54) (n = 21)  
Time off work due to low back pain: (n, %) 16 30% 8 38%  
Back-pain related absenteeism cost      
Scenario 1 1061 2656.4 866 1558.9 194 
(-1043.6,1433.0) 
Scenario 2 1053 2628.4 866 1558.9 187 
(-1039.5,1414.3) 
Scenario 3 966 358.2 869 1570.5 96 
(-1021.8,1214.0) 
Scenario 4 
1061 2656.3 866 1558.9 194 
(-1043.6,1433.0) 
Scenario 5 
1010 2477.4 866 1558.9 144 
(-1021.7,1308.9) 
Back-pain related presenteeism cost 
5369 886.2 5404 6339.7 -35 
(-3603.2,3531.8) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB.  










8.6.5 SBT Friction cost approach: Impact of absenteeism, presenteeism and 
multiplier effects. 
The friction cost approach has often been associated with lower societal costs compared to 
the human capital method. In this analysis, an investigation was carried out into the 
potential impact on total societal costs of using the friction cost approach for valuing both 
absenteeism and presenteeism, while including effects of productivity loss on team 
productivity. This was compared to the conventional approach of using the friction cost 
approach for absenteeism and the human capital method for presenteeism. The results in 
Table 8.4 show that applying the friction cost approach for both absenteeism and 




Table 8:4 Back pain mean (SD) societal costs per patient and year for patients reporting resource utilisation 
data 





(95% CI BC) 
Mean SD Mean SD 
Absence days  4.6 21.2 12.18 35.1  
Health-care costs (£) 240 261.3 274  278.2 -34  
(-76.87; 3.3) 
Total  back pain related costs using FCA approach for absenteeism and presenteeism 
Scenario 1 1881 4152.3 2568 5899.5 -687 
(-1373.4, -1.4) 
Scenario 2 1879 4147.9 2601 6066.2 -722 
(-1417.5,-26.6) 
Scenario 3 1862 4105.8 2565 5926.6 -703 
(-1386.8,-19.3) 
Scenario 4 1881 4152.3 2600 6025.5 -719 
(-1413.0,-26.3) 
Scenario 5 1871 4124.8 2535 5765.3 -663 
(-1339.5,12.4) 
Total  back pain related costs using FCA approach for absenteeism and HCM presenteeism 
Scenario 1 1613 3402.7 2090 4500.0 -477 
(-1020.0,65.8) 
Scenario 2 1612 3403.5 2104  4572.4 -491 
(-1038.0,55.6) 
Scenario 3 1599 3367.7 2087 4509.4 -488 
(-1028.7,52.5) 
Scenario 4 1613 3402.7 2107 4550.4 -494 
(-1040.2, 51.4) 
Scenario 5 1606 3382.3 2071  4437.2 -465 
(-1003.1, 72.4) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB.  
 
8.6.6 SBT Friction cost approach: Impact of absenteeism, presenteeism and 
multiplier effects in subgroup analysis. 
As shown in Tables 8.5 to 8.7, the costs when applying the friction cost approach and 
incorporating multiplier effects were generally higher than costs generated using the more 
conventional friction cost approach among risk-group populations. Again, the main cost 
driver for this difference was the effect of including multiplier estimates. Moreover, there 
were no significant differences between the total societal costs for the occupational level 
friction period cost scenarios. Overall, similar results to the overall analysis were observed in 




Table 8:5 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Low-risk 





(95% CI BC) 
 Mean SD Mean SD  
Absence days  0.37 1.2 3.0 11.9  














Total  back pain related costs using FCA approach for absenteeism and presenteeism 
 
Scenario 1 1445 3188.6 2188 6006.6 -743 
(-1961.7,475.2) 
Scenario 2 1445 3188.6 2188 6006.6 -743 
(-1961.7,475.2) 
Scenario 3 1445 3188.6 2196 6050.9 -751 
(-1975.4,472.0) 
Scenario 4 
1445 3188.6 2188 6006.6 -743 
(-1961.7,475.2) 
Scenario 5 
1445 3188.6 2188 6006.6 -743 
(-1961.7,475.2) 
 
Total  back pain related costs using FCA approach for absenteeism and HCM for presenteeism 
 
Scenario 1 1169 2477.1 1632 4303.1 -467 
(-1763.4; 422.8) 
Scenario 2 1169 2477.1 1632  4303.1 -467 
(-1763.4; 422.8) 
Scenario 3 1169 2477.1 1644 4342.9 -475 
(-1691.1; 374.9) 
Scenario 4 
1169 2477.1 1636 4303.1 -467 
(-1650.0 ; 442.7) 
Scenario 5 
1169 2477.1 1636 4303.1 -467 
(-1792.5; 443.3) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 




Table 8:6 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Medium-risk 






 Mean SD Mean SD  
Absence days 4.13 15.94 18.44  47.2  
Health-care costs (£) 235 229.6 288 283.8     -53 
(-105.0;-.4) 
 
Total back pain related costs using FCA approach for absenteeism and presenteeism 
 
Scenario 1 1819 3977.8 3136  6451.3 -1317 
(-2355.0 ,278.9) 
Scenario 2 1812 3957.4 3221  6839.8 -1409 
(-2480.7,-337.4) 
Scenario 3 1792 3896.3 3138  6553.9 -1345 
(-2384.3,-307.6) 
Scenario 4 
1814 3963.4 3219  6761.6 -1405 
(-2470.3,-340.3) 
Scenario 5 
1802 3924.6 3077  6263.3 -1274 
(-2289.0,-259.2) 
 
Total back pain related costs using FCA approach for absenteeism and HCM for presenteeism 
 
Scenario 1 1595 3442.6 2579  4952.4 -983 
(-1967.0;-142.7) 
Scenario 2 1592 3437.7 2616  5105.9 -1024 
(-2024.8; -84.8) 
Scenario 3 1579 3393.9 2567  4951.4 -988 
(-1914.9;-105.8) 
Scenario 4 
1595 3442.6 2616  5046.0 -1021 
(-2132.3;-116.6) 
Scenario 5 
1587 3414.7 2537  4830.3 -950 
(-2001.7;-68.8) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 




Table 8:7 Back- pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: High-risk category 






 Mean SD Mean SD  
Absence days 9.85 35.4 10.57 18.2  
Health-care 
perspective (£) 
384    304.6  358 323.5 26 
(-53.9; 121.0) 
Total  back pain related costs using FCA approach for absenteeism and presenteeism 
Scenario 1 2404 5122.5 1956 4531.8 448 
 (-892.6,1788.9) 
Scenario 2 2401 5117.8 1956 4531.8 445  
(-894.0,1785.6) 
Scenario 3 2373 5075.1 1956 4532.9 416  
(-915.4,1748.4) 
Scenario 4 
2404 5122.5 1956 4531.8 448 
 (-892.5,1788.9) 
Scenario 5 
2387 5093.4 1956 4531.8 431  
(-903.7,1766.8) 
Total  back pain related costs using FCA approach for absenteeism and HCM for presenteeism 
Scenario 1 2063 4000.7 1701 3810.4 362  
(-829.8; 1309.5) 
Scenario 2 2068 4011.0 1693 3773.2 375  
(-736.0; 1356.3) 
Scenario 3 2039 3965.3 1702  3811.2 338  
(-776.7; 1347.1) 
Scenario 4 
2063 4000.7 1701 3810.4 362  
(-808.6; 1313.7) 
Scenario 5 
2051 3979.0 1701 3810.5 349  
(-802.7; 1236.3) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB.  
 
8.6.7 Cost-utility analysis 
From the healthcare perspective, the stratified management intervention was associated 
with greater mean health benefit at lower mean healthcare costs (0.039 additional QALYs 
and a mean healthcare cost difference of -£34.39). Similarly, to the healthcare perspective, 
the stratified management intervention was cost-effective from a societal perspective in the 
overall analysis and in risk-defined groups (Table 8.8). For the overall analysis, a dominant 
position was observed for stratified management care as the intervention was associated 




In the subgroup analysis, stratified care had the highest probability of being cost-effective 
among medium-risk patients for willingness-to-pay (WTP) thresholds of £20,000 and below. 
However, at WTP thresholds greater than £20,000, stratified care was highly cost-effective 
among high-risk patients. More specifically, the observed mean societal incremental cost-
effectiveness ratio (ICER) in the high-risk group ranged from £7,298 to £7,860 per QALY 
gained in the various cost scenarios, well below the accepted £30,000 threshold (McCabe et 
al., 2008).  
 
Among low-risk category patients, the intervention was marginally less effective (-0.001 
QALYs) and less costly (range:-£751 to -£743). The observed ICER was over £700,000 saved 
per QALY lost for stratified care. Although the QALY difference was not statistically 
significant, these results suggest that the cost saving is worth making. For patients in the 
medium-risk group, a dominant position of stratified care was observed in all cost scenarios 
as there were observed health benefits achieved at lower costs  
(range -£1,409 to -£1,274) (Table 8.8). 
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Table 8:8 Incremental societal costs and incremental QALYs: Point estimates for the SBT base-case analysis 
 P1 P2 P3 P4 P5 
Societal Care perspective: Overall  
Mean cost difference per patient  (£)   -687 -722 -703 -719 -663 
Mean QALY difference 0·039 
ICER: Societal Cost per QALY gained (£) Dominant Dominant Dominant Dominant Dominant 
Low-risk category 
Mean cost difference per patient  (£)   -743 -743 -751 -743 -743 
Mean QALY difference -0.001 
ICER: Societal Cost per QALY gained (£) 743,000 743,000 743,000 743,000 743,000 
Medium-risk category      
Mean cost difference per patient (£)   -1,317 -1,409 -1,345 -1,405 -1,274 
Mean QALY difference 0.044 
ICER: Cost per QALY gained (£) Dominant  Dominant Dominant Dominant Dominant 
High-risk category      
Mean cost difference per patient  (£) 448 445 416 448 431 
Mean QALY difference 0.057 
ICER: Cost per QALY gained (£) 7,860 7,807 7,298 7,860 7,561 
P1, single-friction period, P2 – two level friction period DLA, P3 five-level friction period CIPD , P4 five-level friction period ONS, P5 five-level 
friction period UoB.  
 
8.6.8 Cost-effectiveness planes – overall healthcare and societal cost perspective 
The Cost-effectiveness planes showing the scatter plot of incremental costs versus 
incremental QALYs for the overall analyses from the healthcare and societal perspectives 
analyses are presented in Figures 8.1 and 8.2 respectively. The location of the majority of 
bootstrapped cost-utility pairs was used to identify the nature of the uncertainty in the 
incremental costs and QALY estimates 
 
From a healthcare perspective, the dominance of the stratified management intervention 
was observed with 96% of cost-utility pairs located in the south-east quadrant.  The societal 
perspective strengthened the case for the intervention with stratified management care 
remaining dominant (98% average of the cost-effect pairs located in the southeast quadrant) 
in all societal cost scenarios (Figure 8.1).  
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Figure 8:1 Cost-utility plane for the overall comparison of stratified management care compared to usual 
care for societal costs 
(A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) Societal 
cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal cost perspective five-





























































































































































































































































8.6.9 Cost-effectiveness planes for the subgroup analysis     
In the subgroup analysis, Figures 8.2 to 8.4 show the scatter plots for the incremental costs 
versus incremental QALY in the different risk groups. The results indicate much uncertainty 
in the bootstrapped data among the low-risk patient group as demonstrated by the 























Figure 8:2 Cost-utility planes for the stratified analysis of stratified management care compared to usual care 
for a societal perspective – low-risk group 
(A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) Societal 
cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal cost perspective five-








































































































































































































































The findings in Figure 8.3 indicate that cost savings and increased benefits were observed for 
all scenarios among medium risk group patients (average 99% of bootstrapped CU pairs in SE 
quadrant). In other words, stratified care dominates usual care in 99% of the cases. Similar 
findings were demonstrated in the high-risk group with increased benefits and costs in all 
























Figure 8:3 Cost-utility plane for the stratified analysis of stratified management care compared to usual care 
for a societal perspective: medium-risk category 
(A)  Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) 
Societal cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal 






















































































































































































































































Figure 8:4 Cost-utility plane for the stratified analysis of stratified management care compared to usual care 
for a societal perspective: High-risk category 
(A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal Cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) Societal 
cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal cost perspective five-






















































































































































































































































8.6.10 Healthcare perspective cost-effectiveness acceptability curves (CEACs) 
The CEAC for the incremental cost-effectiveness ratios from a healthcare perspective is 
shown in Figure 8.5. The findings show that the stratified management intervention was 
associated with probabilities of being cost-effective exceeding 95% even with the 
willingness-to-pay value at £1000. This is well below the £30,000 per QALY UK threshold.  
The curve has an intercept of 96% reflecting the total proportion of points in the SW (0.4%) 
and SE (95.6%) quadrants. At high WTP values, the height of the curve approaches 99.4% 
reflecting the proportion of points in the NE (3.9%) and SE (95.6%) quadrants (See Figure 8.1).   
 
 
Figure 8:5 CEAC for the healthcare perspective 
 
8.6.11 Societal cost perspective CEACs: overall analysis  
The CEACs for the incremental cost-effectiveness ratios with friction period values 
disaggregated by occupation for the overall analysis are shown in Figure 8.6. The results 
showed very high probabilities of stratified care being cost-effective for all cost scenarios 
even with the willingness-to-pay threshold values as low as £5000. The total costs of the 
240 
 
interventions were estimated according to cost scenarios with varying friction periods at 
two-level and five-level occupational classes. 
 
 
Figure 8:6 CEAC for the overall healthcare and societal perspective 
*HCY human capital method, SCP1X Single friction period, SCP2X two-level period DLA, SCP5X five-level period CIPD, SCP5bX five-level 
period ONS, SCP5bX five-level period UoB. 
 
8.6.12 Healthcare and societal cost perspective CEACs for the stratified analysis  
In the healthcare perspective analysis, and at the £30,000 per QALY threshold, the 
probability of stratified care being cost-effective compared with usual care was highest 
among medium-risk and high-risk patients for WTP exceeding £10,000 QALYs. More 
specifically, the probabilities of stratified care being cost-effective at the £30,000 per QALY 
threshold in the low-risk, medium-risk and high-risk groups were on average across all cost-
scenarios 0.52, 0.99, 0.96 (Figure 8.7). The probability of the intervention being cost-
effective was highest (exceeding 0.9) for threshold values of £5,000 and below in all three 






Figure 8:7 CEACs curves for the three risk group comparisons of stratified primary care management 
compared to current best practice from a healthcare perspective. 
 
In addition, Figure 8.7 represents CEACs categorised by patient risk groups that have been 
drawn from a population which provided the overall CEAC reported in Figure 8.5. It should 
therefore be noted that the probability of cost-effectiveness of the intervention at any given 
WTP that has been reported is not an all-population weighted or unweighted average of the 
probabilities for the subgroups. This is because the CEAC represents a Bayesian probability 
that the intervention is cost-effective on the population as a whole and is not intended to 
show the proportion of patients for whom the intervention is expected to be cost-effective. 
There is therefore a greater degree of certainty about the cost-effectiveness of the 
intervention when considered as applying to the whole population than there is when it is 
applied to any particular subgroup. This is mainly because the all-population results are 





From a societal perspective, the probabilities of stratified care being cost-effective at the 
£30,000 per QALY threshold in the low-risk, medium-risk and high-risk groups were on 
average 0.80, 0.99, 0.90 across all cost-scenarios. The medium-risk category was associated 
with very high probabilities for the intervention being cost-effective for all WTP thresholds. 
There was much uncertainty in the data regarding cost-effectiveness levels of the 
intervention at different WTP per QALY gain values after incorporating absenteeism, 
presenteeism and multiplier effects. For example, there was an increment in the probability 
of stratified management care being cost-effective among low-risk patients from 0.52 to 




Figure 8:8 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier effects 





Figure 8:9 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier effects 
based on a two-level category friction period DLA. 
 
 
Figure 8:10 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier effects 






Figure 8:11 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier effects 
based on a five-level friction period ONS 
 
 
Figure 8:12 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice incorporating productivity costs of absenteeism, presenteeism and multiplier effects 










8.6.13 Sensitivity Analysis 
8.6.13.1 Regular approach: FCA for absenteeism and HCM for presenteeism excluding 
multiplier effects.  
The fundamental interpretation of the cost-effectiveness analysis in both studies remained 
the same after applications of the more conventional societal perspective approach, which 
values presenteeism using the HCM and excludes multiplier effects in the overall analyses 
(Table 8.9). The intervention remained highly cost-effective at all WTP values investigated 
for all friction period values in the overall analysis. More specifically, stratified care remained 
highly cost-effective among medium-risk group patients across all WTP values investigated 
(Figures 8.13 and 8.14).  
 
 
Figure 8:13 CEAC for the societal perspective excluding multiplier effects 





Figure 8:14 CEACs for the three risk group comparisons of stratified primary care management compared to 
current best practice from a societal perspective based on a single friction period using the FCA for 
absenteeism and HCA for presenteeism 
 
8.6.14 Sensitivity analysis on cost-utility estimates  
Similarly, the cost-effectiveness outcomes remained the same in the sensitivity analysis 
using the FCA for absenteeism and the HCM for presenteeism (SA1), the application of a 
higher elasticity factor of 1 assuming no short-term compensation mechanisms (SA2) and 
using adjusted multiplier values (SA3) (Table 8.9). The results showed that the dominant 
position for stratified care was not changed in the overall analysis or in the medium-risk 




Table 8:9 Mean cost differences, mean QALY differences, incremental cost-effectiveness ratios from varying 
friction periods and corresponding three sensitivity analyses (SA1, SA2 and SA3) 
 P1 P2 P3 P4 P5 
Societal costs (£): Overall 
Analysis 
     
Main  -687 -722 -703 -719 -663 
SA1   -803 -837 -809 -873 -779 
SA2   -477 -491 -488 494 465 
SA3 -355 -380 -372 -378 -341 
Mean QALY difference 0·039 
ICER Main Dominant Dominant Dominant Dominant Dominant 
ICER SA1   Dominant Dominant Dominant Dominant Dominant 
ICER SA2   Dominant Dominant Dominant Dominant Dominant 
ICER SA3 Dominant Dominant Dominant Dominant Dominant 
      
Low-risk category  
Main  -743 -743 -751 -743 -743 
SA1   -912 -912 -905 -912 -912 
SA2   -467 -465 -475 -467 -467 
SA3 -269 -269 -279 -270 -270 
Mean QALY difference -0.001 
      
ICER Main 743,000 743,000 751,000 743,000 743,000 
ICER SA1   912,000 912,000 905,000 912,000 912,000 
ICER SA2   466,900 464,500 475,000 475,000 466,900 
ICER SA3 269,000 269,000 279,000 270,000 270,000 
      
Medium-risk category      
      
Main -1317 -1409 -1345 -1405 -1274 
SA1 -1543 -1616 -1552 -1695 -1481 
SA2   -984 -1024 -988 -1021 -951 
SA3 -1106 -1157 -1110 -1155 -1061 
Mean QALY difference 0.044 
ICER Main Dominant Dominant Dominant Dominant Dominant 
ICER SA1 Dominant Dominant Dominant Dominant Dominant 
ICER SA2 Dominant Dominant Dominant Dominant Dominant 
High-risk category      
Main  448 445 416 448 431 
SA1   535 533 522 535 519 
SA2   362 375 338 362 349 
SA3 822 818 773 822 796 
Mean QALY difference 0.057 
ICER Main 7,860 7,807 7,298 7,860 7,561 
ICER SA1   9,386 9,351 9,158 9,386 9,105 
ICER SA2   6,346 6,574 5,928 6,349 6,128 
ICER SA3 14,421 14,351 13,561 14,421 13,965 
      
Main - Estimates from the suggested approach using the FCA for valuing absenteeism and presenteeism with adjusted multiplier values. 
SA1 - Estimates from the conventional approach using the FCA for valuing absenteeism and the HCM for valuing presenteeism  
SA2 - Using an elasticity factor value of 1assuming not short-term compensation costs 
 SA3 adjusting multiplier estimates in the suggested friction cost approach. 
P1, single-friction period, P2 – two level friction period DLA, P3 five-level friction period CIPD , P4 five-level friction period ONS, P5 five-level 







8.7.1 Study population  
A total of 922 participants were considered in the base-case analysis. The study included 368 
individuals in the phase 1 strategy (current practice) and 554 individuals in the phase 3 
strategy (stratified care). 539 (54%) patients were employed at 6 months, with 215 of 289 
(74%) reportedly taking time off in the past 6 months. Table 8.10 shows the work-related 
outcomes and costs for the overall and stratified analysis according to different risk groups.  
 
8.7.2 Work-related outcomes 
Key outcomes for the study are presented in Table 8.10 below. The results for the average 
productivity costs per patient demonstrate lower productivity loss among patients in the 
phase 3 strategy compared to the phase 1 strategy. Additionally, work absence results were 
similar in both intervention phases (25% and 27%: phase 3 and phase 1). The overall absence 
from work for phase 3 was 4.2 days compared to 7.8 days in phase 1, a difference of 3.6 days 
(95% CI -8.0 to 0.8; p = 0.109).  
 
In the case of presenteeism, the phase 3 intervention was associated with a productivity loss 
of 2 days compared to 2.2 days in phase 1, a difference of 0.2 days (95% C: -0.75 to 0.42 ; 
0.574). Moreover, the phase 3 intervention was associated with lower absence days in the 
high-risk (11.0 days versus 5.0 days for phase 1 and phase 3 respectively) and in the 
medium-risk groups (15.4 days versus 9.0 days for phase 1 and phase 3 respectively). 
Relatively similar work absence levels were observed between the two interventions among 
the low-risk patients (1.5 days versus 1.2 days for phase 1 and phase 3 respectively). 
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Table 8:10 Comparison of overall work-related outcomes for participants in paid employment (work status, 
absenteeism and presenteeism loss) between the two study arms 
Resource/Cost Component 
 
Cost(£) Mean difference 
95% CI Phase 1 
(n = 132) 
Phase 3 
(n = 158) 
Work-related outcomes - HCM n/Mean %/SD n/Mean %/SD   
Time off work due to low back pain 
(n, %):  
35 27% 39 25%   
Absenteeism days 7.8 23.5 4.2 14.32 -3.6 
( -8.02,0.82) 




2.2 2.5 2 2.5 -0.2 
(-0.75,0.418) 
Back-pain related presenteeism cost 
3233 3839.3 2209 2690.9 -1013 
(-2600.3,572.6) 
Work-related outcomes – FCA incorporating multiplier effects 
Back pain related absenteeism cost          
Scenario 1 












972 3307.4 514  1684.2 -457 
(-1065.6,150.2) 
Scenario 5 
940 3130.2 507  1669.9 -433 
(-1015.1,148.5) 
Back pain related presenteeism cost 3721 4563.5 3013  4006.9 
-709 
(-2783.7, 1366.8) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period 
CIPD , Scenario 4 five-level friction period ONS, Scenario 5 five-level friction period UoB,  
*Mean difference = Phase 3 mean cost estimate - Phase 1 mean cost estimate 
*The estimation of productivity loss focussed on the subsample of respondents in paid employment at 6 months 
for IBS 132 of 229 (58%) in Phase 1, 158 of 310 (51%) in Phase 3. 
 
 
8.7.3 Productivity costs: Human capital method related costs  
As shown in Table 8.10, the results show that the mean absenteeism costs based on the 
human capital method were lower in the phase 3 strategy (stratified care) compared to the 
phase 1 strategy (usual practice) in the overall (£717 versus £343; phase 1 versus phase 3) 
and risk-defined subgroup analysis with the exception of the low-risk patients category 
(£223 versus £29; phase 1 versus phase 3) (Table 8.10 and 8.11). Mean presenteeism costs 
were lower in the phase 3 strategy than in the phase 1 strategy in the overall analysis and 
risk-defined subgroup analysis with the exception of the low-risk category. 
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8.7.4 Methodological applications of the friction cost approach 
Resource use data on the total work-related costs in relation to the phase 3 and phase 1 
strategies is presented in Table 8.10. Similar to the SBT results, the results are presented for 
five cost scenarios generated by the friction cost approach: i) scenario 1 applies a single 
friction period ii) scenario 2 applies a two occupational level friction period iii) scenarios 
three, four and five apply five occupational level friction periods from 3 different datasets. 
As shown in Table 8.10, estimating productivity costs based on occupation generated 
relatively similar productivity costs for the different scenarios with varying friction periods. 
The observed mean costs in the phase 3 strategy were between £490 and £518 compared 
with over £900 in the phase 1 strategy depending on the friction period occupational level 
used (Table 8.10). The corresponding presenteeism costs were £3721 and £3693 for the 
phase 1 and 3 strategy respectively.  
 
Mean productivity costs for the phase 3 and phase 1 strategy for the subgroup analyses are 
presented in Table 8.11. The results from Table 8.11 indicate there were no observed 










Table 8:11 Comparison of work-related outcomes for participants in paid employment (work status, 
absenteeism and presenteeism loss) between the two groups 
Resource/Cost Component 
 
Cost(£) Mean difference 
(95% CI) 
Phase 1 Phase 3  
Low-risk (n = 52) (n = 62)  
 n/Mean %/SD n/Mean %/SD  
Time off work due to low back pain: (n, %) 
Back-pain related absenteeism cost  
5 10% 7 11%  
Scenario 1 29 104.8 223 1043.1 193 
(-100.12, 487.04) 
Scenario 2 29 104.8 223 1043.1 193 
(-100.12 ,487.04) 




29 104.8 223 1043.1 193 
(-100.12 ,487.04) 
Scenario 5 29 104.8 223 1043.1 193 
(-100.12, 487.04) 
Back pain related presenteeism cost 2774 3789.2 4530 5549.8 1756 
(-4883, 8395.7) 
Medium-risk (n=56) (n=67)  
Time off work due to low back pain: n (%) 19 34% 19 29%  
Absenteeism    
Scenario 1 1477 3840.4 438 1182.9 -1038 
(-2039.7,-372.0) 
Scenario 2 1577 4315.9 433 1159.1 -1144 
(-2255.8,-32.4) 
Scenario 3 1469 3906.9 373 934.7 -1096 
(-2094.7,-98.2) 
Scenario 4 1471 3741.5 429 1136.6 -1042 
(-2106.6,-68.4) 
Scenario 5 1400 3481.7 412 1084.3 -987 
(-1896.0,-78.5) 
Back pain related presenteeism cost 2788 3291.5 1982 3347.3 -805 
(-3130.2,1518.7) 
High-risk (n=24) (n=29)  
Time off work due to low back pain: n (%) 11  46% 13  45%   
Absenteeism   
Scenario 1 1883 5297.3 1341 3117.0 -542 
(-2955.7,1871.2) 
Scenario 2 2045 6059.1 1341 3117.0 -704 
(-3371.5,1963.5) 
Scenario 3 1826 5396.0 1341 3117.0 -484 
(-2930.0,1961.2) 
Scenario 4 
1790 4976.0 1341 3117.0 -449 
(-2758.5,1859.9) 
Scenario 5 
1785 4795.0 1341 3117.0 -444 
(-2695.7,1806.9) 
Back pain related presenteeism cost 7001 7994.7 5677 6318.5 -1324 
(-7522.2,4873.7) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB  








8.7.5 IBS Friction cost approach: Impact of absenteeism, presenteeism and 
multiplier effects 
In the IBS analysis, an investigation was carried out on the potential impact on total societal 
costs of using the friction cost approach for valuing productivity costs while incorporating 
adjustments for multiplier effects. These estimates were then compared with the 
conventional societal cost estimates. 
 
As shown in Table 8.12, adjusting the conventional friction cost approach to productivity 
costs for multiplier effects leads to higher societal costs than the conventional friction cost 
approach and human capital generated estimates. In all cost scenarios, the main cost drivers 
were the effects of productivity loss on team productivity. Mean societal costs were lower in 




Table 8:12 Back pain mean (SD) societal costs per patient and year for patients reporting resource utilisation 
data: Overall analysis 





(95% CI BC) 
Mean SD Mean SD 
Absence days* 7.9 23.5 4.3 14.5 0·49 
(0·44, 0·55) 
Health-care costs (£) 274 278.2 240 261.3 -34.4  
(-76.87; 3.3) 
Total  back pain related costs using FCA approach for absenteeism and presenteeism 
Scenario 1  937 3074.4 583 2023.4 -354 
(-683.4,-24.5) 
Scenario 2 963 3287.3 582 2021.1 -380  
(-723.4,-36.8) 
Scenario 3 932 3010.0 576 2000.6 -356  
(-686.2,-27.7) 
Scenario 4 
930 3008.2 582 2018.6 -348 
(-673.1,-23.3) 
Scenario 5 
919 2932.2 580 2014.5 -339 
(-658.8,-19.3) 
Total  back pain related costs using FCA approach for absenteeism and HCM for presenteeism  
Scenario 1 750 2130.4 534 1249.1 -285 
(-503.4,-65.8) 
Scenario 2 763 2225.3 464 1245.8 -298 
(-523.6,-73.4) 
Scenario 3 743 2126.2 458 1217.3 -285 
(-501.6, 68.4) 
Scenario 4 
745 2096.6 464 1241.6 -281 
(-497.4,-65.2) 
Scenario 5 
739 2064.4 462 1237.5 -276 
(-490.6,-63.3) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB  
*The analysis of work absence outcomes focused on the subsample of respondents in paid employment at 6-month follow-up; 132 of 229 
(58%) in Phase 1, 158 of 310 (51%) in Phase 3. 
 
8.7.6 IBS Friction cost approach: Impact of absenteeism, presenteeism and 
multiplier effects in subgroup analysis 
The findings in the overall analysis were replicated in the subgroup analyses. Productivity 
costs incorporating multiplier effects generated higher costs than the more conventional 
approach that excludes multiplier effects in all risk groups. The differences in costs between 
the interventions were largely driven by the effects of absenteeism and presenteeism on 
team productivity (Table 8.13 to 8.15). The phase 1 strategy was associated with lower mean 




Table 8:13 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Low-risk 





(95% CI BC) 
 Mean SD Mean SD   
Absence days* 0·52 2.29 0·85 3.40 -0.32 
(-1.43,0.78) 
Health-care costs (£) 141 210.1 138 171.3 2.90 
(-39.3,45.3) 
 
Total back pain related costs using FCA approach for absenteeism and presenteeism  
 
Scenario 1 243 821.4 306 1523.8 63  
(-216.6,342.9) 
Scenario 2 243 821.4 306 1523.8 63  
(-216.6,342.9) 
Scenario 3 243 821.4 306 1523.8 63  
(-216.6,342.9) 
Scenario 4 
243 821.4 306 1523.8 63  
(-216.6,342.9) 
Scenario 5 
243 821.4 306 1523.8 63  
(-216.6,342.9) 
 
Total back pain related costs using FCA approach for absenteeism and HCM for presenteeism 
 
Scenario 1 232 727.2 224 750.9 -8.1 
(-153.4, 176.3) 
Scenario 2 232 727.2 223 750.9 -8.1 
(-139.5, 184.8) 
Scenario 3 232 727.2 223 750.9 -8.1 
(-144.4, 186.6) 
Scenario 4 
232 727.2 223 750.9 -8.1 
(-147.6, 169.7) 
Scenario 5 
232 727.2 223 750.9 -8.1 
(-125.7, 190.9) 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB  






Table 8:14 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: Medium-risk 






Mean SD Mean SD 
Absence days 6.11 20.0 2.3 12.8 -3.7 
(-7.8, 0.43) 
Health-care costs (£) 
292 361.3 284.0 314.1 -7.79 
(-73.4,56.9) 
 
Total back pain related costs using FCA approach for absenteeism and presenteeism  
 
Scenario 1 








1105 3234.6 516 1287.9 
-588 
(-1054.3,-123.5) 
Scenario 4 1105 3154.7 531 1354.1 
-574 
(-1035.3,-113.4) 




Total back pain related costs using FCA approach for absenteeism and HCM presenteeism 
 
Scenario 1 834 2064.1 462 1034.5 -372 
(-727.4,-49.7) 
Scenario 2 854 2180.6 461 1025.2 -393 
(-816.0,-62.7) 
Scenario 3 
830 2067.5 446 939.3 
-385 
(-810.5,-61.2) 
Scenario 4 834 2038.8 459 1012.7 
-374 
(-751.2,-63.2) 
Scenario 5 819 1980.2 455 1000.7 
-364 
(-768.3, -61.9) 
Scenario 1, single-friction period, Scenario 2 – two level friction period, Scenario 3 five-level friction period 1st data set , Scenario 4, five-
level friction period 2nd dataset, Scenario 5 five-level friction period 3rd dataset  





Table 8:15 Back pain related mean (SD) societal costs per patient and year for patients reporting resource 
utilisation data: High-risk 






Mean SD Mean SD 




384 304.6  358 323.5  
26 
(-53.9; 121.0) 
Total  back pain related costs using FCA approach for absenteeism and presenteeism 
 
Scenario 1 








1767 4657.8 1237 3447.9 
-530  
(-1693.2,632.6) 
Scenario 4 1757 4490.3 1237 3447.9 
-520  
(-1658.7,619.2) 
Scenario 5 1756 4427.3 1237 3447.9 
-519  
(-1648.3,611.7) 
Total  back pain related costs using FCA approach for absenteeism and presenteeism 
 
Scenario 1 1464 3309.5 953 2067.2 -512  
(-1393.8, 210.0) 
Scenario 2 1488 3446.8 953 2067.2 -536  
(-1472.3, 226.0) 
Scenario 3 1442 3298.0 953 2067.2 -490  
(-1503.9, 278.9) 
Scenario 4 1446 3243.6 953 2067.2 -493  
(- 1257.5,270.9) 
Scenario 5 1445 3217.4 952 2067.2 -493  
(-1252.7, 267.7) 
 
Scenario 1, single-friction period, Scenario 2 – two level friction period DLA, Scenario 3 five-level friction period CIPD , Scenario 4 five-level 
friction period ONS, Scenario 5 five-level friction period UoB  
*Work loss evaluation was based on a total subsample of 290 of 547 responders who reported being currently employed at 6 months 
follow-up 
 
8.7.7 Estimation of the cost-utility analysis from a societal perspective 
In the healthcare perspective, stratified care was associated with a small mean health 
benefit at a lower mean healthcare cost (0.003 additional QALYs and a reduced mean 
healthcare cost of -£33.54). Similarly, when considering the societal perspective for the 
overall analysis, a dominant position was observed for the phase 3 strategy, which was 
associated with a small increased health benefit achieved at a lower cost (0.003 additional 
QALYs and reduced mean societal costs ranging from -£380 to -£339).  
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The investigation was then carried out with a focus on subgroups of patients, comprising 
low-risk, medium-risk and high-risk patients. The results demonstrated a small but significant 
difference between the two groups among high-risk patients (0.0196 additional QALYs and 
reduced mean costs ranging from -£595 to -£519 (Tables 8.14 and 8.15). The high-risk cost-
effectiveness planes show that on average 80% of the bootstrapped cost-utility pairs were 
situated in the southeast quadrant, indicating more effectiveness and fewer costs for the 
phase 3 strategy. Accordingly, stratified care dominates usual care, i.e. is more cost-effective 
regardless of the willingness-to- pay per QALY among high-risk patients. A dominant position 
negates the need to calculate an ICER. 
 
However, there was considerable uncertainty around the incremental costs and effects in 
the low-risk category. A small health benefit of 0.00294 was observed at an increased 
average cost of £63 across all cost scenarios, resulting in an average incremental cost-per 
QALY gained of £21,429 when considering friction periods disaggregated by occupation. The 
results in this risk group demonstrate that the additional health benefits are worth the 
additional cost of the phase 3 intervention (Table 8.16).  
 
Finally for the medium-risk group, stratified care was associated with lower mean societal 
costs ranging from -£611 to -£553 and a lower mean health benefit (0.00795 fewer QALYs). 
The observed incremental cost-effectiveness ratios ranging from £69,560 to £76,855 indicate 
that the additional cost required to achieve the small health benefit associated with the 




Table 8:16 Incremental societal costs and incremental QALYs: Point estimates incorporating absenteeism and 
presenteeism for the IBS base-case analysis 
 




     
Mean cost difference per patient  (£) -354 -380 -357 -349 -340 
Mean QALY difference 0.003  
ICER: Cost per QALY gained Dominant Dominant Dominant Dominant Dominant 
Low-risk category      
Mean cost difference per patient  (£) 63 63 63 63 63 
Mean QALY difference 0.00294  
ICER: Cost per QALY gained 21,429 21,429 21,429 21,429 21,429 
Medium-risk category      
Mean cost difference per patient (£) -573 -611 -588 -574 -533 
Mean QALY difference -0.00795  
ICER: Cost per QALY gained 72,075 76,855 73,962 72,201 69,560 
High-risk category      
Mean cost difference per patient  (£) -547 -595 -530 -520 -519 
Mean QALY difference 0.01956  
ICER: Cost per QALY gained Dominant Dominant Dominant Dominant Dominant 
      
ICER: incremental cost-effectiveness ratio; QALY quality adjusted life year. P1 single-occupational category friction period, P2 two-level 
occupational category friction period, P3, P4, P5 five-level occupational category friction periods 
 
8.7.8 Cost-utility planes – overall healthcare and societal cost perspective  
Figure 8.15 shows the cost-effectiveness (CE) planes of incremental costs versus incremental 
QALYs for the overall analysis, based on 5000 bootstrap replicates. The planes illustrate the 
level of uncertainty in the mean incremental costs and QALY estimates. The findings 
demonstrate cost savings and increased health benefits in the overall analysis (the majority 
of replications (63%) located in the south-east quadrant).  
 
In the societal cost analysis (Figure 8.15) the dominant position of stratified care (phase 3) 
was further strengthened with an average 67% of replications located in the southeast 







Figure 8:15 Cost-utility plane for the overall comparison of stratified care (phase 3) compared to usual care 
(phase 1) for the societal perspective 
(A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) 
Societal cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal 


















































































































































































































































8.7.9 Cost-effectiveness planes for the subgroup analysis     
Cost-effectiveness planes for the risk-group analysis showing the uncertainty around the 
cost-effectiveness ratios of the main QALY outcome are presented in Figure 8.16 to 8.18. 
There was much uncertainty in the bootstrapped data among the low-risk patients as seen 
by the distribution of the cost-effectiveness pairs in the four quadrants of the CU planes 























Figure 8:16 Cost-utility plane for the low-risk group analysis of stratified care (phase 3) compared to usual 
care (phase 1) from societal perspective 
(A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) 
Societal cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal 












































































































































































































































The scatter plots for the medium-risk and high-risk patients are displayed in Figures 8.17 and 
8.18. The intervention was associated with cost-savings, but no significant differences in 
health benefits between the two groups among medium-risk group patients. The majority 
(average 85% for all cost-scenarios) of the cost-utility pairs were located in the south-west 
quadrant (Figures 8.17). In contrast, the stratified care strategy was associated with cost-
savings and increased effectiveness among the high-risk group, as the majority (average 80%) 






















Figure 8:17 Cost-utility plane for the Medium-risk group analysis of stratified care (phase 3) compared to 
usual care (phase 1) from societal perspective
 
 (A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) Societal 
cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal cost perspective five-



































































































































































































































Figure 8:18 Cost-utility plane for the High-risk group analysis of stratified care (phase 3) compared to usual 
care (phase 1) from societal perspective 
 (A) Cost–utility plane comparing the stratified management approach (‘intervention’) to current best practice (‘control’) healthcare 
perspective. (B) Societal Cost perspective average friction period. (C) Societal cost perspective two-level friction period DLA. (D) Societal 
cost perspective five-level friction period CIPD. (E) Societal cost perspective five-level friction period ONS. (F) Societal cost perspective five-








































































































































































































































8.7.10 Healthcare and societal cost perspective cost-effectiveness acceptability 
curves (CEACs)  
Figure 8.19 presents the cost effectiveness acceptability curve showing the probability of the 
phase 3 strategy being cost-effective compared with the phase 1 strategy for the overall 
analysis from a healthcare and societal perspective. The results show that the phase 3 
strategy was associated with relatively high probabilities of being cost-effective for all 
willingness-to-pay thresholds investigated (up to £50,000 per QALY), but with the greatest 
probability of the intervention being cost-effective observed at low threshold values (below 
£10,000).  
 
The CEACs for the societal perspective for the overall analysis are also presented in Figure 
8.19 alongside the detailed friction period (varying friction periods at two and five-
occupation levels) cost scenarios. As in the healthcare perspective, the phase 3 strategy was 
associated with a very high probability of being cost-effective (over 95% compared to 75% 
from the healthcare perspective) for the majority of willingness-to-pay thresholds 
investigated. The inclusion of productivity costs therefore further strengthened the case for 
the phase 3 strategy. Similar results were demonstrated in all cost scenarios applying the 





Figure 8:19 CEAC for the overall healthcare and societal perspective 
HCY Healthcare perspective, SCP1X Single friction period, SCP2X two-level period DLA, SCP5X five-level period CIPD, SCP5bX five-level 
period ONS, SCP5bX five-level period UoB. 
 
8.7.11 Cost-effectiveness acceptability curves (CEACs) for the subgroup analysis   
The CEACs for the healthcare perspective and societal cost perspectives are presented in 
Figures 8.20 to 8.25 with all three risk group analyses presented on the same figure. In the 
analyses from the healthcare perspective, and at the £30,000 per QALY threshold, the phase 
3 strategy was associated with very high probabilities (exceeding 95%) of being cost-
effective among high-risk patients. For the medium-risk group, the plateau of around 20% 
for probability of stratified care (phase 3 strategy) being cost-effective at the £30,000 
threshold reflects the negligible difference in benefits between the two groups. The 
probabilities that stratified care was cost-effective at the £30,000 per QALY threshold in low-
risk, medium-risk and high-risk patients were on average across all cost-scenarios (i.e. 





Figure 8:20 Cost-utility acceptability curves for the three risk groups analysis of stratified care (phase 3) 
compared to usual care (phase 1) (healthcare perspective). 
 
8.7.11.2 Cost-effectiveness acceptability curves: Societal cost perspective 
The inclusion of societal costs significantly altered the probabilities of stratified care being 
cost-effective in the subgroup analyses, particularly among medium-risk patients. Societal 
costs were calculated according to cost scenarios with varying friction periods at two-level 
and five-level occupational classes. The probabilities that stratified care was cost-effective at 
the £30,000 per QALY threshold in low-risk, medium-risk and high-risk patients were on 
average across all cost-scenarios 0.50, 0.80, 0.90. Slight but insignificant changes in the 
probability of stratified care being cost-effective were observed in the different cost 
scenarios. Notable, however, was the increment in the probability of stratified care being 
cost-effective among medium-risk patients from 0.20 to 0.80 at the £30,000 per QALY 
threshold.  The improved cost-effectiveness of stratified care at low WTP could potentially 




However, the stratified care strategy remained highly cost-effective among high-risk patients 
with probabilities exceeding 90% of being cost-effective at WTP threshold values greater 
than £5000 per QALY gained for all cost scenarios (Figures 8.20 to 8.25). In the low-risk 
category, the correspondingly observed probability plateau averaging 50% in all cost 
scenarios reflects the relatively small difference in QALY gains (0.00294 QALYs).  
 
Overall, there were no significant alterations in the probability of the phase 3 strategy being 
cost-effective within the different cost scenarios as a result of using stratified occupational 
level friction periods. Consequently, the same policy conclusions are observed irrespective of 
the level of friction period used. 
 
 
Figure 8:21 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 







Figure 8:22 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 




Figure 8:23 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 








Figure 8:24 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 




Figure 8:25 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 







8.7.12 Sensitivity Analysis 
8.7.12.1 Regular approach: FCA for absenteeism and HCM for presenteeism excluding 
multiplier effects. 
Overall, similar policy implications to the base-case were replicated in the sensitivity 
analyses. The CEAC for the incremental cost-utility ratios for a societal perspective with 
disaggregated friction period values for the overall analysis is shown in Figure 8.26. From a 
societal perspective, stratified care (phase 3) was associated with a very high probability of 
being cost-effective (over 90%) for the majority of willingness-to-pay thresholds investigated. 
At the £30,000 per QALY threshold, stratified care was highly cost-effective with 
probabilities exceeding 90%. 
 
 
Figure 8:26 CEAC for the overall societal perspective sensitivity analysis 
 
Sensitivity analysis results from the subgroup analysis are shown in Figure 8.27 with results 
presented only for the single-friction period. The findings were generally in the same 
direction as the base-case analysis. However, relatively lower probabilities for the phase 3 
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strategy being cost-effective were observed in the medium-risk group, and higher 
probabilities observed in the low-risk patient group, when the conventional friction cost 
approach was applied in all three risk-groups.  
 
Figure 8:27 Cost-utility acceptability curves for the three risk group analysis of stratified care (phase 3) 
compared to usual care (phase 1) (a single occupation friction period) 
 
8.7.13 Sensitivity analysis on cost-utility estimates  
In the overall analysis, and for each risk-defined group, the findings were in the same 
direction as in the base-case analysis with similar interpretations of the cost-effectiveness 
outcomes replicated in all sensitivity analyses. As in the healthcare perspective, the phase 3 
strategy remained cost-effective in the overall analysis and among patients in the high-risk 
group. The sensitivity analyses were based on calculating societal costs using the more 
conventional approach that values absenteeism using the FCA and presenteeism using the 
HCM (SA1), incorporating a higher elasticity factor of 1 assuming no short-term 
compensation mechanisms (SA2) and adjusting multiplier estimates in the suggested friction 
cost approach (SA3) (Table 8.17). 
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Table 8:17 Mean cost differences, mean QALY differences, incremental cost-effectiveness ratios from varying 
friction periods and corresponding three sensitivity analyses (SA1, SA2 and SA3) 
 
P1 P2 P3 P4 P5 
 
Societal costs: Overall Analysis      
Main  -354 -380 -356 -348 -339 
SA1   -383 -409 -378 -415 -415 
SA2   -285 -298 -285 -281 -277 
SA3 -366 -385 -366 -362 -357 
Mean QALY difference 0.003 
ICER Main Dominant Dominant Dominant Dominant Dominant 
ICER SA1   Dominant Dominant Dominant Dominant Dominant 
ICER SA2   Dominant Dominant Dominant Dominant Dominant 
ICER SA3 Dominant Dominant Dominant Dominant Dominant 
Low-risk category  
Main  63 63 63 63 63 
SA1   96 96 96 96 96 
SA2   -8 -8 -8 -8 -8 
SA3 24 24 24 24 24 
Mean QALY difference 0.00294 
ICER Main 21,429 21,429 21,429 21,429 21,429 
ICER SA1   32,653 32,653 32,653 32,653 32,653 
ICER SA2   -2742 -2742 -2742 -2742 -2742 
ICER SA3 8,163 8,163 8,163 8,163 8,163 
Medium-risk category      
Main -573 -611 -588 -574 -553 
SA1 -662 -700 -659 -715 -717 
SA2   -372 -393 -385 -374 -364 
SA3 -521 -549 -536 -523 -512 
Mean QALY difference -0.00795 
ICER Main 72,075 76,855 73,962 72,201 69,560 
ICER SA1   83,270 88,050 82,893 90,189 90,189 
ICER SA2   46,793 49,434 48,428 47,044 45,786 
ICER SA3 65,535 69,057 67,421 65,786 64,403 
High-risk category      
Main  -547 -595 -530 -541 -519 
SA1   -534 -582 -517 -577 -577 
SA2   -512 -536 -490 -493 -493 
SA3 -656 -689 -631 -633 -632 
Mean QALY difference   0.01956   
ICER Main Dominant Dominant Dominant Dominant Dominant 
ICER SA1   Dominant Dominant Dominant Dominant Dominant 
ICER SA2   Dominant Dominant Dominant Dominant Dominant 
ICER SA3 Dominant Dominant Dominant Dominant Dominant 
      
Main estimates from the suggested approach using the FCA for valuing absenteeism and presenteeism with adjusted multiplier values, SA1 
estimates from the conventional approach using the FCA for valuing absenteeism and the HCM for valuing presenteeism; SA2 using an 










In this chapter, two economic evaluation case studies were presented illustrating a practical 
application of the friction cost approach in a UK setting. Cost-effectiveness was estimated in 
a clinical trial and in routine primary care practice. The analysis used friction period 
estimates from Chapter Six and a single-item presenteeism question validated in Chapter 
Seven to measure presenteeism.  
 
The current studies were the first to examine the cost-effectiveness of stratified care in 
primary care while incorporating absenteeism, presenteeism and multiplier effects alongside 
friction period estimates disaggregated by occupational categories. The findings were 
consistent in a clinical trial and routine practice setting both from the healthcare and societal 
perspectives. The cost-effectiveness result in both cases was favourable to the stratified care 
intervention in low back pain sufferers when compared to standard UK cost-effectiveness 
thresholds (Appleby et al., 2007; McCabe et al., 2008). The results demonstrate that the 
inclusion of productivity costs strengthened the case for stratified care in the overall analysis 
for both studies.  
 
An important finding was that there were observed changes in cost-effectiveness results 
among subgroup populations when productivity costs and multiplier effects were 
incorporated. For example, the probability that stratified care was cost-effective among low-
risk patients improved from 52% to 80% when productivity costs were incorporated within 
the SBT analysis at the £30,000 cost-effectiveness threshold. Stratified care was associated 
with improved probabilities (from 20% to 78%) among medium-risk patients as a result of 
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including productivity costs in the IBS analysis. The stratified care model appears appropriate 
for a general primary care setting. When considering subgroups, the model appears to be 
more appropriate for high-risk patients in routine practice.  
 
The results in this chapter provide insights into the implications of using more detailed 
friction periods disaggregated by SOC occupational categories. The results indicate that the 
use of stratified friction periods in this population did not, in these particular cost-
effectiveness evaluations, alter the overall outcome of the base-case analysis.  
 
To date, there is no evidence from economic evaluations that have simultaneously 
incorporated presenteeism, multiplier effects, and stratified friction period estimates in the 
UK. A previous review showed a scarcity of studies estimating productivity costs using the 
friction cost approach in comparison to the total number of economic evaluations, 
particularly in the UK (Pritchard and Sculpher, 2000). Although Pritchard and Sculpher’s 
(2000) findings may have been due to the date of their review in relation to the 
development of the friction cost approach, similar findings were found in the systematic 
review within Chapter Four of this thesis. This found few economic evaluations in the UK 
applying the friction cost approach, and no studies that have attempted to estimate reduced 
productivity loss using the friction cost approach in the UK or that have considered multiplier 
effects resulting from absenteeism and presenteeism in other countries (Nicholson et al., 
2006; Zhang et al., 2012). Applications of the friction cost approach remain important as the 
method potentially generates more realistic productivity costs than the conventionally 
applied human capital method (Koopmanschap and Rutten, 1996). 
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The decision to include or exclude productivity costs has been shown to significantly impact 
incremental costs in depressive disorders (Krol et al., 2011) and in neck pain interventions 
(Lewis et al., 2007). Although their inclusion in the evaluations in this chapter did not alter 
the overall cost-effectiveness decision, back pain has been associated with significant 
absence and disability costs (Ostelo et al., 2008). The exclusion of back pain productivity 
related costs could therefore generate underestimates of the true value of interventions 
providing treatment in this area. Additional empirical research on productivity costs in 
economic evaluations is important in light of the significant proportion of productivity costs 
in relation to total costs. The findings in both studies showed that productivity costs on 
average comprised more than half of the societal costs for stratified care among low back 
pain sufferers. And, their inclusion in the economic evaluation studies altered the probability 
level of the stratified care model being cost-effective at acceptable willingness-to-pay 
threshold values particularly within the subgroup analyses.  
  
In the analyses presented here, cost-effectiveness acceptability curves were used to assess 
the cost-effectiveness of stratified care for increasing monetary valuations per QALY gained 
and assessed based on the £30,000 per QALY threshold. Although many cost-effectiveness 
analyses of healthcare interventions using the QALY outcome in the UK are based on this 
threshold value (Appleby et al., 2007; McCabe et al., 2008), there is currently no clear 
guidance on an acceptable threshold for an additional QALY gained in the UK when 
considering a societal perspective. Cost-effectiveness studies performed from a societal 
perspective provide further support for the hypothesis that inclusion of productivity costs 
may necessitate application of different ICER thresholds from the traditional £30,000 per 
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QALY threshold (Eichler et al., 2004). Some questions remain unanswered from recent 
research towards adjusting the threshold based on the social value for a QALY, and on 
opportunity costs of foregone health (Donaldson et al., 2011; Claxton et al., 2013). In future 
investigations, evidence is needed on whether and how to estimate this threshold when 
considering a societal perspective. 
 
Methodologically, the results presented in this investigation provide further insights into the 
impact of including seldom considered productivity costs of presenteeism and multiplier 
effects within an economic evaluation setting in applications of the friction cost approach. 
There has been a lot of discussion about whether and how to value indirect costs of lost 
productivity in relation to presenteeism (Brooks et al., 2010; Johns, 2010). Several issues 
remain unresolved at present on this topic. Some have argued that these costs should be 
excluded, at least, or used with considerable caution because of criticisms on existing 
conversion and monetary translation approaches (Brooks et al., 2010). Given that both 
presenteeism and absenteeism costs are highly associated with the clinical area of back pain, 
however, excluding these costs could potentially lead to the generation of inaccurate 
estimates. In this thesis, the costs of presenteeism were therefore calculated with 
applications of the friction cost approach for the first time in the UK by applying the 
elasticity value of 0.8 on the calculated presenteeism costs. 
 
Additionally, costs resulting from negative impacts of absenteeism and presenteeism on 
productivity of co-workers particularly where team work is involved (multiplier effects) were 
incorporated in the economic analyses presented in this thesis using multiplier values 
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derived from a UK national study (Zhang et al., 2012). Empirical evidence on multiplier 
effects and their impact on overall societal economic evaluation outcomes remain scarce in 
UK studies. This exploration therefore increased knowledge on how multiplier effects from 
secondary sources can be used and their impact on productivity costs and cost-effectiveness 
outcomes. There is room for further progress in this area by determining a wider set of 
multiplier values as well as work related compensation mechanisms for UK data. 
 
Previous studies have demonstrated that multiplier effects significantly impact on overall 
productivity costs (Zhang et al., 2012; Krol et al., 2012). In the literature, productivity costs 
have been estimated to be 28% higher than the regular friction cost approach estimates 
when multiplier effects are incorporated (Krol et al., 2012). The findings here agreed with 
previous research showing alterations in total societal costs as a result of incorporating 
multiplier effects. The cost-effectiveness analyses incorporating multiplier effects did not 
alter policy implications compared with analysis conducted from the healthcare perspective. 
However, their inclusion alongside absenteeism and presenteeism costs seemed to generate 
much uncertainty in the data among subgroup populations. The validity of the findings 
provided here, however, may require further empirical investigation since the multiplier 
values applied were obtained from a UK cohort of rheumatoid arthritis patients with very 
small sample sizes. Overall, the results provided suggest that current estimates of 
productivity costs in economic evaluation studies could be underestimated, in that multiplier 




On the other hand, it has been suggested that productivity loss is often partially 
compensated during working hours by colleagues and/or sick employees (Severens et al., 
1998; Pauly et al., 2002; Krol et al., 2012; Zhang et al., 2012). In such cases, it has been 
argued that productivity loss from an absent individual or an individual working with 
limitations could potentially be reduced (Krol et al., 2012). It was not possible to incorporate 
such effects of work compensation in the cost-effectiveness studies presented in this thesis 
because data on compensation during working hours and extra workers were not collected. 
Although not investigated here, the estimation of job-related compensation mechanisms 
and how to translate such costs into productivity loss, and consequently incorporate their 
effects on cost-effectiveness outcomes, deserves further attention. 
 
As part of a sensitivity analysis, the impact of key assumptions on the overall societal costs 
was assessed. All sensitivity analyses carried out generated similar results to the base-case 
analyses. For instance, the elasticity factor is a key parameter normally used in valuing 
productivity costs. It is common practice in applying the friction cost approach to use an 
elasticity value of 0.8 according to the Dutch costing guidelines as was done here. Although 
used by various studies, mostly in the Netherlands, there have not been any other reported 
published estimates of this elasticity factor. It therefore remains unclear how appropriate 
this value currently is, particularly within the UK context. The impact of changing the 
elasticity value on cost-effectiveness results was investigated in the sensitivity analysis, 
seeing there is no reported value in the UK. An elasticity value of 1 was applied in the 
sensitivity analysis. The results showed that, in this case, the overall policy implications were 
not changed as a result of altering the elasticity value. Similarly, in order to assess the impact 
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of different methodological approaches to productivity cost estimates, cost-effectiveness 
estimates were recalculated using a possibly more conventional approach of incorporating 
productivity costs, i.e., using the friction cost approach for valuing absenteeism and the 
human capital method for valuing presenteeism and excluding multiplier effects. The results 
from both studies showed approximately similar policy implications to the regular friction 
cost approach of valuing productivity costs, suggesting the traditional valuation approach 
generates comparable policy implications in this case study. 
 
Strengths of the economic analysis  
The analysis presented here has some key strengths. The economic analyses were conducted 
alongside a large RCT and replicated in routine practice. Hence all resource use, work-related 
data and health outcomes data were obtained prospectively during the study periods. This is 
an important strength, as reliable resource use data with corresponding outcome data may 
not readily be available retrospectively. Another strength of this study is that the multiple 
imputation technique was used in dealing with missing data for back pain patients who 
dropped out before the end of the study period. This involved imputation of five samples of 
cost and effects which allowed the use of full costs and effects, for patients who did not 
complete the study. Adopting a complete-case analysis could have underestimated the real 
costs involved in the stratified and usual care interventions and among subgroups, as 
severely affected back pain patients are more likely to drop out of the study than less 




Few studies have provided evidence on the impact of simultaneously including absenteeism, 
presenteeism and multiplier effects alongside healthcare costs in economic evaluations. This 
research therefore contributes to this evidence base. Moreover, these are the first studies to 
explore application of friction periods stratified by occupational levels. Various cost-
valuation models were used to generate societal costs for varying occupational level friction 
periods. This analysis therefore provides estimates that go beyond the more conventional 
friction cost approach of applying a single friction period. The results are also presented by 
risk-based subgroup populations. These are all important strengths of this research.  
 
Limitations of this analysis  
A limitation of the evaluations presented and discussed here is that the productivity cost 
analyses were limited to few participants who provided work loss related data. Moreover, 
the results presented here only focus on economic evaluations of low back pain sufferers, 
and it is a question as to how generalisable the implications of including productivity costs 
would be to other interventions for other conditions. The methodological approaches 
developed here should be explored further in other disease conditions for their impact to be 
more clearly understood.  
 
Furthermore, inherent challenges were observed in the current data collection tools for 
estimating work related productivity loss. The lack of episode specific work related data 
during economic evaluation studies posed challenges in the practical application of the 
friction cost approach. The collection of such data requires the identification of individual 
sickness episode occurrences and duration data that were not available here. This would 
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require detailed capture of time off work data from patients throughout the study period. 
Nevertheless, although criticised for using complicated data, which are not always available 
at the national level (Luce, 1996; Liljas, 1998; Knies et al., 2010), the friction cost approach 
provides more realistic estimates than the traditionally used human capital method. Also, 
the application of the friction cost approach in valuing productivity costs is steadily growing 
in the literature as demonstrated by the review studies reported in Chapter Three.  
 
The SIPQ used to assess presenteeism in this investigation was first validated among LBP 
patients and then applied to assess reduced productivity, although estimates from other 
instruments could potentially lead to different results. Furthermore this instrument does not 
allow for capture of multi-dimensional work aspects or aspects of teamwork and 
substitutability. However, the SIPQ can potentially be used alongside other questionnaires 
that are able to measure such aspects, and provides the essential basis for presenteeism 
valuation within an economic evaluation. 
 
The feasibility of applying the friction cost approach when incorporating more detailed 
friction period estimates is a necessary consideration in economic analysis. However, 
improvements in the tools used to obtain data on specific illness episodes and their duration 
within trial based studies is a necessary requirement for fostering increased application of 
the friction cost approach. Furthermore, regular updates and standardisation of friction 
period data sources are important, particularly at the national population level, as they are 
likely to vary depending on the state of the economy. Ideally, the increased availability of 
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these data will provide more accurate estimates of friction cost related productivity costs. 
   
Importantly, it was not possible to adjust productivity loss for compensation mechanisms 
due to the lack of appropriate work characteristic compensation data. Nevertheless, the 
importance of these work compensation costs has been clearly established as earlier 
discussed. For this investigation, it was assumed that the application of a 0.8 elasticity factor 
within the cost equation possibly incorporates workers compensating for short-term 
absences during normal working hours. However, additional analyses incorporating both 
multiplier effects and detailed compensation mechanisms estimates would be very 
informative and desirable. Furthermore, the multiplier values used here were based on 
values from an external study, and the validity of the approaches used in generating these 
estimates relies on the population for that investigation (defined by Rheumatoid Arthritis) 
being representative for low back pain sufferers.  
 
 
This chapter presented and discussed cost-effectiveness results of the stratified care model 
in a clinical trial and in routine care practice while taking into consideration absenteeism, 
presenteeism and multiplier effects. The analyses concluded that the stratified care model 
was highly cost-effective in both settings. An interesting finding was the considerable change 
in probability levels for the stratified care model being cost-effective among subgroup 
populations when multiplier effects and other work related outcomes such as presenteeism 
and absenteeism are incorporated in the cost-effectiveness analysis. Applications of 
stratified friction periods using the friction cost approach, however, did not alter the overall 
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fundamental interpretation of cost-effectiveness outcomes. This finding provides further 
support for future research in economic evaluations in other interventions and disease areas. 
In the next Chapter, the overall discussion, conclusions and recommendations of the thesis 





















CHAPTER NINE  
 
The overall objective of the thesis was to contribute to the debate on the valuation of 
productivity costs using the friction cost approach and the inclusion of absence from work 
(absenteeism), reduced productivity (presenteeism) and wage-related multiplier effects in 
economic evaluation. To achieve this objective, the thesis addressed four research areas that 
relate to the estimation and inclusion of productivity costs and multiplier effects resulting 
from effects of productivity loss on team productivity within economic evaluations, in the 
United Kingdom. The research questions emerged from systematic reviews of cost-of-illness 
and economic evaluation studies that applied the friction cost approach and reported 
presenteeism costs. The searches were conducted in a systematic and rigorous way to 
obtain a diverse set of studies across different clinical areas. Methodological and empirical 
studies were then presented and discussed in Chapters Six and Seven of this thesis. The first 
study in Chapter Six focussed on estimating the length of friction period estimates for the UK 
setting. The second included a comparison study of sickness certification records with self-
reported data. In Chapter Seven, the construct validity and responsiveness of the single-item 
presenteeism question as a standalone measure among low back pain sufferers was 
investigated. The empirical work from both chapters was then applied in Chapter Eight to 
investigate the potential impact on cost-effectiveness results of including full productivity 
costs in relation to absenteeism, presenteeism and multiplier effects on cost-effectiveness 




The aim of this chapter is to pull together the methodological and empirical work contained 
in this thesis. The first section provides an overview of the findings from the study questions 
addressed and compares the findings here to existing literature. The next section then 
considers the implications of the findings for policy and future research. Finally, an overall 
conclusion from the research is drawn.  
 
 
How common is the application of the friction cost approach in valuing productivity costs 
in UK cost-of-illness and economic evaluation studies?  
While there has been much debate about the benefits associated with the friction cost 
approach in valuing lost productivity, little evidence exists on whether and how the friction 
cost approach has been applied within cost-of-illness and economic evaluation studies. 
Chapter Three found that few attempts have been made at valuing productivity costs using 
this approach in the UK, but there is a general lack of clarity on the parameters and methods 
used. The friction cost approach is commonly applied in studies performed in the 
Netherlands, where the approach originated (Koopmanschap and van Ineveld, 1992; 
Koopmanschap et al., 1995), and where there appears to be more readily available country 
specific parameters necessary for its application. Nevertheless, variations in key parameters 
such as the friction period were observed across the studies from the different countries.  
 
One of the key issues emerging from this review was that evidence of friction periods 
remains sparse in the UK, and no attempts have been made to estimate friction periods 
using occupational status, which is more relevant to economic evaluation. The findings from 
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this systematic review further supported the idea of estimating country specific parameters 
for the friction cost approach, if increased application of this approach is to be realised. No 
attempts have been made to incorporate multiplier effects resulting from absenteeism and 
presenteeism in existing economic evaluation studies. The findings of the review conducted 
here supported earlier work showing that the friction cost approach needs to be given 
further consideration in the UK (Pritchard and Sculpher, 2000). The gaps in application of this 
approach informed part of the work in this thesis. 
 
How has presenteeism been measured and valued in cost-of-illness and economic 
evaluation research?  
A systematic review of economic studies assessing productivity costs in practice was 
reported in Chapter Four of this thesis, showing variations in standard and non-standardised 
presenteeism questionnaires. The findings of the review were in agreement with previous 
research, particularly Schultz et al., (2009) showing limited applications of presenteeism 
costs compared with other work-place outcomes such as absenteeism. Most of the 
assessment of presenteeism costs in current practice was found to be in cost-of-illness 
studies, with very few economic evaluations assessing presenteeism. On the costs of 
presenteeism in relation to absenteeism and overall total costs of illness, the systematic 
review here found presenteeism comprised the greatest proportion of total illness costs, 
being greater than absenteeism costs. Chapter Four showed that the effects of presenteeism 
on team productivity were not taken into account. Further, economic evaluation studies 
which take into account presenteeism costs and their effects on teamwork need to be 
undertaken. Only one study from the Netherlands, reported generating presenteeism costs 
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using the friction cost approach, and not one in the area in the UK. It is possible therefore 
that attempts to apply the friction cost approach in generating presenteeism costs may lead 
to lower productivity loss estimates than current estimates based on the human capital 
method. Further research is needed to add to this evidence base. An important finding was 
that a number of studies using a global presenteeism question were identified. Little was 
known, however, about the validity of using the global item presenteeism questions.  
 
The results were significant in at least three major aspects: i) cost-effectiveness results 
excluding full presenteeism costs may possibly fall short of true societal costs; ii) further 
empirical research is needed to use the friction cost approach in providing more realistic 
presenteeism cost estimates; and iii) no attempts have been made to estimate presenteeism 
using the friction cost approach in the UK or to consider multiplier effects resulting from the 
impact of presenteeism on teams. Further studies exploring this issue were recommended 
and, in particular it was noted that further work was necessary to establish the validity of the 
standalone global presenteeism question. These issues formed part of the foci of this thesis.  
 
What is the appropriate length of a friction period for the UK?  
Chapter Six provided the first UK specific length of friction period values which can be used 
when applying the friction cost approach in a UK setting. The overall friction period values 
obtained were comparable to previous friction period estimates reported in the literature 
review described in Chapter Three (For example, (Maniadakis and Gray, 2000; Luengo-




Further, these data were also used to generate friction period values stratified by SOC 
occupational level categories. No such estimates have been generated before in the UK.  
However, a previous study by Koopmanschap et al., (1995) estimated friction period values 
that were disaggregated according to educational levels in the Netherlands. The observed 
friction period estimates in this thesis varied according to different occupational level 
categories. The friction period was longer for higher occupational levels suggesting higher 
unemployment levels in lower occupational jobs, and a longer period needed for hiring 
higher occupational level employees. These findings contribute to better understanding of 
the implications of varying friction periods when applying the friction cost approach in 
economic evaluations. Further, empirical research was recommended to investigate the 
impact of using stratified friction period values to avoid an inaccurate estimation of 
productivity costs. A practical illustration of the impact of the estimates generated here 
within a cost-effectiveness framework is provided in Chapter Eight of the thesis.  
 
Can sickness certification records be used as a proxy for self-reported work absence data?  
Several methods are available for collecting productivity loss, the most popular in use have 
been self-reported questionnaires and administrative records (Pole et al., 2006; Evans, 2004). 
A strong relationship between self-reported sickness absence records and administrative 
database records has been reported in the literature (Ferrie et al., 2005; Severens et al., 
2000). Administrative database records have limitations in data accessibility, as multiple 
providers have to be approached for each patient, while self-reported questionnaires are 
susceptible to recall bias. GP sickness certification records may provide a rich source of 
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sickness absence data; however, the relationship between these records and self-reported 
records has not been firmly established.  
 
The study carried out in Chapter Six of this thesis found poor comparability between self-
reported sickness absence and GP sickness certification records. Furthermore, the findings of 
this study suggest that using sickness certification records to generate time-off work data is 
not a viable option in economic evaluation. The results from the current research, which 
considered periods of 6 months and 12 months, differed from a previous study that found 
good comparability between the two data sources over a period of two weeks (Wynne-Jones 
et al., 2008). The results were however in agreement with the study by Wynne-Jones et al., 
(2008) study that showed a lack of work absence duration data from GP certification records. 
As a result it was not possible to analyse the comparability of GP sickness certification 
duration data with self-reported work absence duration data. These results provide further 
support for continued improvements in self-report sickness absence questionnaires used to 
estimate work absence in economic evaluation studies. In their current state, sickness 
certification records might have a limited role in estimating time off work for economic 
evaluation research. However, more research on this topic is needed before the association 
between self-report absence records and GP certification records is more clearly understood. 
The identification of productivity loss is a necessary component in economic evaluations 
performed from a societal perspective. Until GP certification data improves, this study shows 
self-reported questionnaires offer the best possibility for deriving work absence data in 
economic evaluation studies. However, there is a need for improved methods of capturing 
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duration of absence data relevant for the friction cost approach when using self-reported 
instruments.  
 
Is the Single-Item Presenteeism Question (SIPQ) a valid and responsive measure among 
low back pain patients?  
In Chapter Four, the review found that presenteeism costs have rarely been incorporated in 
economic evaluation studies. To some extent, this could be explained by the majority of 
existing measurement instruments that are sometimes lengthy and complex, with several 
disparate questions compared with a single-item global presenteeism question. As discussed 
in Chapter Four, commonly used multi-item measures such as the WLQ (Lerner et al., 2001), 
HPQ (Kessler et al., 2003), WPAI (Reilly et al., 1993), and SPS (Turpin et al., 2004) differ in the 
type of presenteeism questions asked and in their detail. The validity of these measures has 
previously been investigated and reported (Lofland et al., 2004; Prasad et al., 2004). Single-
item global questions have practical advantages for researchers in terms of simplicity, cost 
and the possibility of generating presenteeism estimates in diverse occupations that could 
be used in cost-effectiveness analysis (Bowling, 2005). However, the validity and 
responsiveness of a single-item presenteeism question has not been fully investigated. 
 
In Chapter Seven of this thesis, evidence is provided showing the construct validity and 
responsiveness of a single-item presenteeism question (SIPQ) among LBP patients from the 
two thesis datasets. As such, it appears that the SIPQ work loss outcomes are assessing 
constructs that are relevant to patients with low back pain. The validity and responsiveness 
of the single-item presenteeism question has not been fully established against commonly 
292 
 
used multi-item presenteeism questionnaires. However, a previous research study 
investigated the agreement between a multi-item Work Activity Index (WAI) and single-item 
question on work ability among women on long-term sick leave, and found a strong 
association between the two measures for all participants (Ahlstrom et al., 2010). There is, 
therefore, room for further progress in comparing standard presenteeism questionnaires 
against non-standardised presenteeism global questions. The use of a single-item 
presenteeism question to estimate presenteeism costs could be preferable to ignoring these 
costs due to theoretical and practical limitations of existing multi-item measures. 
 
How does the inclusion of productivity costs using the alternative valuation methods 
explored in this thesis impact on the results of the cost-effectiveness analyses? 
Chapter Eight provides the first estimates of the cost-effectiveness of stratified care 
compared to usual care in LBP sufferers from a societal perspective using the friction cost 
approach, and incorporating presenteeism and multiplier aspects of presenteeism on team 
productivity. The economic analysis valued productivity costs using more-detailed friction 
periods stratified by SOC occupational level categories. The overview of the clinical area in 
Chapter Five of this thesis showed the significant burden associated with the back pain 
condition in comparison to other illnesses in the UK. 
 
Perhaps contrary to expectations, the inclusion of productivity costs in the evaluations in this 
thesis did not alter the findings on the cost-effectiveness of these strategies when evaluated 
from a healthcare perspective (Hill et al., 2011; Whitehurst et al., 2012). The inclusion of 
detailed productivity costs strengthened the case for stratified care management, as the 
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intervention remained highly cost-effective from both a societal and healthcare perspective. 
An interesting finding was that the incorporation of productivity costs and multiplier effects 
altered the probability of the stratified care model being cost-effective among subgroup 
populations of low back pain patients.  
 
The use of more detailed friction periods stratified by SOC occupational level also did not 
alter the interpretation of the cost-effectiveness results. Similar results were observed in all 
sensitivity analyses performed. However, more research needs to be undertaken to 
investigate the impact of simultaneously including compensation mechanisms and multiplier 
effects alongside other productivity cost outcomes. The present studies were successful in 
illustrating methodological applications of the friction cost approach in the UK. This remains 
an important area for future research. 
 
 
Pritchard and Sculpher (2000) reviewed the way absenteeism costs have been assessed in 
practice within economic evaluations. They found very few studies that have applied the 
friction cost approach in the UK and internationally, and recommended the need for explicit 
and detailed descriptions of the methods when this approach is used. Furthermore, their 
review revealed the need for additional empirical work around testing applications of 
presenteeism within economic evaluations.  
 
The more up-to-date review conducted here, confirmed that applications of the friction cost 
approach remain limited in the United Kingdom. Chapter Six took further steps in generating 
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detailed friction period estimates relevant for the UK and in Chapter Eight, an illustration of 
the practical application of the friction cost approach in economic evaluations was provided 
in a UK context, providing an explicit and detailed description of methods, as recommend by 
Pritchard and Sculpher (2000).  
 
An overview of research studies that have attempted to investigate vacancy durations in the 
United Kingdom and in the Netherlands was also provided in Chapter Six of this thesis. 
Previously published research on vacancy durations, particularly the work of Van Ours and 
Ridder (1991), which modelled vacancy durations according to educational levels in the 
Netherlands were reviewed. Their work was extended by Koopmanschap and colleagues 
(1995) to incorporate data from a large number of Dutch firms. The authors reported their 
friction periods stratified by educational status. In the United Kingdom, four research studies 
were identified (Beaumont, 1978; Roper, 1988; Adams et al., 2002; Andrews et al., 2008) , 
but these do not provide vacancy duration information relevant for estimating a friction 
period that can be used for valuing productivity loss using the friction cost approach. 
Chapter Six, provides more recent estimates of detailed specific vacancy durations relevant 
for a UK context. The friction period estimates generated are comparable to previous 
estimates used in UK economic costing studies, for example, in Maniadakis and Gray (2000), 
and in Rivero-Arias et al (2010). However, the work in this thesis is extended to include 
stratified friction periods as recommended by Koopmanschap et al (1995). 
 
Both Zhang and colleagues (2012) and Krol and colleagues (2012) have recently 
demonstrated the additional productivity costs associated with absenteeism and 
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presenteeism multiplier effects and compensation mechanisms in rheumatoid arthritis 
patients from the United Kingdom and in smokers from the Netherlands respectively. The 
productivity costs incorporating multiplier effects in cost-effectiveness studies within this 
chapter corroborate their findings showing significant alterations in productivity costs when 
these costs are included. Further work is done by assessing the impact of including multiplier 
effects in productivity costs alongside absenteeism and presenteeism costs on the cost-
effectiveness analyses reported in Chapter Eight of this thesis. This was done by adapting the 
multiplier values generated from the study by Zhang et al., (2012) and mapping them as 
closely as possible to the occupations in the study datasets for valuation purposes. It was 
however, not possible to assess the impact of simultaneously including multiplier effects and 




One of the major strengths of this thesis is that it assessed the cost-effectiveness from a 
societal approach of a stratified care model in a large randomised clinical trial and evaluated 
the same model in routine primary care practice, to illustrate the inclusion of productivity 
costs. Further, comprehensive sensitivity analyses were conducted alongside the two 
economic evaluation studies.  
 
The empirical estimation of friction periods for the UK is the first to generate more detailed 
friction period estimates disaggregated by occupation, and will provide researchers with 
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practical data for applying the friction cost approach. A comprehensive illustration of 
methodological applications of the friction cost approach in the UK is also provided.  
 
Another strength is that the choice of empirical work was based on a comprehensive and 
rigorous review of literature on the assessment of productivity cost estimation methods in 
cost-of-illness and economic evaluations in current UK and international practice and an 
overview of the clinical area of low back pain. The lack of appropriate context specific data 
for applications of the FCA, highlighted from the review, has provided support for estimation 
of friction period estimates for the UK. Similarly, the review highlighted the need for 




Although this thesis has addressed some important issues relating to the estimation of 
productivity costs and guidance on how to apply these alternative methods in economic 
evaluations, some limitations are recognised. Many of these provide important grounds for 
further research. Firstly, it is possible that the systematic reviews in Chapters Three and Four 
could have excluded some relevant studies in which the friction cost approach was used, as 
well as studies reporting presenteeism costs because of the search strategy employed. The 
decision to use only original economic costing studies and exclude model-based CEA can be 
limiting. However the aim was to assess how these approaches are used in primary costing 
studies and a comprehensive systematic literature and hand search was carried out to 
identify all relevant studies. 
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The research presented in Chapter Six focussed on estimation of a friction period for the UK 
and a comparability study of GP sickness certification records and self-report data. A 
limitation with the data on friction periods is that it was obtained from a variety of data 
sources with plausible varying degrees of validity, although relatively comparable estimates 
were generated. Nevertheless, a more comprehensive survey for the various SOC levels 
could provide more rigorous friction period estimates for the UK. Moreover more detailed 
explorations were based on broad SOC occupational classifications. Estimations of SOC level 
friction periods have not been investigated previously in the UK and it was not possible to 
make any comparisons with estimates based on other approaches.  
 
The exploration of the validity and responsiveness of the SIPQ was limited to tests against 
health-related and socio-demographic related constructs. It would have been useful to have 
been able to obtain data that included a standard reduced productivity at work instrument 
for validation purposes. Nevertheless, previous validations have made similar comparisons 
(Wahlqvist et al., 2002; Reilly et al., 2008; Reilly et al., 2010). 
 
A further limitation with the economic evaluation studies is practical. A lack of duration data 
led to the pragmatic decision to assume the number of days lost over the study period was 
representative of the total friction period between the measurement points. The impact of 
applying the friction cost approach using these estimates in these case studies therefore 
could be a limited representation of the true impact of this approach, especially in relation 
to absences with short absence durations. This suggests that economists using this approach 
need to collect more detailed data on absence duration, as well as total days of absence. 
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Further, the economic evaluation studies in this thesis did not include unpaid labour as part 
of the assessment of productivity costs. It could be argued that the exclusion of costs outside 
the labour market could also lead to an underestimation of productivity loss estimates and 
potentially lead to the selection of interventions discriminating against those not employed 
(including those caring for dependents, doing voluntary work, retired, students and the 
unemployed) in this clinical area. Unpaid labour costs are commonly measured using 
questionnaires and valued using the proxy good method or opportunity costs method (van 
den Berg et al., 2006). With the opportunity costs method, costs are valued at the rate at 
which individuals would be paid if they were in paid employment. In the proxy good method, 
costs are valued at rates of paid work closely related to the unpaid person’s work (Knies et 
al., 2010). Although there is justification for attaching monetary valuations to non-market 
labour and informal labour costs, it was not possible to include these costs here since lost 
time related to unpaid labour was not collected in the study datasets. Further research 
should attempt also to explore the importance of these costs.  
 
Furthermore, considering economic evaluations in the UK are currently based on a form of 
the extra-welfarist framework, that does not provide for inclusion of productivity costs, little 
attention has been paid to the generation of explicit guidance concerning when productivity 
costs should be considered by decision makers. Although this thesis has discussed and 
presented normative and theoretical support for considering a societal perspective, current 
recommendations from economic guidelines in the UK do not provide for inclusion of such 
costs in both the reference case and non-reference case analyses. The question of whether 
and how the current £20,000 to £30,000 per QALY threshold (Appleby et al., 2009) value 
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should be adjusted in the case of a societal perspective is an important question, but was 
beyond the scope of this thesis.  
 
 
The results of the reviews in Chapter Three and Four indicate that current practice in 
economic evaluations within the UK could benefit from more empirical studies investigating 
applications of the friction cost approach. Several areas of research in productivity cost 
valuation using the friction cost approach in the UK remain unexplored.  
 
Overall, further economic evaluation studies that value productivity costs using the friction 
cost approach, need to be undertaken. On a methodological note, when conducting 
economic evaluations, the choice of the valuation method should be based, where possible, 
on both the human capital method and friction cost approach for comparability purposes.  
 
Another important finding is the significant cost associated with absenteeism and 
presenteeism related multiplier effects. Currently, these costs seem to be largely ignored in 
economic evaluations. More empirical research is needed to investigate the potential 
influence of multiplier effects and compensation mechanisms alongside common work 
related outcomes of absenteeism and presenteeism on overall cost-effectiveness results, 
using more case studies on other disease areas. This would provide more understanding and 





More importantly, current estimates of short-term work compensation mechanisms within 
the UK are generally based on an elasticity value obtained from the Netherlands. The value 
of an appropriate elasticity value for UK and the existence of internal replacement 
mechanisms in firms remains unexplored. Data on unpaid labour were also excluded in the 
analyses presented here. It would be interesting to investigate how to measure unpaid 
productivity loss and incorporate costs of unpaid labour in economic analysis. 
 
In order to facilitate more applications of the friction cost approach in the UK, further 
developments in measuring relevant work absence data are encouraged in this area. For 
example, empirical research on data collection instruments with the best approach for 
measuring absenteeism and presenteeism data relevant for the friction cost approach is 
needed. As a starting framework for future research on this, exploration could include 
comparisons of questions asking respondents to recall self-reported specific sickness 
episodes with selecting a range of absence periods from a questionnaire. Similarly, 
questionnaire approaches could be compared against the more comprehensive diary 
approaches. However, as a start, the findings from this thesis provided some general 
guidance as to what data collection instruments need to include for accurate application of 





















The SIPQ tool provides an easy, less burdensome and less costly option of generating 
presenteeism estimates, than the more commonly applied complex and lengthy 
questionnaires. However, further research is encouraged to enable more definitive 
recommendations of such an approach. A cross validation study against standardised 
instruments is recommended as this would provide comparable data on productivity loss 
and costs estimates from these tools, and provide more credibility to estimates resulting 




Box 9.1 Common items needed for the friction cost approach 
 Individual spells of absenteeism and presenteeism  
 Start and end dates of each spell 
 Categorise absenteeism data into periods of absence shorter or 
longer than the friction period. 
 Incorporate additional questions where relevant to obtain 
information on work characteristics and compensation mechanisms 
 When calculating productivity costs, absences longer than the friction 
period should be considered as representative of the total 
productivity loss during that period. 
 Absences shorter than the friction period should be considered as 
representative of productivity loss subject to an elasticity factor 
(often a value of 0.8 is applied) 
 The friction period should incorporate time until vacancy, time to fill 





The comprehensive length of friction period estimates generated from this thesis are 
relevant to the economic evaluation framework in the UK as they provide practical data that 
can be used to apply the friction cost approach in a UK context. Further research should also 
be conducted to assess the relative impact of using these stratified friction period values on 
cost-effectiveness outcomes in other interventions and disease areas. 
 
On an empirical note, the results showing the validity and responsiveness of the SIPQ 
indicate important results in relation to measuring presenteeism. The results suggest that 
using a single-item question on assessing presenteeism in primary care may be a good 
alternative to the commonly used multi-item instruments among low back pain sufferers. 
The benefits of single-item questions have been discussed by researchers such as Bowling 
(2005) and Ahlstrom et al., (2010), particularly when there is less time, and where ease of 
interpretation, reducing responder burden and cost-effectiveness are important. 
 
The two cost-utility analyses from this research strengthen the case for stratified care 
analysis and sub grouping both from a healthcare and societal perspective as a contribution 
to policy making. Based on the findings here, stratified care should be recommended in a 
primary care setting and among high-risk patients within routine care. The two CEA studies 







Research on application of the friction cost approach in the UK is evolving, compared with 
the human capital method. There is merit for further insight and research on this topic 
because productivity costs need to be calculated as realistically as possible in order to guide 
decision makers in broader healthcare decision making. This thesis, has contributed 
methodological and empirical knowledge on estimation of productivity costs, particularly 
using the friction cost approach. This was done by providing first estimates of stratified 
friction periods by occupation for the UK, and cost-effectiveness analyses incorporating the 
relatively new concepts of presenteeism and multiplier effects alongside healthcare costs 
and absenteeism. The findings can guide future application of the friction cost approach in 
the UK. A simple and valid single-item presenteeism question that can be used across 
diverse occupations to generate cost data in economic evaluations is presented in this thesis. 
Further, the comparability study in Chapter Six shows self-reported data provides more 
complete time off work data for economic evaluation than sickness certification data. 
However, self-reported data can be further modified to ensure they capture specific work 
absence duration episodes when using the friction cost approach.  
 
In summary, the discussions provided in this thesis highlight a merit for further 
methodological and empirical research on the role of productivity costs within the United 
Kingdom and internationally. The findings in the thesis contribute to increased 
understanding about how the friction cost approach can be used to estimate productivity 
costs while stratifying segments of the labour market by occupation. In particular, it provides 
insight to how absenteeism, presenteeism and multiplier effects of team work can be 
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incorporated into cost-effectiveness analysis. A simple way to measure and value 
presenteeism in comparison to the existing lengthy and complex multi-item instruments is 
also presented. Added to this is the length of friction period estimates that can be used 
when applying the friction cost approach in economic evaluation within a UK context. A lack 
of data can limit application of these approaches in a UK context, as was observed in the 
research here.   
 
Overall, the research provided in this thesis contributes to methods for assessing 
productivity costs in economic evaluation, and illustrates the feasibility of using them in the 
UK. Given the significance of productivity costs, this thesis adopted an approach that further 
examined the effect of using more detailed friction periods (in line with the varying labour 
market situation) on overall cost-effectiveness outcomes, rather than a standard friction 
period as often reported in economic evaluation studies. Consequently, the thesis presents a 
more comprehensive and accurate estimation approach of cost-effectiveness outcomes of 
interventions in this clinical area, and therefore provides a starting point for further research 
and also for improving practice in the UK. Further testing of these approaches in other 
clinical areas is merited in the UK, considering the growing evidence and value for accurate 
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C.1.1 Healthcare resource use for the STarT Back Trial  
Cost components analysed in the economic evaluation of the STarT Back trial. Values 
are mean (sd) back pain-related resource, use and costs (£) per patient, by treatment 
group, for patients providing healthcare utilisation data at 12 months (n=567), unless 
stated otherwise. 
Resource use (units)  Cost (£) 
Resource/cost component  Intervention 




(n = 181) 
Study back pain clinic and physiotherapy  107·50 92·8 92·77 83·2 
  Primary care contacts:      
  General Practitioner  33·54 63·6 40·27 63·9 
  Practice Nurse  1·33 9·8 1·27 6·0 
  Hospital-based care:      
  NHS Consultant  25·15 86·5 27·63 79·7 
  Private Consultant  4·82 36·1 4·72 30·5 
  NHS x-ray  1·66 7·5 3·18 11·2 
  NHS CT scan  1·04 12·4 1·10 10·5 
  NHS MRI scan  12·06 48·5 14·83 53·0 
  NHS blood tests  0·27 2·1 0·48 3·8 
  NHS epidural injections  2·72 23·2 2·31 21·4 
  Private diagnostic tests (combined)  0·93 12·9 0·99 13·3 
  Private epidural injections  0·55 10·4 1·14 15·2 
Other healthcare professionals:      
  Additional (non-study) NHS physiotherapy  17·25 57·5 33·13 75·6 
  Private physiotherapy  1·86 17·2 6·42 35·5 
  NHS 'other'  1·45 17·0 3·53 26·8 
  Private 'other'  8·52 44·6 4·38 27·2 
  Out-of-pocket treatments      
  Non-opioid analgesics  1·23 4·7 1·14 3·9 
  Weak opioid analgesics  0·68 8·0 0·27 0·8 











C.1.2 Unit costs for the STarT Back Trial 
Details of the unit costs assigned to healthcare resource use data and periods of  work 
absence collected at 12-month follow-up 
Healthcare resource  Unit Cost (£)  
Study back pain clinic and physiotherapy:   
Initial clinic session (30 minutes)  21·50  
First post-clinic session: high risk 'intervention' group (1 hour)  43·00 
First post-clinic session: all other patients (45 minutes)  32·25 
Follow-up sessions: high risk intervention group (45 minutes)  32·25 
Follow-up sessions: all other patients (30 minutes)  21·50 
Primary care contacts:  
General Practitioner: surgery consultation  31·00 
General Practitioner: home visit  105·00 
Practice Nurse: surgery consultation  11·00 
Practice Nurse: home visit  20·00 
'Other' healthcare professional: surgery consultation  16·00 
Hospital-based care:  
Consultant: first attendance  124·00 
Consultant: follow-up  103·00 
Diagnostic tests: x-ray  31·99 
Diagnostic tests: CT scan  100·00 
Diagnostic tests: MRI scan  179·00 
Diagnostic tests: blood test  17·28 
Epidural injections  204·57 
Other healthcare professionals 
First consultation  38·00 
Follow-up consultation  27·00  
Out-of-pocket treatments  Patient reported costs  
Prescribed medication  Patient-specific 













C.2.1 Healthcare resource use for the IMPaCT Back study 
Back pain-related healthcare (£) per patient, by study phase, for participants providing responses to the 
resource use questions at 6 months (n=547). Values are mean (sd) costs unless stated otherwise. 
   
Cost (£) 
 
Healthcare resource Phase 1 
 
Phase 3 
   
(n = 233) 
 
(n = 314) 
 
Primary care contacts 
   
  
General Practitioner: surgery 36.8 53.5 32.38 50.1 
  
General Practitioner: home visit 0.45 6.9 2.04 20.5 
  
Practice Nurse: surgery 1.51 6.2 0.80 3.8 
  








NHS 33.15 60.8 45.09 77.2 
  








NHS Consultant 33.64 84.5 29.95 80.7 
  
NHS admissions 9.79 91.6 12.84 116.9 
  
NHS x-ray 4.39 12.9 3.97 11.0 
  
NHS CT scan 0.43 6.6 1.32 11.2 
  
NHS MRI scan 16.90 55.0 17.38 53.9 
  
NHS blood tests 0.30 2.2 0.06 1.0 
  
NHS epidural injections 3.51 26.6 2.09 19.9 
  
Private Consultant 15.54 71.5 9.25 55.2 
  
Private admissions 4.97 75.8 3.68 65.3 
  
Private diagnostic tests 3.07 23.3 3.80 25.4 
  
Private epidural injections 0.88 13.4 0.02 0.1 
 






NHS acupuncture 2.44 17.5 1.83 20.6 
  
NHS osteopathy 0.16 2.5 3.19 20.8 
  
NHS 'other' 8.52 46.7 4.96 33.9 
  
Private acupuncture 11.90 67.1 3.34 23.3 
  
Private osteopathy 11.08 37.0 9.02 38.7 
  








17.32 80.1 6.56 19.5 










C.2.2 Unit costs for the IMPaCT Back Trial 
 
Details of the unit costs assigned to healthcare resource use data and periods of work absence 
collected at 6 month follow-up 
 Healthcare resource Unit Cost (£) 
 
Primary care contacts: 
 
  
General Practitioner: surgery consultation 31.00 
  
General Practitioner: home visit 105.00 
  
Practice Nurse: surgery consultation 11.00 
  





Initial 45-minute assessment 32.25 
  
Initial 1-hour assessment (high risk, Phase 3 patients only) 43.00 
  





Consultant: back pain first attendance 124.00 
  
Consultant: back pain follow-up 103.00 
  
Consultant: 'other' first attendance 190.00 
  
Consultant: 'other' follow-up 130.00 
  
NHS admission: day case 562.00 
  
NHS admission: elective stay 1157.00 
  
Diagnostic tests: x-ray 31.99 
  
Diagnostic tests: CT scan 100 
  
Diagnostic tests: MRI scan 179 
  
Diagnostic tests: blood test 17.28 
  
Epidural injections 204.57 
 
Other healthcare professionals 
 
  
First consultation 38.00 
  
Follow-up consultation 29.00 
 
Out-of-pocket treatments Patient reported costs 
 
Prescribed medication Patient-specific 
 
Periods of work absence Patient-specific 
       
a
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